<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Vitamin D for the management of asthma - Williamson, A - 2023 | Cochrane Library</title> <meta content="Vitamin D for the management of asthma - Williamson, A - 2023 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011511.pub3/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Vitamin D for the management of asthma - Williamson, A - 2023 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011511.pub3/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD011511.pub3" name="dc.identifier" scheme="DOI"/> <meta content="Vitamin D for the management of asthma" name="citation_title"/> <meta content="Anne Williamson" name="citation_author"/> <meta content="Queen Mary University of London" name="citation_author_institution"/> <meta content="a.e.williamson@smd19.qmul.ac.uk" name="citation_author_email"/> <meta content="Adrian R Martineau" name="citation_author"/> <meta content="Barts and The London School of Medicine and Dentistry, Queen Mary University of London" name="citation_author_institution"/> <meta content="Aziz Sheikh" name="citation_author"/> <meta content="The University of Edinburgh" name="citation_author_institution"/> <meta content="David Jolliffe" name="citation_author"/> <meta content="Barts and The London School of Medicine and Dentistry, Queen Mary University of London" name="citation_author_institution"/> <meta content="Chris J Griffiths" name="citation_author"/> <meta content="Asthma UK Centre for Applied Research, Wolfson Institute of Population Health, Faculty of Medicine and Dentistry, Queen Mary University of London" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="2" name="citation_issue"/> <meta content="10.1002/14651858.CD011511.pub3" name="citation_doi"/> <meta content="2023" name="citation_date"/> <meta content="2023/02/06" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011511.pub3/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011511.pub3/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011511.pub3/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Adrenal Cortex Hormones [adverse effects]; *Anti-Asthmatic Agents [adverse effects]; *Asthma [drug therapy]; Calcifediol; Cholecalciferol; Disease Progression; Hypercalciuria; Randomized Controlled Trials as Topic; Vitamin D [adverse effects]; Vitamins [adverse effects]" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011511.pub3&amp;doi=10.1002/14651858.CD011511.pub3&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011511.pub3&amp;doi=10.1002/14651858.CD011511.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011511.pub3&amp;doi=10.1002/14651858.CD011511.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011511.pub3&amp;doi=10.1002/14651858.CD011511.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011511.pub3&amp;doi=10.1002/14651858.CD011511.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011511.pub3&amp;doi=10.1002/14651858.CD011511.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011511.pub3&amp;doi=10.1002/14651858.CD011511.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011511.pub3&amp;doi=10.1002/14651858.CD011511.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011511.pub3&amp;doi=10.1002/14651858.CD011511.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011511.pub3&amp;doi=10.1002/14651858.CD011511.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011511.pub3&amp;doi=10.1002/14651858.CD011511.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011511.pub3&amp;doi=10.1002/14651858.CD011511.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011511.pub3&amp;doi=10.1002/14651858.CD011511.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011511.pub3&amp;doi=10.1002/14651858.CD011511.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011511.pub3&amp;doi=10.1002/14651858.CD011511.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011511.pub3&amp;doi=10.1002/14651858.CD011511.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011511.pub3&amp;doi=10.1002/14651858.CD011511.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011511.pub3&amp;doi=10.1002/14651858.CD011511.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011511.pub3&amp;doi=10.1002/14651858.CD011511.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011511.pub3&amp;doi=10.1002/14651858.CD011511.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011511.pub3&amp;doi=10.1002/14651858.CD011511.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011511.pub3&amp;doi=10.1002/14651858.CD011511.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011511.pub3&amp;doi=10.1002/14651858.CD011511.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772874000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772901000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000"}};Liferay.authToken="STpJR8yz";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD011511\x2epub3\x26doi\x3d10\x2e1002\x2f14651858\x2eCD011511\x2epub3\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011511\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011511\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513679709000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","de","ru","ko","ms","fr","zh_HANS","zh_HANT","ja","fa","id","pl","ro"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD011511.pub3",title:"Vitamin D for the management of asthma",firstPublishedDate:"Feb 6, 2023 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Airways Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734064000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=STpJR8yz&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD011511.pub3&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD011511.pub3';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD011511.pub3/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD011511.pub3/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD011511.pub3%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD011511.pub3/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD011511.pub3/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD011511.pub3/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD011511.pub3/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD011511.PUB3" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;},{&quot;language&quot;:&quot;ko&quot;,&quot;title&quot;:&quot;초록&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;摘要&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;de&quot;,&quot;title&quot;:&quot;Zusammenfassung in einfacher Sprache&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;id&quot;,&quot;title&quot;:&quot;Saripati telaah sistematik&quot;},{&quot;language&quot;:&quot;ja&quot;,&quot;title&quot;:&quot;一般語訳&quot;},{&quot;language&quot;:&quot;ko&quot;,&quot;title&quot;:&quot;쉬운 말 요약&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;pl&quot;,&quot;title&quot;:&quot;Streszczenie prostym językiem&quot;},{&quot;language&quot;:&quot;ro&quot;,&quot;title&quot;:&quot;Sumar&quot;},{&quot;language&quot;:&quot;ru&quot;,&quot;title&quot;:&quot;Резюме на простом языке&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;简语概要&quot;},{&quot;language&quot;:&quot;zh_HANT&quot;,&quot;title&quot;:&quot;淺顯易懂的口語結論&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD011511.pub3/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD011511.PUB3" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD011511.pub3/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD011511.pub3/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>13702 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD011511.pub3" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011511.pub3/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011511.pub3/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011511.pub3/full#CD011511-abs-0002"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011511.pub3/full#CD011511-sec-0086"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011511.pub3/full#CD011511-sec-0008"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011511.pub3/full#CD011511-sec-0009"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011511.pub3/full#CD011511-sec-0014"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011511.pub3/full#CD011511-sec-0015"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011511.pub3/full#CD011511-sec-0040"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011511.pub3/full#CD011511-sec-0080"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD011511.pub3/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011511.pub3/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011511.pub3/appendices#CD011511-sec-0091"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011511.pub3/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011511.pub3/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD011511.pub3/media/CDSR/CD011511/supinfo/CD011511StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD011511.pub3/media/CDSR/CD011511/supinfo/CD011511StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011511.pub3/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011511.pub3/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011511.pub3/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD011511.pub3/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD011511.pub3/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD011511.pub3/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2023 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD011511.pub3/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> <div class="inline-status-wrapper"> <ul class="cochrane-status"> <li aria-label="A new search for studies has been conducted." class="status-item up-to-date custom-tooltip" data-status="newsearch" title="A new search for studies has been conducted."> <a class="btn secondary" href="information#history">New search</a> </li> <li aria-label="There has been an important change to the conclusions of the review." class="status-item up-to-date custom-tooltip" data-status="conclusionchanged" title="There has been an important change to the conclusions of the review."> <a class="btn secondary" href="information#history">Conclusions changed</a> </li> </ul> </div> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Vitamin D for the management of asthma</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011511.pub3/information#CD011511-cr-0004"><i class="icon corresponding-author fa fa-envelope"></i>Anne Williamson</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011511.pub3/information#CD011511-cr-0005">Adrian R Martineau</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011511.pub3/information#CD011511-cr-0006">Aziz Sheikh</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011511.pub3/information#CD011511-cr-0007">David Jolliffe</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011511.pub3/information#CD011511-cr-0008">Chris J Griffiths</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD011511.pub3/information/en#CD011511-sec-0105">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 06 February 2023 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD011511.pub3/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD011511.pub3">https://doi.org/10.1002/14651858.CD011511.pub3</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD011511-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD011511-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD011511-abs-0010">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD011511-abs-0016">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD011511-abs-0008">Français</a> </li> <li class="section-language"> <a class="" href="full/ko#CD011511-abs-0005">한국어</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD011511-abs-0012">简体中文</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD011511-abs-0001" lang="en"> <section id="CD011511-sec-0001"> <h3 class="title" id="CD011511-sec-0001">Background</h3> <p>Since the previous Cochrane Review on this topic in 2016, debate has continued surrounding a potential role for vitamin D in reducing risk of asthma exacerbation and improving asthma control. We therefore conducted an updated meta‐analysis to include data from new trials completed since this date. </p> </section> <section id="CD011511-sec-0002"> <h3 class="title" id="CD011511-sec-0002">Objectives</h3> <p>To evaluate the effectiveness and safety of administration of vitamin D or its hydroxylated metabolites in reducing the risk of severe asthma exacerbations (defined as those requiring treatment with systemic corticosteroids) and improving asthma symptom control. </p> </section> <section id="CD011511-sec-0003"> <h3 class="title" id="CD011511-sec-0003">Search methods</h3> <p>We searched the Cochrane Airways Group Trial Register and reference lists of articles. We contacted the authors of studies in order to identify additional trials. Date of last search: 8 September 2022. </p> </section> <section id="CD011511-sec-0004"> <h3 class="title" id="CD011511-sec-0004">Selection criteria</h3> <p>We included double‐blind, randomised, placebo‐controlled trials of vitamin D in children and adults with asthma evaluating exacerbation risk or asthma symptom control, or both. </p> </section> <section id="CD011511-sec-0005"> <h3 class="title" id="CD011511-sec-0005">Data collection and analysis</h3> <p>Four review authors independently applied study inclusion criteria, extracted the data, and assessed risk of bias. We obtained missing data from the authors where possible. We reported results with 95% confidence intervals (CIs). The primary outcome was the incidence of severe asthma exacerbations requiring treatment with systemic corticosteroids. Secondary outcomes included the incidence of asthma exacerbations precipitating an emergency department visit or requiring hospital admission, or both, end‐study childhood Asthma Control Test (cACT) or Asthma Control Test (ACT) scores, and end‐study % predicted forced expiratory volume in one second (FEV1). </p> <p>We performed subgroup analyses to determine whether the effect of vitamin D on risk of asthma exacerbation was modified by baseline vitamin D status, vitamin D dose, frequency of dosing regimen, form of vitamin D given, and age of participants. </p> </section> <section id="CD011511-sec-0006"> <h3 class="title" id="CD011511-sec-0006">Main results</h3> <p>We included 20 studies in this review; 15 trials involving a total of 1155 children and five trials involving a total of 1070 adults contributed data to analyses. Participant ages ranged from 1 to 84 years, with two trials providing data specific to participants under five years (n = 69) and eight trials providing data specific to participants aged 5 to 16 (n = 766). Across the trials, 1245 participants were male and 1229 were female, with two studies not reporting sex distribution. Fifteen trials contributed to the primary outcome analysis of exacerbations requiring systemic corticosteroids. The duration of trials ranged from three to 40 months; all but two investigated effects of administering cholecalciferol (vitamin D3). As in the previous Cochrane Review, the majority of participants had mild to moderate asthma, and profound vitamin D deficiency (25‐hydroxyvitamin D (25(OH)D) &lt; 25 nmol/L) at baseline was rare. </p> <p>Administration of vitamin D or its hydroxylated metabolites did not reduce or increase the proportion of participants experiencing one or more asthma exacerbations treated with systemic corticosteroids (odds ratio (OR) 1.04, 95% CI 0.81 to 1.34; I<sup>2</sup> = 0%; 14 studies, 1778 participants; high‐quality evidence). This equates to an absolute risk of 226 per 1000 (95% CI 185 to 273) in the pooled vitamin D group, compared to a baseline risk of 219 participants per 1000 in the pooled placebo group. </p> <p>We also found no effect of vitamin D supplementation on the rate of exacerbations requiring systemic corticosteroids (rate ratio 0.86, 95% CI 0.62 to 1.19; I<sup>2</sup> = 60%; 10 studies, 1599 participants; high‐quality evidence), or the time to first exacerbation (hazard ratio 0.82, 95% CI 0.59 to 1.15; I<sup>2</sup> = 22%; 3 studies, 850 participants; high‐quality evidence). Subgroup analysis did not reveal any evidence of effect modification by baseline vitamin D status, vitamin D dose, frequency of dosing regimen, or age. A single trial investigating administration of calcidiol reported a benefit of the intervention for the primary outcome of asthma control. </p> <p>Vitamin D supplementation did not influence any secondary efficacy outcome meta‐analysed, which were all based on moderate‐ or high‐quality evidence. We observed no effect on the incidence of serious adverse events (OR 0.89, 95% CI 0.56 to 1.41; I<sup>2</sup> = 0%; 12 studies, 1556 participants; high‐quality evidence). The effect of vitamin D on fatal asthma exacerbations was not estimable, as no such events occurred in any trial. Six studies reported adverse reactions potentially attributable to vitamin D. These occurred across treatment and control arms and included hypercalciuria, hypervitaminosis D, kidney stones, gastrointestinal symptoms and mild itch. In one trial, we could not ascertain the total number of participants with hypercalciuria from the trial report. </p> <p>We assessed three trials as being at high risk of bias in at least one domain; none of these contributed data to the analysis of the outcomes reported above. Sensitivity analyses that excluded these trials from each outcome to which they contributed did not change the null findings. </p> </section> <section id="CD011511-sec-0007"> <h3 class="title" id="CD011511-sec-0007">Authors' conclusions</h3> <p>In contrast to findings of our previous Cochrane Review on this topic, this updated review does not find evidence to support a role for vitamin D supplementation or its hydroxylated metabolites to reduce risk of asthma exacerbations or improve asthma control. Participants with severe asthma and those with baseline 25(OH)D concentrations &lt; 25 nmol/L were poorly represented, so further research is warranted here. A single study investigating effects of calcidiol yielded positive results, so further studies investigating effects of this metabolite are needed. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD011511-abs-0002" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD011511-abs-0002">English</a> </li> <li class="section-language"> <a class="" href="full/de#CD011511-abs-0003">Deutsch</a> </li> <li class="section-language"> <a class="" href="full/es#CD011511-abs-0011">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD011511-abs-0017">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD011511-abs-0009">Français</a> </li> <li class="section-language"> <a class="" href="full/id#CD011511-abs-0018">Bahasa Indonesia</a> </li> <li class="section-language"> <a class="" href="full/ja#CD011511-abs-0015">日本語</a> </li> <li class="section-language"> <a class="" href="full/ko#CD011511-abs-0006">한국어</a> </li> <li class="section-language"> <a class="" href="full/ms#CD011511-abs-0007">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/pl#CD011511-abs-0019">Polski</a> </li> <li class="section-language"> <a class="" href="full/ro#CD011511-abs-0020">Română</a> </li> <li class="section-language"> <a class="" href="full/ru#CD011511-abs-0004">Русский</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD011511-abs-0013">简体中文</a> </li> <li class="section-language"> <a class="" href="full/zh_HANT#CD011511-abs-0014">繁體中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD011511-abs-0002" lang="en"> <h3>Does vitamin D reduce risk of severe asthma attacks or improve control of asthma symptoms?</h3> <p><b>Key messages</b> </p> <p>1) In contrast to our previous Cochrane Review on this topic, this updated review does not find that vitamin D offers protection against severe asthma attacks or improves control of symptoms. </p> <p>2) Further trials are required in people with frequent severe asthma attacks and those with very low baseline vitamin D status, and into the potential for calcidiol (a particular form of vitamin D) to offer protective effects. </p> <p><b>Why did we think that vitamin D might benefit patients with asthma?</b> </p> <p>Low blood levels of vitamin D (the 'sunshine vitamin') have been linked to an increased risk of severe asthma attacks, defined as those requiring oral (systemic) steroid medications. </p> <p>Our previous Cochrane Review on this topic in 2016 found that vitamin D reduced the risk of asthma attacks, yet debate has continued, and some subsequent trials found vitamin D to have no effect. We therefore conducted an updated meta‐analysis to include data from new trials completed since our last review. </p> <p><b>What did we want to find out?</b> </p> <p>We wanted to find out if vitamin D supplementation:</p> <p>• reduces the risk of severe asthma attacks;</p> <p>• improves control of asthma symptoms;</p> <p>• leads to any negative side effects.</p> <p><b>What did we do?</b> </p> <p>We searched for randomised controlled trials that assessed the effect of vitamin D supplementation on the risk of severe asthma attacks and asthma symptom control. We compared and summarised the results of the studies and rated our confidence in the evidence, based on factors such as study methods. </p> <p>We also analysed whether effects of vitamin D supplementation differed according to baseline vitamin D status, the dose or form of supplements administered, how often people took the supplements, or the age of participants. </p> <p><b>What did we find?</b> </p> <p>We included data from 20 clinical trials in this review that involved a total of 2225 people; nine of these were included in the previous Cochrane Review on the topic and 11 were published since then. Of the 20 studies, 15 reported data on severe asthma attacks. The trials lasted between three and 40 months, and all but two investigated a particular form of vitamin D called cholecalciferol or vitamin D3. This is the most common form of vitamin D tablet. </p> <p>• People given vitamin D supplements did not have a lower risk of severe asthma attacks compared to those given placebo (dummy medication). </p> <p>• Vitamin D supplementation did not influence measurements of asthma control or breathing capacity; neither did it affect risk of serious harmful side effects. </p> <p><b>What are the limitations of the evidence?</b> </p> <p>• People with severe asthma and those with very low vitamin D levels prior to supplementation were poorly represented, so we cannot assess whether vitamin D supplements might help these individuals. </p> <p>• A single study investigating effects of calcidiol, an alternative form of vitamin D, showed a protective effect. Further investigation of this form of vitamin D is needed. </p> <p><b>How up to date is this evidence?</b> </p> <p>This review updates our previous review. The evidence is up to date to September 2022.</p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD011511-sec-0086" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD011511-sec-0086"></div> <h3 class="title" id="CD011511-sec-0087">Implications for practice</h3> <section id="CD011511-sec-0087"> <p>This systematic review does not find evidence to support a role for vitamin D supplementation to reduce risk of asthma exacerbations or improve asthma control. The null findings of this review are based on the largest pool of evidence analysed to date, and are consistent for primary and secondary outcomes. We deemed this evidence to be high quality for the primary outcome of reductions in asthma exacerbations requiring systemic corticosteroids, and also for several of the secondary outcomes. Nonetheless, participants with severe asthma and those with baseline 25‐hydroxyvitamin D (25(OH)D) concentrations &lt; 25 nmol/L were poorly represented, and a protective effect of the intervention cannot be excluded in these groups. A single study investigating effects of calcidiol yielded positive results; further studies investigating effects of this metabolite are needed. </p> </section> <h3 class="title" id="CD011511-sec-0088">Implications for research</h3> <section id="CD011511-sec-0088"> <p>Further research is required to clarify potential effects of calcidiol on risk of asthma exacerbation, and to determine whether vitamin D supplementation may yet have an effect in people with severe asthma or those with the lowest levels of baseline vitamin D (25(OH)D &lt; 25 nmol/L), in whom a significant protective effect cannot currently be excluded. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD011511-sec-0008" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD011511-sec-0008"></div> <div class="table" id="CD011511-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Summary of findings table ‐ Vitamin D compared to placebo for the management of asthma</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Vitamin D compared to placebo for the management of asthma</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> children and adults with predominantly mild to moderate asthma<br/><b>Setting:</b> primary and secondary care<br/><b>Intervention:</b> vitamin D<br/><b>Comparison:</b> placebo </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with placebo</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with vitamin D</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Proportion of participants with one or more exacerbations treated with systemic corticosteroids<br/>follow‐up: range 3 months to 40 months </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>219 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>226 per 1000</b><br/>(185 to 273) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>OR 1.04</b><br/>(0.81 to 1.34) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1778<br/>(14 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊕<br/>High<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Proportion of participants with one or more exacerbations requiring emergency department visit or hospitalisation, or both </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>79 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>46 per 1000</b><br/>(22 to 94) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>OR 0.56</b><br/>(0.26 to 1.21) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1070<br/>(9 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/>Moderate<sup>b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>End‐study asthma control test score<br/>assessed with: childhood Asthma Control Test, or linearly transformed Asthma Control Test<br/>Scale from: 0 to 27 </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean end‐study asthma control test score was <b>22.98</b> points </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD <b>0.23 points higher</b><br/>(0.26 lower to 0.73 higher) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1271<br/>(7 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/>Moderate<sup>c</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>End‐study forced expiratory volume in 1 second, % predicted</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean end‐study forced expiratory volume in 1 second, % predicted was <b>93.80</b> % </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD <b>0.2 % higher</b><br/>(1.24 lower to 1.63 higher) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1286<br/>(11 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊕<br/>High </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Proportion of participants with one or more serious adverse events due to any cause</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>55 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>49 per 1000</b><br/>(32 to 76) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>OR 0.89</b><br/>(0.56 to 1.41) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1556<br/>(12 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊕<br/>High </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Proportion of participants with fatal asthma exacerbation</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>0 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>0 per 1000</b><br/>(0 to 0) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1976<br/>(16 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>Low<sup>d</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Withdrawals from trial</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>86 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>90 per 1000</b><br/>(68 to 119) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>OR 1.05</b><br/>(0.77 to 1.43) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2225<br/>(20 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊕<br/>High </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><br/><b>CI:</b> confidence interval; <b>MD:</b> mean difference; <b>OR:</b> odds ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>See interactive version of this table: <a href="https://gdt.gradepro.org/presentations/#/isof/isof_question_revman_web_436923543367697621" target="_blank">https://gdt.gradepro.org/presentations/#/isof/isof_question_revman_web_436923543367697621</a>. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup> Each of these GRADE assessments is discussed in full under Quality of the evidence.<br/><sup>b</sup> Downgraded one level due to imprecision, as 95% CI ranged from 0.26 to 1.21 and evidence drew on fewer studies than the primary outcome<br/><sup>c</sup> Downgraded one level due to heterogeneity, as I² = 29%<br/><sup>d</sup> Downgraded two levels due to imprecision, as no events occurred in either arm of any trial considered </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD011511-sec-0009" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD011511-sec-0009"></div> <section id="CD011511-sec-0010"> <h3 class="title" id="CD011511-sec-0010">Description of the condition</h3> <p>Asthma is a chronic inflammatory condition of the airways, characterised by recurrent attacks of breathlessness, wheezing, cough, and chest tightness, commonly termed exacerbations. The prevalence of asthma varies widely between countries, ranging from 2.20% (China) to 12.1% (Tonga) (<a href="./references#CD011511-bbs2-0112" title="Soriano JB , Kendrick PJ , Paulson KR , Gupta V , Abrams EM , Adedoyin RA, et al. Prevalence and attributable health burden of chronic respiratory diseases, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Respiratory Medicine2020;8:585–96. [DOI: 10.1016/S2213-2600(20)30105-3]">Soriano 2020</a>). It can be diagnosed by respiratory pulmonary function testing showing reversible airway obstruction, including spirometry with bronchodilator reversibility or diurnal peak flow variation. Raised fractional exhaled nitric oxide levels can also be used to inform asthma diagnosis (<a href="./references#CD011511-bbs2-0104" title="ReddelHK , TaylorDR , BatemanED , BouletLP , BousheyHA , BusseWW , et al. An official American Thoracic Society/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice. American Journal of Respiratory and Critical Care Medicine2009;180(1):59-99.">Reddel 2009</a>). Exacerbations represent the major cause of morbidity and mortality in people with asthma (<a href="./references#CD011511-bbs2-0070" title="BriggsA , NasserS , HammerbyE , BuchsS , VirchowJC . The impact of moderate and severe asthma exacerbations on quality of life: a post hoc analysis of randomised controlled trial data. Journal of Patient-Reported Outcomes2021;5(1):6. [DOI: 10.1186/s41687-020-00274-x]">Briggs 2021</a>; <a href="./references#CD011511-bbs2-0087" title="JohnstonNW , SearsMR . Asthma exacerbations 1: epidemiology. Thorax2006;61(8):722-8.">Johnston 2006</a>). Asthma exacerbations are commonly classified as severe when they require treatment with systemic corticosteroids or when they result in emergency department attendance, hospitalisation, or death (<a href="./references#CD011511-bbs2-0104" title="ReddelHK , TaylorDR , BatemanED , BouletLP , BousheyHA , BusseWW , et al. An official American Thoracic Society/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice. American Journal of Respiratory and Critical Care Medicine2009;180(1):59-99.">Reddel 2009</a>). Severity of exacerbations may also be classified by patient symptoms, or by peak expiratory flow relative to patient baseline. Common precipitants of asthma exacerbation include acute respiratory infections and exposure to allergens and particulates (<a href="./references#CD011511-bbs2-0111" title="SinghAM , BusseWW . Asthma exacerbations 2: aetiology. Thorax2006;61(9):809-16.">Singh 2006</a>). Beyond exacerbations, asthma may also affect patient quality of life through ongoing symptoms such as breathlessness, functional impairment, financial burden of treatment, and emotional impacts (<a href="./references#CD011511-bbs2-0104" title="ReddelHK , TaylorDR , BatemanED , BouletLP , BousheyHA , BusseWW , et al. An official American Thoracic Society/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice. American Journal of Respiratory and Critical Care Medicine2009;180(1):59-99.">Reddel 2009</a>). </p> </section> <section id="CD011511-sec-0011"> <h3 class="title" id="CD011511-sec-0011">Description of the intervention</h3> <p>Vitamin D is a fat‐soluble micronutrient that has two parent forms: cholecalciferol (vitamin D<sub>3</sub>) and ergocalciferol (vitamin D<sub>2</sub>). Cholecalciferol is synthesised in human skin from its precursor molecule 7‐dehydrocholesterol on exposure to ultraviolet B (UVB) radiation in sunlight; it may also be ingested, either in the diet (primarily from eating oily fish or vitamin D‐fortified foods) or as vitamin D supplements. Ergocalciferol is the plant and fungal form of the vitamin, which may be ingested in the diet (primarily by eating fungi) or as vitamin D supplements. In situations where cutaneous exposure to UVB radiation of appropriate intensity is limited (for example, during winter at latitudes above 34ºN or below 34ºS, or in settings where people do not regularly expose their skin to sunlight), dietary sources of vitamin D or vitamin D supplements may be required to meet the body’s vitamin D requirement (<a href="./references#CD011511-bbs2-0084" title="HolickMF . Vitamin D deficiency. New England Journal of Medicine2007;357(3):266-81.">Holick 2007</a>). </p> <p>Following cutaneous synthesis or ingestion, both forms of parent vitamin D undergo metabolism to form 25‐hydroxyvitamin D (25(OH)D), the major circulating vitamin D metabolite whose serum concentration indicates vitamin D status. 25‐hydroxylation may occur in the liver and in extra‐hepatic tissues, including leucocytes (<a href="./references#CD011511-bbs2-0084" title="HolickMF . Vitamin D deficiency. New England Journal of Medicine2007;357(3):266-81.">Holick 2007</a>). Serum 25(OH)D concentrations less than 50 nmol/L are widely accepted to indicate vitamin D deficiency; concentrations less than 25 nmol/L represent profound deficiency. Concentrations of 50 nmol/L to 74 nmol/L may represent a milder state of inadequate vitamin D status, commonly termed ‘vitamin D insufficiency’ (<a href="./references#CD011511-bbs2-0084" title="HolickMF . Vitamin D deficiency. New England Journal of Medicine2007;357(3):266-81.">Holick 2007</a>). 25(OH)D undergoes a second hydroxylation step at the 1‐alpha position to form 1,25‐dihydroxyvitamin D (1,25(OH)<sub>2</sub>D), the steroid hormone and active vitamin D metabolite that mediates the biological actions of vitamin D by binding the vitamin D receptor to regulate gene expression (<a href="./references#CD011511-bbs2-0084" title="HolickMF . Vitamin D deficiency. New England Journal of Medicine2007;357(3):266-81.">Holick 2007</a>). This 1‐alpha hydroxylation step is catalysed by the enzyme CYP27B1, which is expressed in many tissues including the kidney, leucocytes, and pulmonary epithelium; expression of CYP27B1 in leucocytes and pulmonary epithelium is up‐regulated in response to infection and inflammation (<a href="./references#CD011511-bbs2-0078" title="GreillerCL , MartineauAR . Modulation of the immune response to respiratory viruses by vitamin D. Nutrients2015;7(6):4240-70.">Greiller 2015</a>). </p> <p>This review included randomised controlled trials evaluating the effects of administration of vitamin D<sub>3</sub>, vitamin D<sub>2</sub>, 25(OH)D, or 1,25(OH)<sub>2</sub>D, by any route and at any dose. Vitamin D<sub>3</sub>, vitamin D<sub>2,</sub> and 25(OH)D are usually administered orally; the ‘parent compounds’ vitamin D<sub>3</sub> and vitamin D<sub>2</sub> may also be given intramuscularly. Intramuscular administration of a bolus dose of vitamin D induces a slower increase and a lower peak in serum 25(OH)D than oral administration of the same dose (<a href="./references#CD011511-bbs2-0107" title="RomagnoliE , MasciaML , CiprianiC , FassinoV , MazzeiF , D'ErasmoE , et al. Short and long-term variations in serum calciotropic hormones after a single very large dose of ergocalciferol (vitamin D2) or cholecalciferol (vitamin D3) in the elderly. Journal of Clinical Endocrinology and Metabolism2008;93(8):3015-20.">Romagnoli 2008</a>); consequently, this route of administration is not widely employed in clinical trials of vitamin D. The functional in vivo half‐life of 25(OH)D in the circulation is one to two months; accordingly, it takes at least three months to attain steady‐state concentrations of 25(OH)D in response to daily administration of vitamin D (<a href="./references#CD011511-bbs2-0081" title="HeaneyRP , DaviesKM , ChenTC , HolickMF , Barger-LuxMJ . Human serum 25-hydroxycholecalciferol response to extended oral dosing with cholecalciferol. American Journal of Clinical Nutrition2003;77:204-10.">Heaney 2003</a>). Due to the relatively long half‐life of 25(OH)D, parent vitamin D and 25(OH)D may be administered intermittently as well as daily; weekly and monthly dosing regimens are often employed, and more widely spaced dosing regimens are also sometimes used. However, intermittent bolus dosing may result in large non‐physiological fluctuations in serum 25(OH)D concentration, which may cause undesirable effects including increased risk of recurrent pneumonia, falls and fractures (<a href="./references#CD011511-bbs2-0085" title="HollisBW , WagnerCL . The role of the parent compound vitamin D with respect to metabolism and function: why clinical dose intervals can affect clinical outcomes. Journal of Clinical Endocrinology and Metabolism2013;98(12):4619-28.">Hollis 2013</a>; <a href="./references#CD011511-bbs2-0098" title="MartineauAR . Bolus-dose vitamin D and prevention of childhood pneumonia. Lancet2012;379(9824):1373-5.">Martineau 2012</a>; <a href="./references#CD011511-bbs2-0108" title="SandersKM , StuartAL , WilliamsonEJ , SimpsonJA , KotowiczMA , YoungD , et al. Annual high-dose oral vitamin D and falls and fractures in older women: a randomized controlled trial. JAMA2010;303(18):1815-22. [DOI: 10.1001/jama.2010.594]">Sanders 2010</a>; <a href="./references#CD011511-bbs2-0113" title="ViethR . How to optimize vitamin D supplementation to prevent cancer, based on cellular adaptation and hydroxylase enzymology. Anticancer Research2009;29(9):3675-84.">Vieth 2009</a>). </p> </section> <section id="CD011511-sec-0012"> <h3 class="title" id="CD011511-sec-0012">How the intervention might work</h3> <p>About one billion people worldwide are estimated to have 25(OH)D levels of less than 75 nmol/L (<a href="./references#CD011511-bbs2-0084" title="HolickMF . Vitamin D deficiency. New England Journal of Medicine2007;357(3):266-81.">Holick 2007</a>). Inadequate vitamin D status has been reported to be common among people with asthma in a variety of settings. Cross‐sectional (<a href="./references#CD011511-bbs2-0069" title="BrehmJM , Acosta-PerezE , KleiL , RoederK , BarmadaM , BoutaouiN , et al. Vitamin D insufficiency and severe asthma exacerbations in Puerto Rican children. American Journal of Respiratory and Critical Care Medicine2012;186(2):140-6.">Brehm 2012</a>; <a href="./references#CD011511-bbs2-0110" title="ShahinM , El-lawahA , AminA , El-TawilI . Study of serum vitamin D level in adult patients with bronchial asthma. Egyptian Journal of Chest Diseases and Tuberculosis2017;66(1):5-9. [DOI: 10.1016/j.ejcdt.2016.11.005]">Shahin 2017</a>) and cohort (<a href="./references#CD011511-bbs2-0068" title="BrehmJM , SchuemannB , FuhlbriggeAL , HollisBW , StrunkRC , ZeigerRS , et al. Serum vitamin D levels and severe asthma exacerbations in the Childhood Asthma Management Program study. Journal of Allergy and Clinical Immunology2010;126(1):52-8 e5.">Brehm 2010</a>; <a href="./references#CD011511-bbs2-0072" title="Confino-CohenR , BrufmanI , GoldbergA , FeldmanBS . Vitamin D, asthma prevalence and asthma exacerbations: a large adult population-based study. Allergy2014;69(12):1673-80.">Confino‐Cohen 2014</a>) studies have demonstrated independent associations between inadequate vitamin D status and increased risk of exacerbations. Administration of vitamin D<sub>3</sub>, vitamin D<sub>2</sub>, or 25(OH)D results in increased circulating concentrations of 25(OH)D. This 25(OH)D acts as a substrate for CYP27B1 expressed in the kidney and multiple extra‐renal tissues. Of particular relevance for asthma, CYP27B1 expression in the airway and leucocytes is induced during infection and inflammation, so that the active vitamin D metabolite 1,25(OH)<sub>2</sub>D is synthesised locally in the lung. 1,25(OH)<sub>2</sub>D ligates the vitamin D receptor (VDR) to induce antimicrobial activity, (for example, by induction of antimicrobial peptide expression) (<a href="./references#CD011511-bbs2-0078" title="GreillerCL , MartineauAR . Modulation of the immune response to respiratory viruses by vitamin D. Nutrients2015;7(6):4240-70.">Greiller 2015</a>; <a href="./references#CD011511-bbs2-0097" title="MartineauAR , WilkinsonKA , NewtonSM , FlotoRA , NormanAW , SkolimowskaK , et al. IFN-gamma- and TNF-independent vitamin D-inducible human suppression of mycobacteria: the role of cathelicidin LL-37. Journal of Immunology2007;178(11):7190-8.">Martineau 2007</a>), and exert anti‐inflammatory activity (for example by induction of the anti‐inflammatory cytokine IL‐10, suppression of pro‐inflammatory tumour necrosis factor and interferon‐γ inducible chemokines, and inhibition of lipopolysaccharide‐induced synthesis of reactive oxygen species) (<a href="./references#CD011511-bbs2-0073" title="CoussensAK , WilkinsonRJ , HanifaY , NikolayevskyyV , ElkingtonPT , IslamK , et al. Vitamin D accelerates resolution of inflammatory responses during tuberculosis treatment. Proceedings of the National Academy of Sciences2012;109(38):15449-54.">Coussens 2012</a>; <a href="./references#CD011511-bbs2-0093" title="LanN , LuoG , YangX , ChengY , ZhangY , WangX , et al. 25-hydroxyvitamin d3-deficiency enhances oxidative stress and corticosteroid resistance in severe asthma exacerbation. PLoS ONE2014;9(11):e111599.">Lan 2014</a>; <a href="./references#CD011511-bbs2-0096" title="MannEH , ChambersES , PfefferPE , HawrylowiczCM . Immunoregulatory mechanisms of vitamin D relevant to respiratory health and asthma. Annals of the New York Academy of Sciences2014;1317:57-69.">Mann 2014</a>). This combination of antimicrobial, antiviral, and anti‐inflammatory activity might decrease the risk of exacerbations, which are often precipitated by respiratory infection and which are characterised by dysregulated pulmonary inflammation. Of particular relevance to asthma, 1,25(OH)<sub>2</sub>D has been shown to inhibit TH17 cytokine production and enhance responsiveness to inhaled corticosteroids for production of interleukin‐10 ex vivo in people with asthma (<a href="./references#CD011511-bbs2-0043" title="ChambersES , NanzerAM , PfefferPE , RichardsDF , MartineauAR , GriffithsCJ , et al. Calcitriol restores glucocorticoid responsiveness in steroid resistant asthmatics through reduction of IL-17A. Immunology2014;143:50. ChambersES , NanzerAM , PfefferPE , RichardsDF , TimmsPM , MartineauAR , et al. Distinct endotypes of steroid-resistant asthma characterized by IL-17A (high) and IFN-gamma (high) immunophenotypes: Potential benefits of calcitriol. Journal of Allergy and Clinical Immunology2015;136(3):628-37. ChambersES , NanzerAM , RichardsDF , FreemanA , RyannaK , GriffithsC , et al. Serum 25(OH)D levels can predict Foxp3+ treg frequency and steroid responsiveness in severe asthmatics. Immunology2011;135:S1. NanzerAM , ChambersES , RyannaK , FreemanAT , ColliganG , RichardsDF , et al. The effects of calcitriol treatment in glucocorticoid-resistant asthma. Journal of Allergy and Clinical Immunology2014;133(6):1755-7. ">Nanzer 2014</a>; <a href="./references#CD011511-bbs2-0115" title="XystrakisE , KusumakarS , BoswellS , PeekE , UrryZ , RichardsDF , et al. Reversing the defective induction of IL-10-secreting regulatory T cells in glucocorticoid-resistant asthma patients. Journal of Clinical Investigation2006;116(1):146-55.">Xystrakis 2006</a>). These findings raise the possibility that administration of vitamin D or its hydroxylated metabolites may have a role in reducing exacerbation risk and improving symptom control in combination with inhaled corticosteroids, as well as independently. However, controversy exists regarding what dose of vitamin D, if any, is optimal for reducing the risk of asthma exacerbations, and whether benefits of supplementation are restricted to those with baseline vitamin D deficiency. </p> </section> <section id="CD011511-sec-0013"> <h3 class="title" id="CD011511-sec-0013">Why it is important to do this review</h3> <p>There is considerable interest in the therapeutic potential of vitamin D in asthma to improve symptom control and reduce exacerbation risk. Our 2016 Cochrane Review on this topic found that vitamin D offers protection against severe asthma attacks in adults with mild to moderate asthma (<a href="./references#CD011511-bbs2-0117" title="MartineauAR , CatesCJ , UrashimaM , JensenM , GriffithsAP , NurmatovU , et al. Vitamin D for the management of asthma. Cochrane Database of Systematic Reviews2016, Issue 9. Art. No: CD011511. [DOI: 10.1002/14651858.CD011511.pub2]">Martineau 2016</a>), defined as requiring Global Initiative for Asthma (GINA) step 4 treatment or below (<a href="./references#CD011511-bbs2-0076" title="Global Initiative for Asthma. 2022 GINA Report, Global Strategy for Asthma Management and Prevention. ginasthma.org/gina-reports/ (accessed prior to 27 July 2022).">GINA 2022</a>). However, it identified several research gaps, identifying a need for further trials focusing on children, those with profoundly deficient baseline vitamin D status (&lt; 25 nmol/L), and those experiencing frequent severe exacerbations. Debate regarding a potential therapeutic role for vitamin D in asthma has continued due to inconsistency of outcomes of randomised controlled trials conducted since January 2016 (the end‐date of our literature search for the previous review). We therefore conducted an updated meta‐analysis to include data from these new trials (<a href="./references#CD011511-bbs2-0001" title="AglipayM , BirkenC , DaiD , ParkinP , MaguireJ . 70 high dose vitamin D for the prevention of wheezing in preschoolers: a secondary analysis of a randomized clinical trial. Paediatrics and Child Health2019;24(S2):e27-8. [DOI: 10.1093/pch/pxz066.069]AglipayM , BirkenCS , ParkinPC , LoebMB , ThorpeK , ChenY , et al. TARGet Kids! Collaboration. Effect of high-dose vs standard-dose wintertime vitamin D supplementation on viral upper respiratory tract infections in young healthy children. JAMA2017;318(3):245-54. [DOI: 10.1001/jama.2017.8708.]">Aglipay 2019</a>; <a href="./references#CD011511-bbs2-0002" title="Andújar-EspinosaR , Aparicio-VicenteM , Ruiz-LópezFJ , Salinero-GonzálezL . Influence of vitamin D supplementation on the quality of life of asthma patients: Findings from ACVID randomised clinical trial. Respiratory Medicine2021;185:106484. [DOI: 10.1016/j.rmed.2021.106484]Andújar-EspinosaR , Salinero-GonzálezL , Illán-GómezF , Castilla-MartínezM , Hu-YangC , Ruiz-LópezFJ . Effect of vitamin D supplementation on asthma control in patients with vitamin D deficiency: the ACVID randomised clinical trial. Thorax2021;76(2):126–33. [DOI: 10.1136/thoraxjnl-2019-213936]">Andújar‐Espinosa 2021</a>; <a href="./references#CD011511-bbs2-0003" title="CamargoC , ToopL , SluyterJ , LawesCM , WaayerD , KhawKT , et al. Effect of monthly vitamin D supplementation on preventing exacerbations of asthma or chronic obstructive pulmonary disease in older adults: post hoc analysis of a randomized controlled trial. Nutrients2021;13:521. [DOI: 10.3390/nu13020521]SluyterJ , CamargoCA , WaayerD , LawesCM , ToopL , KhawKT , et al. Effect of monthly, high-dose, long-term vitamin D on lung function: a randomized controlled trial. Nutrients2017;9:1353. [DOI: 10.3390/nu9121353]">Camargo 2021</a>; <a href="./references#CD011511-bbs2-0005" title="DucharmeFM , JensenM , MailhotG , AlosN , WhiteJ , RousseauE , et al. Impact of two oral doses of 100,000 IU of vitamin D3 in preschoolers with viral induced asthma: a pilot randomised controlled trial. Trials2019;20(1):138. [DOI: 10.1186/s13063-019-3184-z]">Ducharme 2019</a>; <a href="./references#CD011511-bbs2-0006" title="FornoE , BacharierLB , PhipatanakulW , GuilbertTW , CabanaMD , RossK , et al. Effect of vitamin D3 supplementation on severe asthma exacerbations in children with asthma and low vitamin D levels: The VDKA Randomized Clinical Trial. JAMA2020;324(8):752-60. HanYY , FornoE , BacharierLB , PhipatanakulW , GuilbertTW , CabanaMD , et al. Vitamin D supplementation, lung function and asthma control in children with asthma and low vitamin D levels. European Respiratory Journal2021;58(4):2100989. [DOI: 10.1183/13993003.00989-2021]N/a. Errors in flow diagram. JAMA2021;326(1):90. [DOI: 10.1001/jama.2021.9465.]RosserFJ , HanYY , FornoE , BacharierLB , PhipatanakulW , GuilbertTW , et al. Effect of vitamin D supplementation on total andallergen-specific IgE in children with asthma andlow vitamin D levels. Journal of Allergy and Clinical Immunology2021;149(1):440-4.E2. [PMID: 10.1016/j.jaci.2021.05.037]">Forno 2020</a>; <a href="./references#CD011511-bbs2-0007" title="JatKR , GoelN , GuptaN , ChandraPG , SudipD , RakeshL , et al. Efficacy of vitamin D supplementation in asthmatic childrenwith vitamin D deficiency: a randomized controlled trial(ESDAC trial). Pediatric Allergy and Immunology2021;32(3):479– 88. [DOI: 10.1111/pai.13415]">Jat 2020</a>; <a href="./references#CD011511-bbs2-0009" title="JerzynskaJ , StelmachW , RychlikB , LechańskaJ , PodleckaD , StelmachI . The clinical effect of vitamin D supplementation combined with grass-specific sublingual immunotherapy in children with allergic rhinitis. Allergy and Asthma Proceedings2016;37(2):105-14. [DOI: 10.2500/aap.2016.37.3921]">Jerzynska 2016</a>; <a href="./references#CD011511-bbs2-0010" title="JiangC , YiR , NaH , LinS . A randomized controlled study of Vitamin D3 supplementation on childhood asthma control. Chongqing Medicine2017;46(32):4505-7. [DOI: 10.3969/j.issn.1671-8348.2017.32.011]">Jiang 2017</a>; <a href="./references#CD011511-bbs2-0011" title="KerleyCP , HutchinsonK , CormicanL , FaulJ , GreallyP , CoghlanD , et al. Vitamin D3 for uncontrolled childhood asthma: A pilot study. Paediatric Allergy and Immunology2016;27:404-12. [PMID: 10.1111/pai.12547]">Kerley 2016</a>; <a href="./references#CD011511-bbs2-0016" title="Ramos-MartínezE , López-VancellMR , Fernández de Córdova-AguirreJC , Rojas-SerranoJ , ChavarríaA , Velasco-MedinaA , et al. Reduction of respiratory infections in asthma patients supplemented with vitamin D is related to increased serum IL-10 and IFNγ levels and cathelicidin expression. Cytokine2018;108:239–46. ">Ramos‐Martínez 2018</a>; <a href="./references#CD011511-bbs2-0018" title="ThakurC , KumarJ , KumarP , GoyalJP , SinghK , GuptaA . Vitamin‐D supplementation as an adjunct to standard treatmentof asthma in children: a randomized controlled trial (ViDASTA Trial). Pediatric Pulmonology2021;56:1427–33. [DOI: 10.1002/ppul.25287]">Thakur 2021</a>). </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD011511-sec-0014" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD011511-sec-0014"></div> <p>To evaluate the effectiveness and safety of administration of vitamin D or its hydroxylated metabolites in reducing the risk of severe asthma exacerbations (defined as those requiring treatment with systemic corticosteroids) and improving asthma symptom control. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD011511-sec-0015" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD011511-sec-0015"></div> <section id="CD011511-sec-0016"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD011511-sec-0017"> <h4 class="title">Types of studies</h4> <p>We reviewed double‐blind, randomised, placebo‐controlled trials of at least 12 weeks’ duration as per the previous Cochrane Review on this topic. We included studies reported as full text and unpublished data. Where eligible studies were published as abstracts only, we contacted the authors to request the full text of the trial report; where the full text was unavailable, we listed such studies as 'ongoing'. </p> </section> <section id="CD011511-sec-0018"> <h4 class="title">Types of participants</h4> <p>We included children and adults with a clinical diagnosis of asthma, based on the presence of characteristic symptoms and signs (i.e. wheeze, shortness of breath, chest tightness, or cough), variable airflow obstruction, or both. We imposed no restrictions regarding disease severity, baseline vitamin D status, or duration of treatment with asthma medication. </p> </section> <section id="CD011511-sec-0019"> <h4 class="title">Types of interventions</h4> <p>The review was open to studies in which vitamin D<sub>3</sub>, vitamin D<sub>2</sub>, 25(OH)D or 1,25(OH)<sub>2</sub>D were administered at any dose. </p> </section> <section id="CD011511-sec-0020"> <h4 class="title">Types of outcome measures</h4> <section id="CD011511-sec-0021"> <h5 class="title">Primary outcomes</h5> <p> <ol id="CD011511-list-0001"> <li> <p>Incidence of severe asthma exacerbations, defined as those requiring treatment with systemic corticosteroids </p> </li> </ol> </p> </section> <section id="CD011511-sec-0022"> <h5 class="title">Secondary outcomes</h5> <p> <ol id="CD011511-list-0002"> <li> <p>Incidence of asthma exacerbations precipitating an emergency department visit or requiring hospital admission, or both </p> </li> <li> <p>End‐study Childhood Asthma Control Test (cACT) or Asthma Control Test (ACT) score</p> </li> <li> <p>End‐study % predicted forced expiratory volume in one second (FEV1)</p> </li> <li> <p>Incidence of any severe adverse event, any cause</p> </li> <li> <p>Incidence of adverse reactions attributed to administration of vitamin D or its metabolites</p> </li> <li> <p>Incidence of fatal asthma exacerbation</p> </li> <li> <p>Incidence of asthma exacerbation as defined in the study protocol</p> </li> <li> <p>End‐study % lower airway eosinophils</p> </li> <li> <p>End‐study log10 total IgE, IU/ml</p> </li> <li> <p>End‐study % predicted forced vital capacity (FVC)</p> </li> <li> <p>End‐study peak expiratory flow rate (PEFR)</p> </li> <li> <p>Proportion of participants withdrawing from the trial</p> </li> </ol> </p> <p>We integrated cACT and ACT scores into a single composite scale to allow for comparison, following the standardised linear transformation outlined in <a href="./references#CD011511-bbs2-0079" title="HanYY , FornoE , BacharierL , PhipatanakulW , GuilbertTW , CabanaMD , et al. Vitamin D supplementation, lung function, and asthma control in children with asthma and low vitamin D levels. European Respiratory Journal2021;58(4):2100989. [DOI: 10.1183/13993003.00989-2021]">Han 2021</a>: ACT’ = c*(ACT‐a)/(b‐a) where a denotes the ACT minimum score; b denotes the ACT maximum score; and c denotes the cACT maximum score. </p> <p>We would have meta‐analysed the following secondary outcomes had sufficient data been available. </p> <p> <ol id="CD011511-list-0003"> <li> <p>Time off school or work due to asthma symptoms</p> </li> <li> <p>Beta2‐agonist inhaler use</p> </li> <li> <p>End‐study asthma quality of life as judged by use of a validated instrument</p> </li> <li> <p>End‐study fractional exhaled nitric oxide (FeNO) concentration</p> </li> <li> <p>End‐study airway reactivity (PC20)</p> </li> <li> <p>Costs from the perspective of healthcare providers</p> </li> </ol> </p> <p>Results for these outcomes are instead presented in narrative form where data are available. </p> </section> </section> </section> <section id="CD011511-sec-0023"> <h3 class="title">Search methods for identification of studies</h3> <section id="CD011511-sec-0024"> <h4 class="title">Electronic searches</h4> <p>We identified trials from the Cochrane Airways Group's Specialised Register (CAGR), which is maintained by the information specialist for the Group. The Register contains trial reports identified through systematic searches of bibliographic databases including the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE, Embase, Cumulative Index to Nursing and Allied Health Literature (CINAHL), Allied and Complementary Medicine (AMED), and PsycINFO, and hand‐searching of respiratory journals and meeting abstracts (please see <a href="./appendices#CD011511-sec-0092">Appendix 1</a> for further details). We searched all records in the CAGR using the search strategy in <a href="./appendices#CD011511-sec-0098">Appendix 2</a>. </p> <p>We also conducted searches of ClinicalTrials.gov (<a href="http://www.ClinicalTrials.gov" target="_blank">www.ClinicalTrials.gov</a>) the World Health Organization trials portal (<a href="http://www.who.int/ictrp/en/" target="_blank">www.who.int/ictrp/en/</a>), the ISRCTN registry (<a href="http://www.isrctn.com/" target="_blank">www.isrctn.com/</a>), the Australian New Zealand Clinical Trials Registry (<a href="http://www.anzctr.org.au/" target="_blank">www.anzctr.org.au/</a>), and the UMIN Clinical Trials Registry (<a href="http://www.umin.ac.jp/ctr/" target="_blank">www.umin.ac.jp/ctr/</a>). We searched all databases from their inception to 8 September 2022, and imposed no restriction on language of publication. </p> </section> <section id="CD011511-sec-0025"> <h4 class="title">Searching other resources</h4> <p>We checked reference lists of all primary studies and review articles for additional references. We searched relevant manufacturers' websites for trial information. </p> <p>We searched for errata or retractions from included studies published in full text on PubMed (<a href="http://www.ncbi.nlm.nih.gov/pubmed" target="_blank">www.ncbi.nlm.nih.gov/pubmed</a>) at the time of our final database search on 8 September 2022. We included these alongside the relevant trials. </p> <p>We also contacted a panel of international experts for information on trials in progress.</p> </section> </section> <section id="CD011511-sec-0026"> <h3 class="title" id="CD011511-sec-0026">Data collection and analysis</h3> <section id="CD011511-sec-0027"> <h4 class="title">Selection of studies</h4> <p>Four review authors assessed eligibility. Anne Williamson (AW) and Adrian R Martineau (ARM) independently screened the titles and abstracts of all the potentially relevant new studies identified by the search, coding them as 'retrieve' (eligible or potentially eligible/unclear) or 'do not retrieve'. We then retrieved the full‐text study reports/publication, and two people (AW and ARM) independently screened the full text, identifying studies for inclusion and identifying and recording reasons for exclusion of the ineligible studies. Any disagreements were resolved through discussion, or by consultation with other members of the review team (Christopher J Griffiths (CJG) and Aziz Sheikh (AS)), or both. Three review authors (AW, AS, CJG) assessed eligibility of one new study co‐authored by ARM (<a href="./references#CD011511-bbs2-0003" title="CamargoC , ToopL , SluyterJ , LawesCM , WaayerD , KhawKT , et al. Effect of monthly vitamin D supplementation on preventing exacerbations of asthma or chronic obstructive pulmonary disease in older adults: post hoc analysis of a randomized controlled trial. Nutrients2021;13:521. [DOI: 10.3390/nu13020521]SluyterJ , CamargoCA , WaayerD , LawesCM , ToopL , KhawKT , et al. Effect of monthly, high-dose, long-term vitamin D on lung function: a randomized controlled trial. Nutrients2017;9:1353. [DOI: 10.3390/nu9121353]">Camargo 2021</a>). We identified and excluded duplicates and collated multiple reports of the same study so that each study, rather than each report, was the unit of interest in the review. We recorded the selection process in sufficient detail to complete a PRISMA flow diagram and 'Characteristics of excluded studies' table (<a href="./references#CD011511-bbs2-0101" title="MoherD , LiberatiA , TetzlaffJ , AltmanDG . Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Medicine2009;6(7):e1000097. [DOI: 10.1371/journal.pmed.1000097]">Moher 2009</a>). The eligibility of studies included in the previous review was not re‐assessed, with all studies previously assessed as eligible being included in this current review. </p> </section> <section id="CD011511-sec-0028"> <h4 class="title">Data extraction and management</h4> <p>We used the same data collection form for study characteristics and outcome data as for our previous review (<a href="./references#CD011511-bbs2-0117" title="MartineauAR , CatesCJ , UrashimaM , JensenM , GriffithsAP , NurmatovU , et al. Vitamin D for the management of asthma. Cochrane Database of Systematic Reviews2016, Issue 9. Art. No: CD011511. [DOI: 10.1002/14651858.CD011511.pub2]">Martineau 2016</a>). Two review authors (AW, ARM, and/or DJ) extracted study characteristics from each included study. We extracted the following study characteristics. </p> <p> <ol id="CD011511-list-0004"> <li> <p>Methods: study design, total duration of study, details of any 'run‐in' period, number of study centres and location, study setting, withdrawals, and date of study. </p> </li> <li> <p>Participants: number, mean age, age range, sex, body mass index, severity of condition, diagnostic criteria, baseline lung function, smoking history, inclusion criteria, and exclusion criteria. </p> </li> <li> <p>Interventions: intervention, comparison, concomitant medications, and excluded medications.</p> </li> <li> <p>Outcomes: primary and secondary outcomes specified and collected, and time points reported. </p> </li> <li> <p>Notes: funding for trial, and notable conflicts of interest of trial authors.</p> </li> </ol> </p> <p>Two review authors (AW and ARM) independently extracted outcome data from each newly included study, except for the new study co‐authored by ARM (<a href="./references#CD011511-bbs2-0003" title="CamargoC , ToopL , SluyterJ , LawesCM , WaayerD , KhawKT , et al. Effect of monthly vitamin D supplementation on preventing exacerbations of asthma or chronic obstructive pulmonary disease in older adults: post hoc analysis of a randomized controlled trial. Nutrients2021;13:521. [DOI: 10.3390/nu13020521]SluyterJ , CamargoCA , WaayerD , LawesCM , ToopL , KhawKT , et al. Effect of monthly, high-dose, long-term vitamin D on lung function: a randomized controlled trial. Nutrients2017;9:1353. [DOI: 10.3390/nu9121353]">Camargo 2021</a>), for which AW and CJG extracted data. If studies did not report outcome data in a usable way, we noted this in the 'Characteristics of included studies' table. We resolved disagreements by consensus or by involving a third person (CJG or AS). One review author (AW) transferred data into the <a href="./references#CD011511-bbs2-0105" title="Review Manager Web (RevMan Web). Version 4.12.0. The Cochrane Collaboration, 2020. Available at revman.cochrane.org.">RevMan 2020</a> file. We double‐checked that data were entered correctly by comparing the data presented in the systematic review with the study reports. </p> </section> <section id="CD011511-sec-0029"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>Two review authors (ARM and AW) independently assessed the risk of bias for each newly included study using the criteria outlined in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD011511-bbs2-0082" title="HigginsJP , AltmanDG , SterneJA , editor(s). Chapter 8: Assessing risk of bias in included studies. In: Higgins JP, Churchill R, Chandler J, Cumpston MS, editor(s), Cochrane Handbook for Systematic Reviews of Interventions version 5.2.0 (updated June 2017), Cochrane, 2017. Available from training.cochrane.org/handbook/PDF/v5.2/.">Higgins 2017</a>). We resolved any disagreements by discussion or by involving another review author (CJG, AS, or DJ). AW and CJG performed the risk of bias assessment for the study co‐authored by ARM (<a href="./references#CD011511-bbs2-0003" title="CamargoC , ToopL , SluyterJ , LawesCM , WaayerD , KhawKT , et al. Effect of monthly vitamin D supplementation on preventing exacerbations of asthma or chronic obstructive pulmonary disease in older adults: post hoc analysis of a randomized controlled trial. Nutrients2021;13:521. [DOI: 10.3390/nu13020521]SluyterJ , CamargoCA , WaayerD , LawesCM , ToopL , KhawKT , et al. Effect of monthly, high-dose, long-term vitamin D on lung function: a randomized controlled trial. Nutrients2017;9:1353. [DOI: 10.3390/nu9121353]">Camargo 2021</a>). We assessed the risk of bias according to the following domains. </p> <p> <ol id="CD011511-list-0005"> <li> <p>Random sequence generation</p> </li> <li> <p>Allocation concealment</p> </li> <li> <p>Blinding of participants and personnel</p> </li> <li> <p>Blinding of outcome assessment</p> </li> <li> <p>Incomplete outcome data</p> </li> <li> <p>Selective outcome reporting</p> </li> <li> <p>Other biases, including study size.</p> </li> </ol> </p> <p>We graded each potential source of bias as high, low, or unclear and provide a quote from the study report together with a justification for our judgement in the risk of bias table. We summarised the risk of bias judgements across different studies for each of the domains listed. Where information on risk of bias related to unpublished data or correspondence with a trialist, we noted this in the risk of bias table. When considering treatment effects, we took into account the risk of bias for the studies contributing to that outcome. </p> </section> <section id="CD011511-sec-0030"> <h4 class="title">Assessment of bias in conducting the systematic review</h4> <p>We conducted the review according to a published protocol (<a href="./references#CD011511-bbs2-0100" title="MartineauA , WilliamsonA , SheikhA , GriffithsCJ . Intervention protocol: vitamin D for the management of asthma (2021). figshare.com/articles/journal_contribution/Intervention_Protocol_Vitamin_D_for_the_management_of_asthma_2021_/16926430. [DOI: 10.6084/m9.figshare.16926430.v1]">Martineau 2021</a>), and have reported any deviations from it in the <a href="#CD011511-sec-0109">Differences between protocol and review</a> section. </p> </section> <section id="CD011511-sec-0031"> <h4 class="title">Measures of treatment effect</h4> <p>We analysed dichotomous data as odds ratios (OR), event rates as rate ratios (RR), and times to first event as hazard ratios (HR). We took RRs directly from the trial results, where reported; otherwise, we calculated ratios from the published number of events and participant years of follow‐up as per Section 9.4.8 of the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD011511-bbs2-0083" title="HigginsJP , ThomasJ , ChandlerJ , CumpstonM , LiT , PageMJ , WelchVA , editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.3 (updated February 2022). Cochrane, 2022. Available from training.cochrane.org/handbook.">Higgins 2022</a>). This was required for four studies: <a href="./references#CD011511-bbs2-0002" title="Andújar-EspinosaR , Aparicio-VicenteM , Ruiz-LópezFJ , Salinero-GonzálezL . Influence of vitamin D supplementation on the quality of life of asthma patients: Findings from ACVID randomised clinical trial. Respiratory Medicine2021;185:106484. [DOI: 10.1016/j.rmed.2021.106484]Andújar-EspinosaR , Salinero-GonzálezL , Illán-GómezF , Castilla-MartínezM , Hu-YangC , Ruiz-LópezFJ . Effect of vitamin D supplementation on asthma control in patients with vitamin D deficiency: the ACVID randomised clinical trial. Thorax2021;76(2):126–33. [DOI: 10.1136/thoraxjnl-2019-213936]">Andújar‐Espinosa 2021</a>; <a href="./references#CD011511-bbs2-0007" title="JatKR , GoelN , GuptaN , ChandraPG , SudipD , RakeshL , et al. Efficacy of vitamin D supplementation in asthmatic childrenwith vitamin D deficiency: a randomized controlled trial(ESDAC trial). Pediatric Allergy and Immunology2021;32(3):479– 88. [DOI: 10.1111/pai.13415]">Jat 2020</a>; <a href="./references#CD011511-bbs2-0008" title="JensenM , MailhotG , AlosN , RousseauE , WhiteJ , KhamessanA , et al. Vitamin D intervention in preschoolers with viral-induced asthma (DIVA): a pilot randomised controlled trial. American Journal of Respiratory and Critical Care Medicine2015;191:A3360. JensenME , MailhotG , AlosN , RousseauE , WhiteJ , KhamessanA , et al. Vitamin D intervention in preschoolers with viral-induced asthma (DIVA): a pilot randomised controlled trial. Trials2016;17:353. [DOI: 10.1186/s13063-016-1483-1]">Jensen 2016</a>; <a href="./references#CD011511-bbs2-0018" title="ThakurC , KumarJ , KumarP , GoyalJP , SinghK , GuptaA . Vitamin‐D supplementation as an adjunct to standard treatmentof asthma in children: a randomized controlled trial (ViDASTA Trial). Pediatric Pulmonology2021;56:1427–33. [DOI: 10.1002/ppul.25287]">Thakur 2021</a>. We analysed other continuous outcome measures as mean difference (MD) or standardised mean difference (SMD). Where results were presented as a median and interquartile range (IQR) with symmetrical data (<a href="./references#CD011511-bbs2-0007" title="JatKR , GoelN , GuptaN , ChandraPG , SudipD , RakeshL , et al. Efficacy of vitamin D supplementation in asthmatic childrenwith vitamin D deficiency: a randomized controlled trial(ESDAC trial). Pediatric Allergy and Immunology2021;32(3):479– 88. [DOI: 10.1111/pai.13415]">Jat 2020</a>), we converted this to mean and standard deviation (SD) following Section 7.7.3.5 of the <i>Cochrane Handbook</i> (<a href="./references#CD011511-bbs2-0083" title="HigginsJP , ThomasJ , ChandlerJ , CumpstonM , LiT , PageMJ , WelchVA , editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.3 (updated February 2022). Cochrane, 2022. Available from training.cochrane.org/handbook.">Higgins 2022</a>). We used generic inverse variance meta‐analysis where adjusted measures of treatment effect from individual trials were included. We entered data presented as a scale with a consistent direction of effect. For analyses of outcomes in which no events occurred in some studies, we also calculated risk differences (RD). </p> </section> <section id="CD011511-sec-0032"> <h4 class="title">Unit of analysis issues</h4> <p>Where multiple trial arms were reported in a single trial, for instance people with asthma versus people with chronic obstructive pulmonary disease (COPD), we included only the relevant arms (<a href="./references#CD011511-bbs2-0001" title="AglipayM , BirkenC , DaiD , ParkinP , MaguireJ . 70 high dose vitamin D for the prevention of wheezing in preschoolers: a secondary analysis of a randomized clinical trial. Paediatrics and Child Health2019;24(S2):e27-8. [DOI: 10.1093/pch/pxz066.069]AglipayM , BirkenCS , ParkinPC , LoebMB , ThorpeK , ChenY , et al. TARGet Kids! Collaboration. Effect of high-dose vs standard-dose wintertime vitamin D supplementation on viral upper respiratory tract infections in young healthy children. JAMA2017;318(3):245-54. [DOI: 10.1001/jama.2017.8708.]">Aglipay 2019</a>; <a href="./references#CD011511-bbs2-0003" title="CamargoC , ToopL , SluyterJ , LawesCM , WaayerD , KhawKT , et al. Effect of monthly vitamin D supplementation on preventing exacerbations of asthma or chronic obstructive pulmonary disease in older adults: post hoc analysis of a randomized controlled trial. Nutrients2021;13:521. [DOI: 10.3390/nu13020521]SluyterJ , CamargoCA , WaayerD , LawesCM , ToopL , KhawKT , et al. Effect of monthly, high-dose, long-term vitamin D on lung function: a randomized controlled trial. Nutrients2017;9:1353. [DOI: 10.3390/nu9121353]">Camargo 2021</a>; <a href="./references#CD011511-bbs2-0009" title="JerzynskaJ , StelmachW , RychlikB , LechańskaJ , PodleckaD , StelmachI . The clinical effect of vitamin D supplementation combined with grass-specific sublingual immunotherapy in children with allergic rhinitis. Allergy and Asthma Proceedings2016;37(2):105-14. [DOI: 10.2500/aap.2016.37.3921]">Jerzynska 2016</a>). If two comparisons (for example drug A versus placebo and drug B versus placebo) had been combined in the same meta‐analysis, we would have halved the control group to avoid double‐counting. </p> <p>For outcomes measured at different time points, we included the longest time point after randomisation. </p> <p>If data had been expressed in unconventional units of analysis, we would have converted them to conventional units, liaising with the authors if required. </p> </section> <section id="CD011511-sec-0033"> <h4 class="title">Dealing with missing data</h4> <p>We contacted investigators to verify key study characteristics and to obtain missing numerical outcome data where possible. We asked all investigators to provide data relating to exacerbations requiring treatment with systemic corticosteroids or emergency department attendance/hospitalisation, or both, where these were not reported in the manuscript or abstract. </p> </section> <section id="CD011511-sec-0034"> <h4 class="title">Assessment of heterogeneity</h4> <p>We used the I<sup>2</sup> statistic to measure heterogeneity and inconsistency among the trials in each analysis, following the <i>Cochrane Handbook</i>, Section 10.10.2 (<a href="./references#CD011511-bbs2-0083" title="HigginsJP , ThomasJ , ChandlerJ , CumpstonM , LiT , PageMJ , WelchVA , editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.3 (updated February 2022). Cochrane, 2022. Available from training.cochrane.org/handbook.">Higgins 2022</a>). </p> </section> <section id="CD011511-sec-0035"> <h4 class="title">Assessment of reporting biases</h4> <p>We created and examined funnel plots for outcomes with more than 10 trials to explore possible small study biases. </p> </section> <section id="CD011511-sec-0036"> <h4 class="title">Data synthesis</h4> <p>We used a random‐effects model for the primary analysis and performed sensitivity analyses using fixed‐effect models for the primary outcome. We analysed all data by intention‐to‐treat where possible. We synthesised dichotomous data as ORs, event rates as RRs and times to first event as HRs. We synthesised other continuous outcome measures as MD or SMD. We would have calculated the number needed to treat for an additional beneficial outcome (NNTB) using the Visual Rx NNT calculator if meta‐analysis of dichotomous outcomes had revealed a beneficial effect of allocation to vitamin D (<a href="http://www.nntonline.net/visualrx/" target="_blank">www.nntonline.net/visualrx/</a>). We would have similarly calculated the number needed to treat for an additional harmful outcome (NNTH) if meta‐analysis of dichotomous outcomes had revealed a harmful effect of vitamin D. </p> </section> <section id="CD011511-sec-0037"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>We carried out the following prespecified subgroup analysis for the outcome of asthma exacerbation treated with systemic corticosteroids. </p> <p> <ol id="CD011511-list-0006"> <li> <p>Baseline vitamin D status (serum 25(OH)D &lt; 25 nmol/L versus 25 to 49.9 nmol/L versus 50 to 74.9 nmol/L versus ≥ 75 nmol/L). </p> </li> <li> <p>The dose (daily equivalent of &lt; 2000 IU versus &gt; 2000 IU) and form of vitamin D administered (cholecalciferol versus calcidiol versus calcitriol). </p> </li> <li> <p>The frequency of administration (daily versus intermittent bolus doses).</p> </li> <li> <p>The mean age of participants in the trial (&lt; 5 years versus 5 to 16 years versus &gt; 16 years). </p> </li> </ol> </p> <p>Studies administering an initial bolus dose followed by subsequent daily doses were included in the daily dosing subgroup (<a href="./references#CD011511-bbs2-0004" title="CastroM , KingTS , KunselmanSJ , CabanaMD , DenlingerL , HolguinF , et al. Effect of vitamin D3 on asthma treatment failures in adults with symptomatic asthma and lower vitamin D levels: the VIDA randomized clinical trial. JAMA2014;311(20):2083-91. DenlingerLC , KingTS , CardetJC , CraigT , HolguinF , JacksonDJ , et al. Vitamin D supplementation and the risk of colds in patients with asthma. American Journal of Respiratory and Critical Care Medicine2016;193(6):634–41. DenlingerLC , KingTS , CardetJC , CraigTJ , HolguinF , KraftM , et al. Vitamin D supplementation and the risk of colds in patients with asthma. Journal of Allergy and Clinical Immunology2015;135:AB109. JiaoJ , KingTS , McKenzieM , BacharierLB , DixonAE , CodispotiCD , et al. Effects of vitamin D3 supplementation in adults with asthma complicated by sinonasal disease. American Journal of Respiratory and Critical Care Medicine2015;191:A4148. JiaoJ , KingTS , McKenzieM , BacharierLB , DixonAE , CodispotiCD , et al. Vitamin D3 therapy in patients with asthma complicated by sinonasal disease: secondary analysis of the Vitamin D Add-on Therapy Enhances Corticosteroid Responsiveness in Asthma trial. Journal of Allergy and Clinical Immunology2016;138(2):589-92. MooreWC , KingTS , BleeckerER , MeyersDA , PetersSP , WenzelSE . Sarp clinical clusters predict steroid responsiveness and risk of asthma exacerbations in the asthma net vida (vitamin D in asthma) trial. American Journal of Respiratory and Critical Care Medicine2015;191:A6055. ReidB , GirodetP , BoomerJS , Abdel-GadirA , ZhengK , WechslerME , et al. Vitamin D3 treatment of vitamin D insufficient asthmatics does not alter immune cell function. Journal of Allergy and Clinical Immunology2016;138(1):286-9. ">Castro 2014</a>; <a href="./references#CD011511-bbs2-0008" title="JensenM , MailhotG , AlosN , RousseauE , WhiteJ , KhamessanA , et al. Vitamin D intervention in preschoolers with viral-induced asthma (DIVA): a pilot randomised controlled trial. American Journal of Respiratory and Critical Care Medicine2015;191:A3360. JensenME , MailhotG , AlosN , RousseauE , WhiteJ , KhamessanA , et al. Vitamin D intervention in preschoolers with viral-induced asthma (DIVA): a pilot randomised controlled trial. Trials2016;17:353. [DOI: 10.1186/s13063-016-1483-1]">Jensen 2016</a>). Where studies reported data on participants which did not wholly fit into a prespecified age category, we included the results in the subgroup appropriate for median participant age (<a href="./references#CD011511-bbs2-0007" title="JatKR , GoelN , GuptaN , ChandraPG , SudipD , RakeshL , et al. Efficacy of vitamin D supplementation in asthmatic childrenwith vitamin D deficiency: a randomized controlled trial(ESDAC trial). Pediatric Allergy and Immunology2021;32(3):479– 88. [DOI: 10.1111/pai.13415]">Jat 2020</a>; <a href="./references#CD011511-bbs2-0014" title="MajakP , Olszowiec-ChlebnaM , SmejdaK , StelmachI . Vitamin D supplementation in children may prevent asthma exacerbation triggered by acute respiratory infection. Journal of Allergy and Clinical Immunology2011;127(5):1294-6. ">Majak 2011</a>). </p> <p>We formally assessed for heterogeneity across subgroups using the <a href="./references#CD011511-bbs2-0067" title="BorensteinM , HigginsJP . Meta-analysis and subgroups. Prevention Science2013;14:134–43. [DOI: 10.1007/s11121-013-0377-7]">Borenstein 2013</a> test in <a href="./references#CD011511-bbs2-0105" title="Review Manager Web (RevMan Web). Version 4.12.0. The Cochrane Collaboration, 2020. Available at revman.cochrane.org.">RevMan 2020</a>. If this had suggested significant differences in effect size between subgroups including more than one study, we would have conducted a multivariable meta‐regression analysis. </p> <p>We prespecified that we would also carry out the following subgroup analyses for the outcome of asthma exacerbation treated with systemic corticosteroids. </p> <p> <ol id="CD011511-list-0007"> <li> <p>Further subgroups for daily dose equivalent (&lt; 400 IU versus 400 to 2000 IU).</p> </li> <li> <p>Severity of asthma and concomitant asthma treatment being taken (e.g. taking versus not taking inhaled corticosteroids, taking versus not taking leukotriene receptor antagonists). </p> </li> <li> <p>Genetic variation in pathways of vitamin D metabolism, transport, and signalling (e.g. GC 2/2 versus 2/1 versus 1/1 genotype for the GC polymorphism of the vitamin D binding protein). </p> </li> <li> <p>Body mass index (e.g. &lt; 25 kg/m<sup>2</sup> versus ≥ 25 kg/m<sup>2</sup>). </p> </li> </ol> </p> <p>However, limitations of the available data (for example, where data for participants within different subgroups could not be disaggregated, or where numbers of participants or events or both within a subgroup were small) precluded the conduct of such subgroup analyses. </p> </section> <section id="CD011511-sec-0038"> <h4 class="title">Sensitivity analysis</h4> <p>We carried out the following sensitivity analyses.</p> <p> <ol id="CD011511-list-0008"> <li> <p>Exclusion of data from publications assessed as being at high risk of bias in one or more of the following domains: sequence generation, allocation concealment, blinding, completeness of outcome data, or selective outcome reporting. </p> </li> <li> <p>Analysis of our primary outcome using fixed‐effect models rather than random‐effects models. </p> </li> </ol> </p> </section> <section id="CD011511-sec-0039"> <h4 class="title">Summary of findings and assessment of the certainty of the evidence</h4> <p>We created a summary of findings table presenting all primary and secondary outcomes that were meta‐analysed. We used the five GRADE considerations (study limitations, consistency of effect, imprecision, indirectness, and publication bias) to assess the quality of the body of evidence as it related to the studies that contributed data to the meta‐analyses for the prespecified outcomes. </p> <p>Where data from primary studies conducted by review authors contributed to a given outcome, the quality of the evidence was assessed by review authors who were not involved with those primary studies (AW and CJG). We used methods and recommendations described in Section 8.5 and Chapter 12 of the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD011511-bbs2-0083" title="HigginsJP , ThomasJ , ChandlerJ , CumpstonM , LiT , PageMJ , WelchVA , editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.3 (updated February 2022). Cochrane, 2022. Available from training.cochrane.org/handbook.">Higgins 2022</a>), using <a href="./references#CD011511-bbs2-0077" title="GRADEpro GDT. Version accessed prior to 28 July 2022. Hamilton (ON): McMaster University (developed by Evidence Prime). Available at gradepro.org.">GRADEpro GDT </a>software. We justified all decisions to downgrade or upgrade the quality of studies using footnotes where necessary. </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD011511-sec-0040" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD011511-sec-0040"></div> <section id="CD011511-sec-0041"> <h3 class="title">Description of studies</h3> <section id="CD011511-sec-0042"> <h4 class="title">Results of the search</h4> <p>We identified a total of 1055 new references by searching the Cochrane Airways Group Register and clinical trial registries, and in consultation with international experts. The most recent search was run on 8 September 2022. After removing 478 duplicate references (459 by automated screening and 19 manually), we screened 382 references to 321 different studies for eligibility. We excluded 290 studies on the basis of their titles or abstracts or both. We assessed the remaining 32 studies for eligibility by consulting the full text of associated references or contacting study authors, or both. We then excluded 13 further studies which did not meet eligibility criteria for inclusion, and classified eight newly identified studies as ongoing. This resulted in 11 new included studies, in addition to the nine studies analysed in the previous Cochrane Review on this topic. Thus, we included 20 studies in the final analysis (<a href="#CD011511-fig-0001">Figure 1</a>). We have presented the reasons for excluding potentially relevant studies in the <a href="./references#CD011511-sec-0112" title="">Characteristics of excluded studies</a> table. </p> <div class="figure" id="CD011511-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="original image" data-id="CD011511-fig-0001" src="/cdsr/doi/10.1002/14651858.CD011511.pub3/media/CDSR/CD011511/image_n/nCD011511-FIG-01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"></div> </div> </section> <section id="CD011511-sec-0043"> <h4 class="title">Included studies</h4> <p>See <a href="./references#CD011511-sec-0111" title="">Characteristics of included studies</a> for full details. Twenty studies including a total of 2225 participants with asthma met the inclusion criteria for this review (<a href="./references#CD011511-bbs2-0001" title="AglipayM , BirkenC , DaiD , ParkinP , MaguireJ . 70 high dose vitamin D for the prevention of wheezing in preschoolers: a secondary analysis of a randomized clinical trial. Paediatrics and Child Health2019;24(S2):e27-8. [DOI: 10.1093/pch/pxz066.069]AglipayM , BirkenCS , ParkinPC , LoebMB , ThorpeK , ChenY , et al. TARGet Kids! Collaboration. Effect of high-dose vs standard-dose wintertime vitamin D supplementation on viral upper respiratory tract infections in young healthy children. JAMA2017;318(3):245-54. [DOI: 10.1001/jama.2017.8708.]">Aglipay 2019</a>; <a href="./references#CD011511-bbs2-0002" title="Andújar-EspinosaR , Aparicio-VicenteM , Ruiz-LópezFJ , Salinero-GonzálezL . Influence of vitamin D supplementation on the quality of life of asthma patients: Findings from ACVID randomised clinical trial. Respiratory Medicine2021;185:106484. [DOI: 10.1016/j.rmed.2021.106484]Andújar-EspinosaR , Salinero-GonzálezL , Illán-GómezF , Castilla-MartínezM , Hu-YangC , Ruiz-LópezFJ . Effect of vitamin D supplementation on asthma control in patients with vitamin D deficiency: the ACVID randomised clinical trial. Thorax2021;76(2):126–33. [DOI: 10.1136/thoraxjnl-2019-213936]">Andújar‐Espinosa 2021</a>; <a href="./references#CD011511-bbs2-0003" title="CamargoC , ToopL , SluyterJ , LawesCM , WaayerD , KhawKT , et al. Effect of monthly vitamin D supplementation on preventing exacerbations of asthma or chronic obstructive pulmonary disease in older adults: post hoc analysis of a randomized controlled trial. Nutrients2021;13:521. [DOI: 10.3390/nu13020521]SluyterJ , CamargoCA , WaayerD , LawesCM , ToopL , KhawKT , et al. Effect of monthly, high-dose, long-term vitamin D on lung function: a randomized controlled trial. Nutrients2017;9:1353. [DOI: 10.3390/nu9121353]">Camargo 2021</a>; <a href="./references#CD011511-bbs2-0004" title="CastroM , KingTS , KunselmanSJ , CabanaMD , DenlingerL , HolguinF , et al. Effect of vitamin D3 on asthma treatment failures in adults with symptomatic asthma and lower vitamin D levels: the VIDA randomized clinical trial. JAMA2014;311(20):2083-91. DenlingerLC , KingTS , CardetJC , CraigT , HolguinF , JacksonDJ , et al. Vitamin D supplementation and the risk of colds in patients with asthma. American Journal of Respiratory and Critical Care Medicine2016;193(6):634–41. DenlingerLC , KingTS , CardetJC , CraigTJ , HolguinF , KraftM , et al. Vitamin D supplementation and the risk of colds in patients with asthma. Journal of Allergy and Clinical Immunology2015;135:AB109. JiaoJ , KingTS , McKenzieM , BacharierLB , DixonAE , CodispotiCD , et al. Effects of vitamin D3 supplementation in adults with asthma complicated by sinonasal disease. American Journal of Respiratory and Critical Care Medicine2015;191:A4148. JiaoJ , KingTS , McKenzieM , BacharierLB , DixonAE , CodispotiCD , et al. Vitamin D3 therapy in patients with asthma complicated by sinonasal disease: secondary analysis of the Vitamin D Add-on Therapy Enhances Corticosteroid Responsiveness in Asthma trial. Journal of Allergy and Clinical Immunology2016;138(2):589-92. MooreWC , KingTS , BleeckerER , MeyersDA , PetersSP , WenzelSE . Sarp clinical clusters predict steroid responsiveness and risk of asthma exacerbations in the asthma net vida (vitamin D in asthma) trial. American Journal of Respiratory and Critical Care Medicine2015;191:A6055. ReidB , GirodetP , BoomerJS , Abdel-GadirA , ZhengK , WechslerME , et al. Vitamin D3 treatment of vitamin D insufficient asthmatics does not alter immune cell function. Journal of Allergy and Clinical Immunology2016;138(1):286-9. ">Castro 2014</a>; <a href="./references#CD011511-bbs2-0005" title="DucharmeFM , JensenM , MailhotG , AlosN , WhiteJ , RousseauE , et al. Impact of two oral doses of 100,000 IU of vitamin D3 in preschoolers with viral induced asthma: a pilot randomised controlled trial. Trials2019;20(1):138. [DOI: 10.1186/s13063-019-3184-z]">Ducharme 2019</a>; <a href="./references#CD011511-bbs2-0006" title="FornoE , BacharierLB , PhipatanakulW , GuilbertTW , CabanaMD , RossK , et al. Effect of vitamin D3 supplementation on severe asthma exacerbations in children with asthma and low vitamin D levels: The VDKA Randomized Clinical Trial. JAMA2020;324(8):752-60. HanYY , FornoE , BacharierLB , PhipatanakulW , GuilbertTW , CabanaMD , et al. Vitamin D supplementation, lung function and asthma control in children with asthma and low vitamin D levels. European Respiratory Journal2021;58(4):2100989. [DOI: 10.1183/13993003.00989-2021]N/a. Errors in flow diagram. JAMA2021;326(1):90. [DOI: 10.1001/jama.2021.9465.]RosserFJ , HanYY , FornoE , BacharierLB , PhipatanakulW , GuilbertTW , et al. Effect of vitamin D supplementation on total andallergen-specific IgE in children with asthma andlow vitamin D levels. Journal of Allergy and Clinical Immunology2021;149(1):440-4.E2. [PMID: 10.1016/j.jaci.2021.05.037]">Forno 2020</a>; <a href="./references#CD011511-bbs2-0007" title="JatKR , GoelN , GuptaN , ChandraPG , SudipD , RakeshL , et al. Efficacy of vitamin D supplementation in asthmatic childrenwith vitamin D deficiency: a randomized controlled trial(ESDAC trial). Pediatric Allergy and Immunology2021;32(3):479– 88. [DOI: 10.1111/pai.13415]">Jat 2020</a>; <a href="./references#CD011511-bbs2-0008" title="JensenM , MailhotG , AlosN , RousseauE , WhiteJ , KhamessanA , et al. Vitamin D intervention in preschoolers with viral-induced asthma (DIVA): a pilot randomised controlled trial. American Journal of Respiratory and Critical Care Medicine2015;191:A3360. JensenME , MailhotG , AlosN , RousseauE , WhiteJ , KhamessanA , et al. Vitamin D intervention in preschoolers with viral-induced asthma (DIVA): a pilot randomised controlled trial. Trials2016;17:353. [DOI: 10.1186/s13063-016-1483-1]">Jensen 2016</a>; <a href="./references#CD011511-bbs2-0009" title="JerzynskaJ , StelmachW , RychlikB , LechańskaJ , PodleckaD , StelmachI . The clinical effect of vitamin D supplementation combined with grass-specific sublingual immunotherapy in children with allergic rhinitis. Allergy and Asthma Proceedings2016;37(2):105-14. [DOI: 10.2500/aap.2016.37.3921]">Jerzynska 2016</a>; <a href="./references#CD011511-bbs2-0010" title="JiangC , YiR , NaH , LinS . A randomized controlled study of Vitamin D3 supplementation on childhood asthma control. Chongqing Medicine2017;46(32):4505-7. [DOI: 10.3969/j.issn.1671-8348.2017.32.011]">Jiang 2017</a>; <a href="./references#CD011511-bbs2-0011" title="KerleyCP , HutchinsonK , CormicanL , FaulJ , GreallyP , CoghlanD , et al. Vitamin D3 for uncontrolled childhood asthma: A pilot study. Paediatric Allergy and Immunology2016;27:404-12. [PMID: 10.1111/pai.12547]">Kerley 2016</a>; <a href="./references#CD011511-bbs2-0012" title="LewisE , FernandezC , NellaA , HoppR , GallagherJC , CasaleTB . Relationship of 25-hydroxyvitamin D and asthma control in children. Annals of Allergy, Asthma and Immunology2012;108(4):281-2. LewisE , FernandezC , NellaAA , HoppR , CasaleT , GallagherC . The relationship of vitamin D and asthma in children. Journal of Allergy and Clinical Immunology2011;127(2):AB262. ">Lewis 2012</a>; <a href="./references#CD011511-bbs2-0013" title="MajakP , JerzyiskaJ , SmejdaK , StelmachI , TimlerD , StelmachW . Correlation of vitamin D with Foxp3 induction and steroid-sparing effect of immunotherapy in asthmatic children. Annals of Allergy, Asthma and Immunology2012;109(5):329-35. MajakP , RychlikB , StelmachI . The effect of oral steroids with and without vitamin D3 on early efficacy of immunotherapy in asthmatic children. Clinical and Experimental Allergy2009;39(12):1830-41. ">Majak 2009</a>; <a href="./references#CD011511-bbs2-0014" title="MajakP , Olszowiec-ChlebnaM , SmejdaK , StelmachI . Vitamin D supplementation in children may prevent asthma exacerbation triggered by acute respiratory infection. Journal of Allergy and Clinical Immunology2011;127(5):1294-6. ">Majak 2011</a>; <a href="./references#CD011511-bbs2-0015" title="MartineauAR , MacLaughlinBD , HooperRL , BarnesNC , JolliffeDA , ChoudhuryAB , et al. Double-blind multi-centre randomised controlled trial of vitamin D3 supplementation in adults with inhaled corticosteroid-treated asthma (ViDiAs). Thorax2014;69:A51-2. MartineauAR , MacLaughlinBD , HooperRL , BarnesNC , JolliffeDA , GreillerCL , et al. Double-blind randomised placebo-controlled trial of bolus-dose vitamin D3 supplementation in adults with asthma (ViDiAs). Thorax2015;70(5):451-7. ">Martineau 2015</a>; <a href="./references#CD011511-bbs2-0016" title="Ramos-MartínezE , López-VancellMR , Fernández de Córdova-AguirreJC , Rojas-SerranoJ , ChavarríaA , Velasco-MedinaA , et al. Reduction of respiratory infections in asthma patients supplemented with vitamin D is related to increased serum IL-10 and IFNγ levels and cathelicidin expression. Cytokine2018;108:239–46. ">Ramos‐Martínez 2018</a>; <a href="./references#CD011511-bbs2-0017" title="TachimotoH , MezawaH , SegawaT , AkiyamaN , IdaH , UrashimaM . Improved control of childhood asthma with low-dose, short-term vitamin D supplementation: a randomized, double-blind, placebo-controlled trial. Allergy2016;71(7):1001-9. ">Tachimoto 2016</a>; <a href="./references#CD011511-bbs2-0018" title="ThakurC , KumarJ , KumarP , GoyalJP , SinghK , GuptaA . Vitamin‐D supplementation as an adjunct to standard treatmentof asthma in children: a randomized controlled trial (ViDASTA Trial). Pediatric Pulmonology2021;56:1427–33. [DOI: 10.1002/ppul.25287]">Thakur 2021</a>; <a href="./references#CD011511-bbs2-0019" title="UrashimaM , SegawaT , OkazakiM , KuriharaM , WadaY , IdaH . Randomized trial of vitamin D supplementation to prevent seasonal influenza A in school children. American Journal of Clinical Nutrition2010;91(5):1255-60. ">Urashima 2010</a>; <a href="./references#CD011511-bbs2-0020" title="YadavM , MittalK . Effect of vitamin D supplementation on moderate to severe bronchial asthma. Indian Journal of Pediatrics2014;81(7):650-4. ">Yadav 2014</a>). </p> <p><b>Study design</b> </p> <p>All included studies were double‐blind randomised placebo‐controlled trials with a parallel‐group design, open to male and female participants of any ethnic background. Thirteen were conducted at a single centre (<a href="./references#CD011511-bbs2-0002" title="Andújar-EspinosaR , Aparicio-VicenteM , Ruiz-LópezFJ , Salinero-GonzálezL . Influence of vitamin D supplementation on the quality of life of asthma patients: Findings from ACVID randomised clinical trial. Respiratory Medicine2021;185:106484. [DOI: 10.1016/j.rmed.2021.106484]Andújar-EspinosaR , Salinero-GonzálezL , Illán-GómezF , Castilla-MartínezM , Hu-YangC , Ruiz-LópezFJ . Effect of vitamin D supplementation on asthma control in patients with vitamin D deficiency: the ACVID randomised clinical trial. Thorax2021;76(2):126–33. [DOI: 10.1136/thoraxjnl-2019-213936]">Andújar‐Espinosa 2021</a>; <a href="./references#CD011511-bbs2-0005" title="DucharmeFM , JensenM , MailhotG , AlosN , WhiteJ , RousseauE , et al. Impact of two oral doses of 100,000 IU of vitamin D3 in preschoolers with viral induced asthma: a pilot randomised controlled trial. Trials2019;20(1):138. [DOI: 10.1186/s13063-019-3184-z]">Ducharme 2019</a>; <a href="./references#CD011511-bbs2-0007" title="JatKR , GoelN , GuptaN , ChandraPG , SudipD , RakeshL , et al. Efficacy of vitamin D supplementation in asthmatic childrenwith vitamin D deficiency: a randomized controlled trial(ESDAC trial). Pediatric Allergy and Immunology2021;32(3):479– 88. [DOI: 10.1111/pai.13415]">Jat 2020</a>; <a href="./references#CD011511-bbs2-0008" title="JensenM , MailhotG , AlosN , RousseauE , WhiteJ , KhamessanA , et al. Vitamin D intervention in preschoolers with viral-induced asthma (DIVA): a pilot randomised controlled trial. American Journal of Respiratory and Critical Care Medicine2015;191:A3360. JensenME , MailhotG , AlosN , RousseauE , WhiteJ , KhamessanA , et al. Vitamin D intervention in preschoolers with viral-induced asthma (DIVA): a pilot randomised controlled trial. Trials2016;17:353. [DOI: 10.1186/s13063-016-1483-1]">Jensen 2016</a>; <a href="./references#CD011511-bbs2-0009" title="JerzynskaJ , StelmachW , RychlikB , LechańskaJ , PodleckaD , StelmachI . The clinical effect of vitamin D supplementation combined with grass-specific sublingual immunotherapy in children with allergic rhinitis. Allergy and Asthma Proceedings2016;37(2):105-14. [DOI: 10.2500/aap.2016.37.3921]">Jerzynska 2016</a>; <a href="./references#CD011511-bbs2-0010" title="JiangC , YiR , NaH , LinS . A randomized controlled study of Vitamin D3 supplementation on childhood asthma control. Chongqing Medicine2017;46(32):4505-7. [DOI: 10.3969/j.issn.1671-8348.2017.32.011]">Jiang 2017</a>; <a href="./references#CD011511-bbs2-0011" title="KerleyCP , HutchinsonK , CormicanL , FaulJ , GreallyP , CoghlanD , et al. Vitamin D3 for uncontrolled childhood asthma: A pilot study. Paediatric Allergy and Immunology2016;27:404-12. [PMID: 10.1111/pai.12547]">Kerley 2016</a>; <a href="./references#CD011511-bbs2-0012" title="LewisE , FernandezC , NellaA , HoppR , GallagherJC , CasaleTB . Relationship of 25-hydroxyvitamin D and asthma control in children. Annals of Allergy, Asthma and Immunology2012;108(4):281-2. LewisE , FernandezC , NellaAA , HoppR , CasaleT , GallagherC . The relationship of vitamin D and asthma in children. Journal of Allergy and Clinical Immunology2011;127(2):AB262. ">Lewis 2012</a>; <a href="./references#CD011511-bbs2-0013" title="MajakP , JerzyiskaJ , SmejdaK , StelmachI , TimlerD , StelmachW . Correlation of vitamin D with Foxp3 induction and steroid-sparing effect of immunotherapy in asthmatic children. Annals of Allergy, Asthma and Immunology2012;109(5):329-35. MajakP , RychlikB , StelmachI . The effect of oral steroids with and without vitamin D3 on early efficacy of immunotherapy in asthmatic children. Clinical and Experimental Allergy2009;39(12):1830-41. ">Majak 2009</a>; <a href="./references#CD011511-bbs2-0014" title="MajakP , Olszowiec-ChlebnaM , SmejdaK , StelmachI . Vitamin D supplementation in children may prevent asthma exacerbation triggered by acute respiratory infection. Journal of Allergy and Clinical Immunology2011;127(5):1294-6. ">Majak 2011</a>; <a href="./references#CD011511-bbs2-0016" title="Ramos-MartínezE , López-VancellMR , Fernández de Córdova-AguirreJC , Rojas-SerranoJ , ChavarríaA , Velasco-MedinaA , et al. Reduction of respiratory infections in asthma patients supplemented with vitamin D is related to increased serum IL-10 and IFNγ levels and cathelicidin expression. Cytokine2018;108:239–46. ">Ramos‐Martínez 2018</a>; <a href="./references#CD011511-bbs2-0018" title="ThakurC , KumarJ , KumarP , GoyalJP , SinghK , GuptaA . Vitamin‐D supplementation as an adjunct to standard treatmentof asthma in children: a randomized controlled trial (ViDASTA Trial). Pediatric Pulmonology2021;56:1427–33. [DOI: 10.1002/ppul.25287]">Thakur 2021</a>; <a href="./references#CD011511-bbs2-0020" title="YadavM , MittalK . Effect of vitamin D supplementation on moderate to severe bronchial asthma. Indian Journal of Pediatrics2014;81(7):650-4. ">Yadav 2014</a>), and seven were multicentre studies (<a href="./references#CD011511-bbs2-0001" title="AglipayM , BirkenC , DaiD , ParkinP , MaguireJ . 70 high dose vitamin D for the prevention of wheezing in preschoolers: a secondary analysis of a randomized clinical trial. Paediatrics and Child Health2019;24(S2):e27-8. [DOI: 10.1093/pch/pxz066.069]AglipayM , BirkenCS , ParkinPC , LoebMB , ThorpeK , ChenY , et al. TARGet Kids! Collaboration. Effect of high-dose vs standard-dose wintertime vitamin D supplementation on viral upper respiratory tract infections in young healthy children. JAMA2017;318(3):245-54. [DOI: 10.1001/jama.2017.8708.]">Aglipay 2019</a>; <a href="./references#CD011511-bbs2-0003" title="CamargoC , ToopL , SluyterJ , LawesCM , WaayerD , KhawKT , et al. Effect of monthly vitamin D supplementation on preventing exacerbations of asthma or chronic obstructive pulmonary disease in older adults: post hoc analysis of a randomized controlled trial. Nutrients2021;13:521. [DOI: 10.3390/nu13020521]SluyterJ , CamargoCA , WaayerD , LawesCM , ToopL , KhawKT , et al. Effect of monthly, high-dose, long-term vitamin D on lung function: a randomized controlled trial. Nutrients2017;9:1353. [DOI: 10.3390/nu9121353]">Camargo 2021</a>; <a href="./references#CD011511-bbs2-0004" title="CastroM , KingTS , KunselmanSJ , CabanaMD , DenlingerL , HolguinF , et al. Effect of vitamin D3 on asthma treatment failures in adults with symptomatic asthma and lower vitamin D levels: the VIDA randomized clinical trial. JAMA2014;311(20):2083-91. DenlingerLC , KingTS , CardetJC , CraigT , HolguinF , JacksonDJ , et al. Vitamin D supplementation and the risk of colds in patients with asthma. American Journal of Respiratory and Critical Care Medicine2016;193(6):634–41. DenlingerLC , KingTS , CardetJC , CraigTJ , HolguinF , KraftM , et al. Vitamin D supplementation and the risk of colds in patients with asthma. Journal of Allergy and Clinical Immunology2015;135:AB109. JiaoJ , KingTS , McKenzieM , BacharierLB , DixonAE , CodispotiCD , et al. Effects of vitamin D3 supplementation in adults with asthma complicated by sinonasal disease. American Journal of Respiratory and Critical Care Medicine2015;191:A4148. JiaoJ , KingTS , McKenzieM , BacharierLB , DixonAE , CodispotiCD , et al. Vitamin D3 therapy in patients with asthma complicated by sinonasal disease: secondary analysis of the Vitamin D Add-on Therapy Enhances Corticosteroid Responsiveness in Asthma trial. Journal of Allergy and Clinical Immunology2016;138(2):589-92. MooreWC , KingTS , BleeckerER , MeyersDA , PetersSP , WenzelSE . Sarp clinical clusters predict steroid responsiveness and risk of asthma exacerbations in the asthma net vida (vitamin D in asthma) trial. American Journal of Respiratory and Critical Care Medicine2015;191:A6055. ReidB , GirodetP , BoomerJS , Abdel-GadirA , ZhengK , WechslerME , et al. Vitamin D3 treatment of vitamin D insufficient asthmatics does not alter immune cell function. Journal of Allergy and Clinical Immunology2016;138(1):286-9. ">Castro 2014</a>; <a href="./references#CD011511-bbs2-0006" title="FornoE , BacharierLB , PhipatanakulW , GuilbertTW , CabanaMD , RossK , et al. Effect of vitamin D3 supplementation on severe asthma exacerbations in children with asthma and low vitamin D levels: The VDKA Randomized Clinical Trial. JAMA2020;324(8):752-60. HanYY , FornoE , BacharierLB , PhipatanakulW , GuilbertTW , CabanaMD , et al. Vitamin D supplementation, lung function and asthma control in children with asthma and low vitamin D levels. European Respiratory Journal2021;58(4):2100989. [DOI: 10.1183/13993003.00989-2021]N/a. Errors in flow diagram. JAMA2021;326(1):90. [DOI: 10.1001/jama.2021.9465.]RosserFJ , HanYY , FornoE , BacharierLB , PhipatanakulW , GuilbertTW , et al. Effect of vitamin D supplementation on total andallergen-specific IgE in children with asthma andlow vitamin D levels. Journal of Allergy and Clinical Immunology2021;149(1):440-4.E2. [PMID: 10.1016/j.jaci.2021.05.037]">Forno 2020</a>; <a href="./references#CD011511-bbs2-0015" title="MartineauAR , MacLaughlinBD , HooperRL , BarnesNC , JolliffeDA , ChoudhuryAB , et al. Double-blind multi-centre randomised controlled trial of vitamin D3 supplementation in adults with inhaled corticosteroid-treated asthma (ViDiAs). Thorax2014;69:A51-2. MartineauAR , MacLaughlinBD , HooperRL , BarnesNC , JolliffeDA , GreillerCL , et al. Double-blind randomised placebo-controlled trial of bolus-dose vitamin D3 supplementation in adults with asthma (ViDiAs). Thorax2015;70(5):451-7. ">Martineau 2015</a>; <a href="./references#CD011511-bbs2-0017" title="TachimotoH , MezawaH , SegawaT , AkiyamaN , IdaH , UrashimaM . Improved control of childhood asthma with low-dose, short-term vitamin D supplementation: a randomized, double-blind, placebo-controlled trial. Allergy2016;71(7):1001-9. ">Tachimoto 2016</a>; <a href="./references#CD011511-bbs2-0019" title="UrashimaM , SegawaT , OkazakiM , KuriharaM , WadaY , IdaH . Randomized trial of vitamin D supplementation to prevent seasonal influenza A in school children. American Journal of Clinical Nutrition2010;91(5):1255-60. ">Urashima 2010</a>). Seventeen studies recruited only in secondary care, two studies recruited only in primary care (<a href="./references#CD011511-bbs2-0001" title="AglipayM , BirkenC , DaiD , ParkinP , MaguireJ . 70 high dose vitamin D for the prevention of wheezing in preschoolers: a secondary analysis of a randomized clinical trial. Paediatrics and Child Health2019;24(S2):e27-8. [DOI: 10.1093/pch/pxz066.069]AglipayM , BirkenCS , ParkinPC , LoebMB , ThorpeK , ChenY , et al. TARGet Kids! Collaboration. Effect of high-dose vs standard-dose wintertime vitamin D supplementation on viral upper respiratory tract infections in young healthy children. JAMA2017;318(3):245-54. [DOI: 10.1001/jama.2017.8708.]">Aglipay 2019</a>; <a href="./references#CD011511-bbs2-0003" title="CamargoC , ToopL , SluyterJ , LawesCM , WaayerD , KhawKT , et al. Effect of monthly vitamin D supplementation on preventing exacerbations of asthma or chronic obstructive pulmonary disease in older adults: post hoc analysis of a randomized controlled trial. Nutrients2021;13:521. [DOI: 10.3390/nu13020521]SluyterJ , CamargoCA , WaayerD , LawesCM , ToopL , KhawKT , et al. Effect of monthly, high-dose, long-term vitamin D on lung function: a randomized controlled trial. Nutrients2017;9:1353. [DOI: 10.3390/nu9121353]">Camargo 2021</a>), and one study recruited in both settings (<a href="./references#CD011511-bbs2-0015" title="MartineauAR , MacLaughlinBD , HooperRL , BarnesNC , JolliffeDA , ChoudhuryAB , et al. Double-blind multi-centre randomised controlled trial of vitamin D3 supplementation in adults with inhaled corticosteroid-treated asthma (ViDiAs). Thorax2014;69:A51-2. MartineauAR , MacLaughlinBD , HooperRL , BarnesNC , JolliffeDA , GreillerCL , et al. Double-blind randomised placebo-controlled trial of bolus-dose vitamin D3 supplementation in adults with asthma (ViDiAs). Thorax2015;70(5):451-7. ">Martineau 2015</a>). Duration of follow‐up ranged from three months (<a href="./references#CD011511-bbs2-0018" title="ThakurC , KumarJ , KumarP , GoyalJP , SinghK , GuptaA . Vitamin‐D supplementation as an adjunct to standard treatmentof asthma in children: a randomized controlled trial (ViDASTA Trial). Pediatric Pulmonology2021;56:1427–33. [DOI: 10.1002/ppul.25287]">Thakur 2021</a>) to an average of 3.3 years (<a href="./references#CD011511-bbs2-0003" title="CamargoC , ToopL , SluyterJ , LawesCM , WaayerD , KhawKT , et al. Effect of monthly vitamin D supplementation on preventing exacerbations of asthma or chronic obstructive pulmonary disease in older adults: post hoc analysis of a randomized controlled trial. Nutrients2021;13:521. [DOI: 10.3390/nu13020521]SluyterJ , CamargoCA , WaayerD , LawesCM , ToopL , KhawKT , et al. Effect of monthly, high-dose, long-term vitamin D on lung function: a randomized controlled trial. Nutrients2017;9:1353. [DOI: 10.3390/nu9121353]">Camargo 2021</a>). </p> <p>All trials were restricted to individuals with a physician diagnosis of asthma; three trials additionally based eligibility on evidence of reversible or variable airway obstruction (<a href="./references#CD011511-bbs2-0004" title="CastroM , KingTS , KunselmanSJ , CabanaMD , DenlingerL , HolguinF , et al. Effect of vitamin D3 on asthma treatment failures in adults with symptomatic asthma and lower vitamin D levels: the VIDA randomized clinical trial. JAMA2014;311(20):2083-91. DenlingerLC , KingTS , CardetJC , CraigT , HolguinF , JacksonDJ , et al. Vitamin D supplementation and the risk of colds in patients with asthma. American Journal of Respiratory and Critical Care Medicine2016;193(6):634–41. DenlingerLC , KingTS , CardetJC , CraigTJ , HolguinF , KraftM , et al. Vitamin D supplementation and the risk of colds in patients with asthma. Journal of Allergy and Clinical Immunology2015;135:AB109. JiaoJ , KingTS , McKenzieM , BacharierLB , DixonAE , CodispotiCD , et al. Effects of vitamin D3 supplementation in adults with asthma complicated by sinonasal disease. American Journal of Respiratory and Critical Care Medicine2015;191:A4148. JiaoJ , KingTS , McKenzieM , BacharierLB , DixonAE , CodispotiCD , et al. Vitamin D3 therapy in patients with asthma complicated by sinonasal disease: secondary analysis of the Vitamin D Add-on Therapy Enhances Corticosteroid Responsiveness in Asthma trial. Journal of Allergy and Clinical Immunology2016;138(2):589-92. MooreWC , KingTS , BleeckerER , MeyersDA , PetersSP , WenzelSE . Sarp clinical clusters predict steroid responsiveness and risk of asthma exacerbations in the asthma net vida (vitamin D in asthma) trial. American Journal of Respiratory and Critical Care Medicine2015;191:A6055. ReidB , GirodetP , BoomerJS , Abdel-GadirA , ZhengK , WechslerME , et al. Vitamin D3 treatment of vitamin D insufficient asthmatics does not alter immune cell function. Journal of Allergy and Clinical Immunology2016;138(1):286-9. ">Castro 2014</a>; <a href="./references#CD011511-bbs2-0006" title="FornoE , BacharierLB , PhipatanakulW , GuilbertTW , CabanaMD , RossK , et al. Effect of vitamin D3 supplementation on severe asthma exacerbations in children with asthma and low vitamin D levels: The VDKA Randomized Clinical Trial. JAMA2020;324(8):752-60. HanYY , FornoE , BacharierLB , PhipatanakulW , GuilbertTW , CabanaMD , et al. Vitamin D supplementation, lung function and asthma control in children with asthma and low vitamin D levels. European Respiratory Journal2021;58(4):2100989. [DOI: 10.1183/13993003.00989-2021]N/a. Errors in flow diagram. JAMA2021;326(1):90. [DOI: 10.1001/jama.2021.9465.]RosserFJ , HanYY , FornoE , BacharierLB , PhipatanakulW , GuilbertTW , et al. Effect of vitamin D supplementation on total andallergen-specific IgE in children with asthma andlow vitamin D levels. Journal of Allergy and Clinical Immunology2021;149(1):440-4.E2. [PMID: 10.1016/j.jaci.2021.05.037]">Forno 2020</a>; <a href="./references#CD011511-bbs2-0015" title="MartineauAR , MacLaughlinBD , HooperRL , BarnesNC , JolliffeDA , ChoudhuryAB , et al. Double-blind multi-centre randomised controlled trial of vitamin D3 supplementation in adults with inhaled corticosteroid-treated asthma (ViDiAs). Thorax2014;69:A51-2. MartineauAR , MacLaughlinBD , HooperRL , BarnesNC , JolliffeDA , GreillerCL , et al. Double-blind randomised placebo-controlled trial of bolus-dose vitamin D3 supplementation in adults with asthma (ViDiAs). Thorax2015;70(5):451-7. ">Martineau 2015</a>), and one also required participants to have an FEV1 of at least 70% of predicted (<a href="./references#CD011511-bbs2-0006" title="FornoE , BacharierLB , PhipatanakulW , GuilbertTW , CabanaMD , RossK , et al. Effect of vitamin D3 supplementation on severe asthma exacerbations in children with asthma and low vitamin D levels: The VDKA Randomized Clinical Trial. JAMA2020;324(8):752-60. HanYY , FornoE , BacharierLB , PhipatanakulW , GuilbertTW , CabanaMD , et al. Vitamin D supplementation, lung function and asthma control in children with asthma and low vitamin D levels. European Respiratory Journal2021;58(4):2100989. [DOI: 10.1183/13993003.00989-2021]N/a. Errors in flow diagram. JAMA2021;326(1):90. [DOI: 10.1001/jama.2021.9465.]RosserFJ , HanYY , FornoE , BacharierLB , PhipatanakulW , GuilbertTW , et al. Effect of vitamin D supplementation on total andallergen-specific IgE in children with asthma andlow vitamin D levels. Journal of Allergy and Clinical Immunology2021;149(1):440-4.E2. [PMID: 10.1016/j.jaci.2021.05.037]">Forno 2020</a>). Two also required recurrent upper respiratory tract infections (<a href="./references#CD011511-bbs2-0005" title="DucharmeFM , JensenM , MailhotG , AlosN , WhiteJ , RousseauE , et al. Impact of two oral doses of 100,000 IU of vitamin D3 in preschoolers with viral induced asthma: a pilot randomised controlled trial. Trials2019;20(1):138. [DOI: 10.1186/s13063-019-3184-z]">Ducharme 2019</a>; <a href="./references#CD011511-bbs2-0016" title="Ramos-MartínezE , López-VancellMR , Fernández de Córdova-AguirreJC , Rojas-SerranoJ , ChavarríaA , Velasco-MedinaA , et al. Reduction of respiratory infections in asthma patients supplemented with vitamin D is related to increased serum IL-10 and IFNγ levels and cathelicidin expression. Cytokine2018;108:239–46. ">Ramos‐Martínez 2018</a>), and another was restricted to those with a concomitant clinical diagnosis of grass‐related moderate‐to‐severe rhinoconjunctivitis (<a href="./references#CD011511-bbs2-0009" title="JerzynskaJ , StelmachW , RychlikB , LechańskaJ , PodleckaD , StelmachI . The clinical effect of vitamin D supplementation combined with grass-specific sublingual immunotherapy in children with allergic rhinitis. Allergy and Asthma Proceedings2016;37(2):105-14. [DOI: 10.2500/aap.2016.37.3921]">Jerzynska 2016</a>). </p> <p>Current or recent treatment with inhaled corticosteroids was a requirement for six trials (<a href="./references#CD011511-bbs2-0004" title="CastroM , KingTS , KunselmanSJ , CabanaMD , DenlingerL , HolguinF , et al. Effect of vitamin D3 on asthma treatment failures in adults with symptomatic asthma and lower vitamin D levels: the VIDA randomized clinical trial. JAMA2014;311(20):2083-91. DenlingerLC , KingTS , CardetJC , CraigT , HolguinF , JacksonDJ , et al. Vitamin D supplementation and the risk of colds in patients with asthma. American Journal of Respiratory and Critical Care Medicine2016;193(6):634–41. DenlingerLC , KingTS , CardetJC , CraigTJ , HolguinF , KraftM , et al. Vitamin D supplementation and the risk of colds in patients with asthma. Journal of Allergy and Clinical Immunology2015;135:AB109. JiaoJ , KingTS , McKenzieM , BacharierLB , DixonAE , CodispotiCD , et al. Effects of vitamin D3 supplementation in adults with asthma complicated by sinonasal disease. American Journal of Respiratory and Critical Care Medicine2015;191:A4148. JiaoJ , KingTS , McKenzieM , BacharierLB , DixonAE , CodispotiCD , et al. Vitamin D3 therapy in patients with asthma complicated by sinonasal disease: secondary analysis of the Vitamin D Add-on Therapy Enhances Corticosteroid Responsiveness in Asthma trial. Journal of Allergy and Clinical Immunology2016;138(2):589-92. MooreWC , KingTS , BleeckerER , MeyersDA , PetersSP , WenzelSE . Sarp clinical clusters predict steroid responsiveness and risk of asthma exacerbations in the asthma net vida (vitamin D in asthma) trial. American Journal of Respiratory and Critical Care Medicine2015;191:A6055. ReidB , GirodetP , BoomerJS , Abdel-GadirA , ZhengK , WechslerME , et al. Vitamin D3 treatment of vitamin D insufficient asthmatics does not alter immune cell function. Journal of Allergy and Clinical Immunology2016;138(1):286-9. ">Castro 2014</a>; <a href="./references#CD011511-bbs2-0006" title="FornoE , BacharierLB , PhipatanakulW , GuilbertTW , CabanaMD , RossK , et al. Effect of vitamin D3 supplementation on severe asthma exacerbations in children with asthma and low vitamin D levels: The VDKA Randomized Clinical Trial. JAMA2020;324(8):752-60. HanYY , FornoE , BacharierLB , PhipatanakulW , GuilbertTW , CabanaMD , et al. Vitamin D supplementation, lung function and asthma control in children with asthma and low vitamin D levels. European Respiratory Journal2021;58(4):2100989. [DOI: 10.1183/13993003.00989-2021]N/a. Errors in flow diagram. JAMA2021;326(1):90. [DOI: 10.1001/jama.2021.9465.]RosserFJ , HanYY , FornoE , BacharierLB , PhipatanakulW , GuilbertTW , et al. Effect of vitamin D supplementation on total andallergen-specific IgE in children with asthma andlow vitamin D levels. Journal of Allergy and Clinical Immunology2021;149(1):440-4.E2. [PMID: 10.1016/j.jaci.2021.05.037]">Forno 2020</a>; <a href="./references#CD011511-bbs2-0007" title="JatKR , GoelN , GuptaN , ChandraPG , SudipD , RakeshL , et al. Efficacy of vitamin D supplementation in asthmatic childrenwith vitamin D deficiency: a randomized controlled trial(ESDAC trial). Pediatric Allergy and Immunology2021;32(3):479– 88. [DOI: 10.1111/pai.13415]">Jat 2020</a>; <a href="./references#CD011511-bbs2-0011" title="KerleyCP , HutchinsonK , CormicanL , FaulJ , GreallyP , CoghlanD , et al. Vitamin D3 for uncontrolled childhood asthma: A pilot study. Paediatric Allergy and Immunology2016;27:404-12. [PMID: 10.1111/pai.12547]">Kerley 2016</a>; <a href="./references#CD011511-bbs2-0013" title="MajakP , JerzyiskaJ , SmejdaK , StelmachI , TimlerD , StelmachW . Correlation of vitamin D with Foxp3 induction and steroid-sparing effect of immunotherapy in asthmatic children. Annals of Allergy, Asthma and Immunology2012;109(5):329-35. MajakP , RychlikB , StelmachI . The effect of oral steroids with and without vitamin D3 on early efficacy of immunotherapy in asthmatic children. Clinical and Experimental Allergy2009;39(12):1830-41. ">Majak 2009</a>; <a href="./references#CD011511-bbs2-0015" title="MartineauAR , MacLaughlinBD , HooperRL , BarnesNC , JolliffeDA , ChoudhuryAB , et al. Double-blind multi-centre randomised controlled trial of vitamin D3 supplementation in adults with inhaled corticosteroid-treated asthma (ViDiAs). Thorax2014;69:A51-2. MartineauAR , MacLaughlinBD , HooperRL , BarnesNC , JolliffeDA , GreillerCL , et al. Double-blind randomised placebo-controlled trial of bolus-dose vitamin D3 supplementation in adults with asthma (ViDiAs). Thorax2015;70(5):451-7. ">Martineau 2015</a>), and an exclusion criterion for two trials (<a href="./references#CD011511-bbs2-0009" title="JerzynskaJ , StelmachW , RychlikB , LechańskaJ , PodleckaD , StelmachI . The clinical effect of vitamin D supplementation combined with grass-specific sublingual immunotherapy in children with allergic rhinitis. Allergy and Asthma Proceedings2016;37(2):105-14. [DOI: 10.2500/aap.2016.37.3921]">Jerzynska 2016</a>; <a href="./references#CD011511-bbs2-0014" title="MajakP , Olszowiec-ChlebnaM , SmejdaK , StelmachI . Vitamin D supplementation in children may prevent asthma exacerbation triggered by acute respiratory infection. Journal of Allergy and Clinical Immunology2011;127(5):1294-6. ">Majak 2011</a>). One trial excluded participants who had received oral corticosteroid therapy in the year prior to enrolment (<a href="./references#CD011511-bbs2-0019" title="UrashimaM , SegawaT , OkazakiM , KuriharaM , WadaY , IdaH . Randomized trial of vitamin D supplementation to prevent seasonal influenza A in school children. American Journal of Clinical Nutrition2010;91(5):1255-60. ">Urashima 2010</a>), and another excluded those who were receiving chronic oral corticosteroid therapy prior to enrolment (<a href="./references#CD011511-bbs2-0006" title="FornoE , BacharierLB , PhipatanakulW , GuilbertTW , CabanaMD , RossK , et al. Effect of vitamin D3 supplementation on severe asthma exacerbations in children with asthma and low vitamin D levels: The VDKA Randomized Clinical Trial. JAMA2020;324(8):752-60. HanYY , FornoE , BacharierLB , PhipatanakulW , GuilbertTW , CabanaMD , et al. Vitamin D supplementation, lung function and asthma control in children with asthma and low vitamin D levels. European Respiratory Journal2021;58(4):2100989. [DOI: 10.1183/13993003.00989-2021]N/a. Errors in flow diagram. JAMA2021;326(1):90. [DOI: 10.1001/jama.2021.9465.]RosserFJ , HanYY , FornoE , BacharierLB , PhipatanakulW , GuilbertTW , et al. Effect of vitamin D supplementation on total andallergen-specific IgE in children with asthma andlow vitamin D levels. Journal of Allergy and Clinical Immunology2021;149(1):440-4.E2. [PMID: 10.1016/j.jaci.2021.05.037]">Forno 2020</a>). Conversely, three trials required one or more exacerbations requiring rescue oral corticosteroids in the preceding six months or year (<a href="./references#CD011511-bbs2-0005" title="DucharmeFM , JensenM , MailhotG , AlosN , WhiteJ , RousseauE , et al. Impact of two oral doses of 100,000 IU of vitamin D3 in preschoolers with viral induced asthma: a pilot randomised controlled trial. Trials2019;20(1):138. [DOI: 10.1186/s13063-019-3184-z]">Ducharme 2019</a>; <a href="./references#CD011511-bbs2-0006" title="FornoE , BacharierLB , PhipatanakulW , GuilbertTW , CabanaMD , RossK , et al. Effect of vitamin D3 supplementation on severe asthma exacerbations in children with asthma and low vitamin D levels: The VDKA Randomized Clinical Trial. JAMA2020;324(8):752-60. HanYY , FornoE , BacharierLB , PhipatanakulW , GuilbertTW , CabanaMD , et al. Vitamin D supplementation, lung function and asthma control in children with asthma and low vitamin D levels. European Respiratory Journal2021;58(4):2100989. [DOI: 10.1183/13993003.00989-2021]N/a. Errors in flow diagram. JAMA2021;326(1):90. [DOI: 10.1001/jama.2021.9465.]RosserFJ , HanYY , FornoE , BacharierLB , PhipatanakulW , GuilbertTW , et al. Effect of vitamin D supplementation on total andallergen-specific IgE in children with asthma andlow vitamin D levels. Journal of Allergy and Clinical Immunology2021;149(1):440-4.E2. [PMID: 10.1016/j.jaci.2021.05.037]">Forno 2020</a>; <a href="./references#CD011511-bbs2-0008" title="JensenM , MailhotG , AlosN , RousseauE , WhiteJ , KhamessanA , et al. Vitamin D intervention in preschoolers with viral-induced asthma (DIVA): a pilot randomised controlled trial. American Journal of Respiratory and Critical Care Medicine2015;191:A3360. JensenME , MailhotG , AlosN , RousseauE , WhiteJ , KhamessanA , et al. Vitamin D intervention in preschoolers with viral-induced asthma (DIVA): a pilot randomised controlled trial. Trials2016;17:353. [DOI: 10.1186/s13063-016-1483-1]">Jensen 2016</a>). All the remaining trials included at least some participants who were taking inhaled corticosteroids. </p> <p>Six trials included baseline vitamin D status as an eligibility criterion; one restricted eligibility to people with baseline 25(OH)D concentration of 50 nmol/L or less (<a href="./references#CD011511-bbs2-0007" title="JatKR , GoelN , GuptaN , ChandraPG , SudipD , RakeshL , et al. Efficacy of vitamin D supplementation in asthmatic childrenwith vitamin D deficiency: a randomized controlled trial(ESDAC trial). Pediatric Allergy and Immunology2021;32(3):479– 88. [DOI: 10.1111/pai.13415]">Jat 2020</a>), two restricted eligibility to those with baseline 25(OH)D concentration less than 75 nmol/L (<a href="./references#CD011511-bbs2-0002" title="Andújar-EspinosaR , Aparicio-VicenteM , Ruiz-LópezFJ , Salinero-GonzálezL . Influence of vitamin D supplementation on the quality of life of asthma patients: Findings from ACVID randomised clinical trial. Respiratory Medicine2021;185:106484. [DOI: 10.1016/j.rmed.2021.106484]Andújar-EspinosaR , Salinero-GonzálezL , Illán-GómezF , Castilla-MartínezM , Hu-YangC , Ruiz-LópezFJ . Effect of vitamin D supplementation on asthma control in patients with vitamin D deficiency: the ACVID randomised clinical trial. Thorax2021;76(2):126–33. [DOI: 10.1136/thoraxjnl-2019-213936]">Andújar‐Espinosa 2021</a>; <a href="./references#CD011511-bbs2-0004" title="CastroM , KingTS , KunselmanSJ , CabanaMD , DenlingerL , HolguinF , et al. Effect of vitamin D3 on asthma treatment failures in adults with symptomatic asthma and lower vitamin D levels: the VIDA randomized clinical trial. JAMA2014;311(20):2083-91. DenlingerLC , KingTS , CardetJC , CraigT , HolguinF , JacksonDJ , et al. Vitamin D supplementation and the risk of colds in patients with asthma. American Journal of Respiratory and Critical Care Medicine2016;193(6):634–41. DenlingerLC , KingTS , CardetJC , CraigTJ , HolguinF , KraftM , et al. Vitamin D supplementation and the risk of colds in patients with asthma. Journal of Allergy and Clinical Immunology2015;135:AB109. JiaoJ , KingTS , McKenzieM , BacharierLB , DixonAE , CodispotiCD , et al. Effects of vitamin D3 supplementation in adults with asthma complicated by sinonasal disease. American Journal of Respiratory and Critical Care Medicine2015;191:A4148. JiaoJ , KingTS , McKenzieM , BacharierLB , DixonAE , CodispotiCD , et al. Vitamin D3 therapy in patients with asthma complicated by sinonasal disease: secondary analysis of the Vitamin D Add-on Therapy Enhances Corticosteroid Responsiveness in Asthma trial. Journal of Allergy and Clinical Immunology2016;138(2):589-92. MooreWC , KingTS , BleeckerER , MeyersDA , PetersSP , WenzelSE . Sarp clinical clusters predict steroid responsiveness and risk of asthma exacerbations in the asthma net vida (vitamin D in asthma) trial. American Journal of Respiratory and Critical Care Medicine2015;191:A6055. ReidB , GirodetP , BoomerJS , Abdel-GadirA , ZhengK , WechslerME , et al. Vitamin D3 treatment of vitamin D insufficient asthmatics does not alter immune cell function. Journal of Allergy and Clinical Immunology2016;138(1):286-9. ">Castro 2014</a>), one excluded those with a baseline 25(OH)D concentration less than 30 nmol/L (<a href="./references#CD011511-bbs2-0018" title="ThakurC , KumarJ , KumarP , GoyalJP , SinghK , GuptaA . Vitamin‐D supplementation as an adjunct to standard treatmentof asthma in children: a randomized controlled trial (ViDASTA Trial). Pediatric Pulmonology2021;56:1427–33. [DOI: 10.1002/ppul.25287]">Thakur 2021</a>), and one excluded those with a baseline 25(OH)D concentration that was either less than 35 nmol/L or greater than or equal to 75 nmol/L(<a href="./references#CD011511-bbs2-0006" title="FornoE , BacharierLB , PhipatanakulW , GuilbertTW , CabanaMD , RossK , et al. Effect of vitamin D3 supplementation on severe asthma exacerbations in children with asthma and low vitamin D levels: The VDKA Randomized Clinical Trial. JAMA2020;324(8):752-60. HanYY , FornoE , BacharierLB , PhipatanakulW , GuilbertTW , CabanaMD , et al. Vitamin D supplementation, lung function and asthma control in children with asthma and low vitamin D levels. European Respiratory Journal2021;58(4):2100989. [DOI: 10.1183/13993003.00989-2021]N/a. Errors in flow diagram. JAMA2021;326(1):90. [DOI: 10.1001/jama.2021.9465.]RosserFJ , HanYY , FornoE , BacharierLB , PhipatanakulW , GuilbertTW , et al. Effect of vitamin D supplementation on total andallergen-specific IgE in children with asthma andlow vitamin D levels. Journal of Allergy and Clinical Immunology2021;149(1):440-4.E2. [PMID: 10.1016/j.jaci.2021.05.037]">Forno 2020</a>). Fourteen trials had exclusion criteria relating to maximum permitted pre‐trial or concomitant supplemental vitamin D intake, or both (<a href="./references#CD011511-bbs2-0002" title="Andújar-EspinosaR , Aparicio-VicenteM , Ruiz-LópezFJ , Salinero-GonzálezL . Influence of vitamin D supplementation on the quality of life of asthma patients: Findings from ACVID randomised clinical trial. Respiratory Medicine2021;185:106484. [DOI: 10.1016/j.rmed.2021.106484]Andújar-EspinosaR , Salinero-GonzálezL , Illán-GómezF , Castilla-MartínezM , Hu-YangC , Ruiz-LópezFJ . Effect of vitamin D supplementation on asthma control in patients with vitamin D deficiency: the ACVID randomised clinical trial. Thorax2021;76(2):126–33. [DOI: 10.1136/thoraxjnl-2019-213936]">Andújar‐Espinosa 2021</a>; <a href="./references#CD011511-bbs2-0003" title="CamargoC , ToopL , SluyterJ , LawesCM , WaayerD , KhawKT , et al. Effect of monthly vitamin D supplementation on preventing exacerbations of asthma or chronic obstructive pulmonary disease in older adults: post hoc analysis of a randomized controlled trial. Nutrients2021;13:521. [DOI: 10.3390/nu13020521]SluyterJ , CamargoCA , WaayerD , LawesCM , ToopL , KhawKT , et al. Effect of monthly, high-dose, long-term vitamin D on lung function: a randomized controlled trial. Nutrients2017;9:1353. [DOI: 10.3390/nu9121353]">Camargo 2021</a>; <a href="./references#CD011511-bbs2-0004" title="CastroM , KingTS , KunselmanSJ , CabanaMD , DenlingerL , HolguinF , et al. Effect of vitamin D3 on asthma treatment failures in adults with symptomatic asthma and lower vitamin D levels: the VIDA randomized clinical trial. JAMA2014;311(20):2083-91. DenlingerLC , KingTS , CardetJC , CraigT , HolguinF , JacksonDJ , et al. Vitamin D supplementation and the risk of colds in patients with asthma. American Journal of Respiratory and Critical Care Medicine2016;193(6):634–41. DenlingerLC , KingTS , CardetJC , CraigTJ , HolguinF , KraftM , et al. Vitamin D supplementation and the risk of colds in patients with asthma. Journal of Allergy and Clinical Immunology2015;135:AB109. JiaoJ , KingTS , McKenzieM , BacharierLB , DixonAE , CodispotiCD , et al. Effects of vitamin D3 supplementation in adults with asthma complicated by sinonasal disease. American Journal of Respiratory and Critical Care Medicine2015;191:A4148. JiaoJ , KingTS , McKenzieM , BacharierLB , DixonAE , CodispotiCD , et al. Vitamin D3 therapy in patients with asthma complicated by sinonasal disease: secondary analysis of the Vitamin D Add-on Therapy Enhances Corticosteroid Responsiveness in Asthma trial. Journal of Allergy and Clinical Immunology2016;138(2):589-92. MooreWC , KingTS , BleeckerER , MeyersDA , PetersSP , WenzelSE . Sarp clinical clusters predict steroid responsiveness and risk of asthma exacerbations in the asthma net vida (vitamin D in asthma) trial. American Journal of Respiratory and Critical Care Medicine2015;191:A6055. ReidB , GirodetP , BoomerJS , Abdel-GadirA , ZhengK , WechslerME , et al. Vitamin D3 treatment of vitamin D insufficient asthmatics does not alter immune cell function. Journal of Allergy and Clinical Immunology2016;138(1):286-9. ">Castro 2014</a>; <a href="./references#CD011511-bbs2-0005" title="DucharmeFM , JensenM , MailhotG , AlosN , WhiteJ , RousseauE , et al. Impact of two oral doses of 100,000 IU of vitamin D3 in preschoolers with viral induced asthma: a pilot randomised controlled trial. Trials2019;20(1):138. [DOI: 10.1186/s13063-019-3184-z]">Ducharme 2019</a>; <a href="./references#CD011511-bbs2-0006" title="FornoE , BacharierLB , PhipatanakulW , GuilbertTW , CabanaMD , RossK , et al. Effect of vitamin D3 supplementation on severe asthma exacerbations in children with asthma and low vitamin D levels: The VDKA Randomized Clinical Trial. JAMA2020;324(8):752-60. HanYY , FornoE , BacharierLB , PhipatanakulW , GuilbertTW , CabanaMD , et al. Vitamin D supplementation, lung function and asthma control in children with asthma and low vitamin D levels. European Respiratory Journal2021;58(4):2100989. [DOI: 10.1183/13993003.00989-2021]N/a. Errors in flow diagram. JAMA2021;326(1):90. [DOI: 10.1001/jama.2021.9465.]RosserFJ , HanYY , FornoE , BacharierLB , PhipatanakulW , GuilbertTW , et al. Effect of vitamin D supplementation on total andallergen-specific IgE in children with asthma andlow vitamin D levels. Journal of Allergy and Clinical Immunology2021;149(1):440-4.E2. [PMID: 10.1016/j.jaci.2021.05.037]">Forno 2020</a>; <a href="./references#CD011511-bbs2-0007" title="JatKR , GoelN , GuptaN , ChandraPG , SudipD , RakeshL , et al. Efficacy of vitamin D supplementation in asthmatic childrenwith vitamin D deficiency: a randomized controlled trial(ESDAC trial). Pediatric Allergy and Immunology2021;32(3):479– 88. [DOI: 10.1111/pai.13415]">Jat 2020</a>; <a href="./references#CD011511-bbs2-0008" title="JensenM , MailhotG , AlosN , RousseauE , WhiteJ , KhamessanA , et al. Vitamin D intervention in preschoolers with viral-induced asthma (DIVA): a pilot randomised controlled trial. American Journal of Respiratory and Critical Care Medicine2015;191:A3360. JensenME , MailhotG , AlosN , RousseauE , WhiteJ , KhamessanA , et al. Vitamin D intervention in preschoolers with viral-induced asthma (DIVA): a pilot randomised controlled trial. Trials2016;17:353. [DOI: 10.1186/s13063-016-1483-1]">Jensen 2016</a>; <a href="./references#CD011511-bbs2-0009" title="JerzynskaJ , StelmachW , RychlikB , LechańskaJ , PodleckaD , StelmachI . The clinical effect of vitamin D supplementation combined with grass-specific sublingual immunotherapy in children with allergic rhinitis. Allergy and Asthma Proceedings2016;37(2):105-14. [DOI: 10.2500/aap.2016.37.3921]">Jerzynska 2016</a>; <a href="./references#CD011511-bbs2-0010" title="JiangC , YiR , NaH , LinS . A randomized controlled study of Vitamin D3 supplementation on childhood asthma control. Chongqing Medicine2017;46(32):4505-7. [DOI: 10.3969/j.issn.1671-8348.2017.32.011]">Jiang 2017</a>; <a href="./references#CD011511-bbs2-0013" title="MajakP , JerzyiskaJ , SmejdaK , StelmachI , TimlerD , StelmachW . Correlation of vitamin D with Foxp3 induction and steroid-sparing effect of immunotherapy in asthmatic children. Annals of Allergy, Asthma and Immunology2012;109(5):329-35. MajakP , RychlikB , StelmachI . The effect of oral steroids with and without vitamin D3 on early efficacy of immunotherapy in asthmatic children. Clinical and Experimental Allergy2009;39(12):1830-41. ">Majak 2009</a>; <a href="./references#CD011511-bbs2-0014" title="MajakP , Olszowiec-ChlebnaM , SmejdaK , StelmachI . Vitamin D supplementation in children may prevent asthma exacerbation triggered by acute respiratory infection. Journal of Allergy and Clinical Immunology2011;127(5):1294-6. ">Majak 2011</a>; <a href="./references#CD011511-bbs2-0015" title="MartineauAR , MacLaughlinBD , HooperRL , BarnesNC , JolliffeDA , ChoudhuryAB , et al. Double-blind multi-centre randomised controlled trial of vitamin D3 supplementation in adults with inhaled corticosteroid-treated asthma (ViDiAs). Thorax2014;69:A51-2. MartineauAR , MacLaughlinBD , HooperRL , BarnesNC , JolliffeDA , GreillerCL , et al. Double-blind randomised placebo-controlled trial of bolus-dose vitamin D3 supplementation in adults with asthma (ViDiAs). Thorax2015;70(5):451-7. ">Martineau 2015</a>; <a href="./references#CD011511-bbs2-0017" title="TachimotoH , MezawaH , SegawaT , AkiyamaN , IdaH , UrashimaM . Improved control of childhood asthma with low-dose, short-term vitamin D supplementation: a randomized, double-blind, placebo-controlled trial. Allergy2016;71(7):1001-9. ">Tachimoto 2016</a>; <a href="./references#CD011511-bbs2-0018" title="ThakurC , KumarJ , KumarP , GoyalJP , SinghK , GuptaA . Vitamin‐D supplementation as an adjunct to standard treatmentof asthma in children: a randomized controlled trial (ViDASTA Trial). Pediatric Pulmonology2021;56:1427–33. [DOI: 10.1002/ppul.25287]">Thakur 2021</a>). </p> <p><b>Participants</b> </p> <p>Fifteen studies involved a total of 1155 children (<a href="./references#CD011511-bbs2-0001" title="AglipayM , BirkenC , DaiD , ParkinP , MaguireJ . 70 high dose vitamin D for the prevention of wheezing in preschoolers: a secondary analysis of a randomized clinical trial. Paediatrics and Child Health2019;24(S2):e27-8. [DOI: 10.1093/pch/pxz066.069]AglipayM , BirkenCS , ParkinPC , LoebMB , ThorpeK , ChenY , et al. TARGet Kids! Collaboration. Effect of high-dose vs standard-dose wintertime vitamin D supplementation on viral upper respiratory tract infections in young healthy children. JAMA2017;318(3):245-54. [DOI: 10.1001/jama.2017.8708.]">Aglipay 2019</a>; <a href="./references#CD011511-bbs2-0005" title="DucharmeFM , JensenM , MailhotG , AlosN , WhiteJ , RousseauE , et al. Impact of two oral doses of 100,000 IU of vitamin D3 in preschoolers with viral induced asthma: a pilot randomised controlled trial. Trials2019;20(1):138. [DOI: 10.1186/s13063-019-3184-z]">Ducharme 2019</a>; <a href="./references#CD011511-bbs2-0006" title="FornoE , BacharierLB , PhipatanakulW , GuilbertTW , CabanaMD , RossK , et al. Effect of vitamin D3 supplementation on severe asthma exacerbations in children with asthma and low vitamin D levels: The VDKA Randomized Clinical Trial. JAMA2020;324(8):752-60. HanYY , FornoE , BacharierLB , PhipatanakulW , GuilbertTW , CabanaMD , et al. Vitamin D supplementation, lung function and asthma control in children with asthma and low vitamin D levels. European Respiratory Journal2021;58(4):2100989. [DOI: 10.1183/13993003.00989-2021]N/a. Errors in flow diagram. JAMA2021;326(1):90. [DOI: 10.1001/jama.2021.9465.]RosserFJ , HanYY , FornoE , BacharierLB , PhipatanakulW , GuilbertTW , et al. Effect of vitamin D supplementation on total andallergen-specific IgE in children with asthma andlow vitamin D levels. Journal of Allergy and Clinical Immunology2021;149(1):440-4.E2. [PMID: 10.1016/j.jaci.2021.05.037]">Forno 2020</a>; <a href="./references#CD011511-bbs2-0007" title="JatKR , GoelN , GuptaN , ChandraPG , SudipD , RakeshL , et al. Efficacy of vitamin D supplementation in asthmatic childrenwith vitamin D deficiency: a randomized controlled trial(ESDAC trial). Pediatric Allergy and Immunology2021;32(3):479– 88. [DOI: 10.1111/pai.13415]">Jat 2020</a>; <a href="./references#CD011511-bbs2-0008" title="JensenM , MailhotG , AlosN , RousseauE , WhiteJ , KhamessanA , et al. Vitamin D intervention in preschoolers with viral-induced asthma (DIVA): a pilot randomised controlled trial. American Journal of Respiratory and Critical Care Medicine2015;191:A3360. JensenME , MailhotG , AlosN , RousseauE , WhiteJ , KhamessanA , et al. Vitamin D intervention in preschoolers with viral-induced asthma (DIVA): a pilot randomised controlled trial. Trials2016;17:353. [DOI: 10.1186/s13063-016-1483-1]">Jensen 2016</a>; <a href="./references#CD011511-bbs2-0009" title="JerzynskaJ , StelmachW , RychlikB , LechańskaJ , PodleckaD , StelmachI . The clinical effect of vitamin D supplementation combined with grass-specific sublingual immunotherapy in children with allergic rhinitis. Allergy and Asthma Proceedings2016;37(2):105-14. [DOI: 10.2500/aap.2016.37.3921]">Jerzynska 2016</a>; <a href="./references#CD011511-bbs2-0010" title="JiangC , YiR , NaH , LinS . A randomized controlled study of Vitamin D3 supplementation on childhood asthma control. Chongqing Medicine2017;46(32):4505-7. [DOI: 10.3969/j.issn.1671-8348.2017.32.011]">Jiang 2017</a>; <a href="./references#CD011511-bbs2-0011" title="KerleyCP , HutchinsonK , CormicanL , FaulJ , GreallyP , CoghlanD , et al. Vitamin D3 for uncontrolled childhood asthma: A pilot study. Paediatric Allergy and Immunology2016;27:404-12. [PMID: 10.1111/pai.12547]">Kerley 2016</a>; <a href="./references#CD011511-bbs2-0012" title="LewisE , FernandezC , NellaA , HoppR , GallagherJC , CasaleTB . Relationship of 25-hydroxyvitamin D and asthma control in children. Annals of Allergy, Asthma and Immunology2012;108(4):281-2. LewisE , FernandezC , NellaAA , HoppR , CasaleT , GallagherC . The relationship of vitamin D and asthma in children. Journal of Allergy and Clinical Immunology2011;127(2):AB262. ">Lewis 2012</a>; <a href="./references#CD011511-bbs2-0013" title="MajakP , JerzyiskaJ , SmejdaK , StelmachI , TimlerD , StelmachW . Correlation of vitamin D with Foxp3 induction and steroid-sparing effect of immunotherapy in asthmatic children. Annals of Allergy, Asthma and Immunology2012;109(5):329-35. MajakP , RychlikB , StelmachI . The effect of oral steroids with and without vitamin D3 on early efficacy of immunotherapy in asthmatic children. Clinical and Experimental Allergy2009;39(12):1830-41. ">Majak 2009</a>; <a href="./references#CD011511-bbs2-0014" title="MajakP , Olszowiec-ChlebnaM , SmejdaK , StelmachI . Vitamin D supplementation in children may prevent asthma exacerbation triggered by acute respiratory infection. Journal of Allergy and Clinical Immunology2011;127(5):1294-6. ">Majak 2011</a>; <a href="./references#CD011511-bbs2-0017" title="TachimotoH , MezawaH , SegawaT , AkiyamaN , IdaH , UrashimaM . Improved control of childhood asthma with low-dose, short-term vitamin D supplementation: a randomized, double-blind, placebo-controlled trial. Allergy2016;71(7):1001-9. ">Tachimoto 2016</a>; <a href="./references#CD011511-bbs2-0018" title="ThakurC , KumarJ , KumarP , GoyalJP , SinghK , GuptaA . Vitamin‐D supplementation as an adjunct to standard treatmentof asthma in children: a randomized controlled trial (ViDASTA Trial). Pediatric Pulmonology2021;56:1427–33. [DOI: 10.1002/ppul.25287]">Thakur 2021</a>; <a href="./references#CD011511-bbs2-0019" title="UrashimaM , SegawaT , OkazakiM , KuriharaM , WadaY , IdaH . Randomized trial of vitamin D supplementation to prevent seasonal influenza A in school children. American Journal of Clinical Nutrition2010;91(5):1255-60. ">Urashima 2010</a>; <a href="./references#CD011511-bbs2-0020" title="YadavM , MittalK . Effect of vitamin D supplementation on moderate to severe bronchial asthma. Indian Journal of Pediatrics2014;81(7):650-4. ">Yadav 2014</a>), and five studies involved 1070 adults (<a href="./references#CD011511-bbs2-0002" title="Andújar-EspinosaR , Aparicio-VicenteM , Ruiz-LópezFJ , Salinero-GonzálezL . Influence of vitamin D supplementation on the quality of life of asthma patients: Findings from ACVID randomised clinical trial. Respiratory Medicine2021;185:106484. [DOI: 10.1016/j.rmed.2021.106484]Andújar-EspinosaR , Salinero-GonzálezL , Illán-GómezF , Castilla-MartínezM , Hu-YangC , Ruiz-LópezFJ . Effect of vitamin D supplementation on asthma control in patients with vitamin D deficiency: the ACVID randomised clinical trial. Thorax2021;76(2):126–33. [DOI: 10.1136/thoraxjnl-2019-213936]">Andújar‐Espinosa 2021</a>; <a href="./references#CD011511-bbs2-0003" title="CamargoC , ToopL , SluyterJ , LawesCM , WaayerD , KhawKT , et al. Effect of monthly vitamin D supplementation on preventing exacerbations of asthma or chronic obstructive pulmonary disease in older adults: post hoc analysis of a randomized controlled trial. Nutrients2021;13:521. [DOI: 10.3390/nu13020521]SluyterJ , CamargoCA , WaayerD , LawesCM , ToopL , KhawKT , et al. Effect of monthly, high-dose, long-term vitamin D on lung function: a randomized controlled trial. Nutrients2017;9:1353. [DOI: 10.3390/nu9121353]">Camargo 2021</a>; <a href="./references#CD011511-bbs2-0004" title="CastroM , KingTS , KunselmanSJ , CabanaMD , DenlingerL , HolguinF , et al. Effect of vitamin D3 on asthma treatment failures in adults with symptomatic asthma and lower vitamin D levels: the VIDA randomized clinical trial. JAMA2014;311(20):2083-91. DenlingerLC , KingTS , CardetJC , CraigT , HolguinF , JacksonDJ , et al. Vitamin D supplementation and the risk of colds in patients with asthma. American Journal of Respiratory and Critical Care Medicine2016;193(6):634–41. DenlingerLC , KingTS , CardetJC , CraigTJ , HolguinF , KraftM , et al. Vitamin D supplementation and the risk of colds in patients with asthma. Journal of Allergy and Clinical Immunology2015;135:AB109. JiaoJ , KingTS , McKenzieM , BacharierLB , DixonAE , CodispotiCD , et al. Effects of vitamin D3 supplementation in adults with asthma complicated by sinonasal disease. American Journal of Respiratory and Critical Care Medicine2015;191:A4148. JiaoJ , KingTS , McKenzieM , BacharierLB , DixonAE , CodispotiCD , et al. Vitamin D3 therapy in patients with asthma complicated by sinonasal disease: secondary analysis of the Vitamin D Add-on Therapy Enhances Corticosteroid Responsiveness in Asthma trial. Journal of Allergy and Clinical Immunology2016;138(2):589-92. MooreWC , KingTS , BleeckerER , MeyersDA , PetersSP , WenzelSE . Sarp clinical clusters predict steroid responsiveness and risk of asthma exacerbations in the asthma net vida (vitamin D in asthma) trial. American Journal of Respiratory and Critical Care Medicine2015;191:A6055. ReidB , GirodetP , BoomerJS , Abdel-GadirA , ZhengK , WechslerME , et al. Vitamin D3 treatment of vitamin D insufficient asthmatics does not alter immune cell function. Journal of Allergy and Clinical Immunology2016;138(1):286-9. ">Castro 2014</a>; <a href="./references#CD011511-bbs2-0015" title="MartineauAR , MacLaughlinBD , HooperRL , BarnesNC , JolliffeDA , ChoudhuryAB , et al. Double-blind multi-centre randomised controlled trial of vitamin D3 supplementation in adults with inhaled corticosteroid-treated asthma (ViDiAs). Thorax2014;69:A51-2. MartineauAR , MacLaughlinBD , HooperRL , BarnesNC , JolliffeDA , GreillerCL , et al. Double-blind randomised placebo-controlled trial of bolus-dose vitamin D3 supplementation in adults with asthma (ViDiAs). Thorax2015;70(5):451-7. ">Martineau 2015</a>; <a href="./references#CD011511-bbs2-0016" title="Ramos-MartínezE , López-VancellMR , Fernández de Córdova-AguirreJC , Rojas-SerranoJ , ChavarríaA , Velasco-MedinaA , et al. Reduction of respiratory infections in asthma patients supplemented with vitamin D is related to increased serum IL-10 and IFNγ levels and cathelicidin expression. Cytokine2018;108:239–46. ">Ramos‐Martínez 2018</a>). Participants were ethnically diverse, reflecting the broad range of geographic settings: Canada (<a href="./references#CD011511-bbs2-0001" title="AglipayM , BirkenC , DaiD , ParkinP , MaguireJ . 70 high dose vitamin D for the prevention of wheezing in preschoolers: a secondary analysis of a randomized clinical trial. Paediatrics and Child Health2019;24(S2):e27-8. [DOI: 10.1093/pch/pxz066.069]AglipayM , BirkenCS , ParkinPC , LoebMB , ThorpeK , ChenY , et al. TARGet Kids! Collaboration. Effect of high-dose vs standard-dose wintertime vitamin D supplementation on viral upper respiratory tract infections in young healthy children. JAMA2017;318(3):245-54. [DOI: 10.1001/jama.2017.8708.]">Aglipay 2019</a>; <a href="./references#CD011511-bbs2-0005" title="DucharmeFM , JensenM , MailhotG , AlosN , WhiteJ , RousseauE , et al. Impact of two oral doses of 100,000 IU of vitamin D3 in preschoolers with viral induced asthma: a pilot randomised controlled trial. Trials2019;20(1):138. [DOI: 10.1186/s13063-019-3184-z]">Ducharme 2019</a>; <a href="./references#CD011511-bbs2-0008" title="JensenM , MailhotG , AlosN , RousseauE , WhiteJ , KhamessanA , et al. Vitamin D intervention in preschoolers with viral-induced asthma (DIVA): a pilot randomised controlled trial. American Journal of Respiratory and Critical Care Medicine2015;191:A3360. JensenME , MailhotG , AlosN , RousseauE , WhiteJ , KhamessanA , et al. Vitamin D intervention in preschoolers with viral-induced asthma (DIVA): a pilot randomised controlled trial. Trials2016;17:353. [DOI: 10.1186/s13063-016-1483-1]">Jensen 2016</a>), India (<a href="./references#CD011511-bbs2-0007" title="JatKR , GoelN , GuptaN , ChandraPG , SudipD , RakeshL , et al. Efficacy of vitamin D supplementation in asthmatic childrenwith vitamin D deficiency: a randomized controlled trial(ESDAC trial). Pediatric Allergy and Immunology2021;32(3):479– 88. [DOI: 10.1111/pai.13415]">Jat 2020</a>; <a href="./references#CD011511-bbs2-0018" title="ThakurC , KumarJ , KumarP , GoyalJP , SinghK , GuptaA . Vitamin‐D supplementation as an adjunct to standard treatmentof asthma in children: a randomized controlled trial (ViDASTA Trial). Pediatric Pulmonology2021;56:1427–33. [DOI: 10.1002/ppul.25287]">Thakur 2021</a>; <a href="./references#CD011511-bbs2-0020" title="YadavM , MittalK . Effect of vitamin D supplementation on moderate to severe bronchial asthma. Indian Journal of Pediatrics2014;81(7):650-4. ">Yadav 2014</a>), Japan (<a href="./references#CD011511-bbs2-0017" title="TachimotoH , MezawaH , SegawaT , AkiyamaN , IdaH , UrashimaM . Improved control of childhood asthma with low-dose, short-term vitamin D supplementation: a randomized, double-blind, placebo-controlled trial. Allergy2016;71(7):1001-9. ">Tachimoto 2016</a>; <a href="./references#CD011511-bbs2-0019" title="UrashimaM , SegawaT , OkazakiM , KuriharaM , WadaY , IdaH . Randomized trial of vitamin D supplementation to prevent seasonal influenza A in school children. American Journal of Clinical Nutrition2010;91(5):1255-60. ">Urashima 2010</a>), Poland (<a href="./references#CD011511-bbs2-0009" title="JerzynskaJ , StelmachW , RychlikB , LechańskaJ , PodleckaD , StelmachI . The clinical effect of vitamin D supplementation combined with grass-specific sublingual immunotherapy in children with allergic rhinitis. Allergy and Asthma Proceedings2016;37(2):105-14. [DOI: 10.2500/aap.2016.37.3921]">Jerzynska 2016</a>; <a href="./references#CD011511-bbs2-0013" title="MajakP , JerzyiskaJ , SmejdaK , StelmachI , TimlerD , StelmachW . Correlation of vitamin D with Foxp3 induction and steroid-sparing effect of immunotherapy in asthmatic children. Annals of Allergy, Asthma and Immunology2012;109(5):329-35. MajakP , RychlikB , StelmachI . The effect of oral steroids with and without vitamin D3 on early efficacy of immunotherapy in asthmatic children. Clinical and Experimental Allergy2009;39(12):1830-41. ">Majak 2009</a>; <a href="./references#CD011511-bbs2-0014" title="MajakP , Olszowiec-ChlebnaM , SmejdaK , StelmachI . Vitamin D supplementation in children may prevent asthma exacerbation triggered by acute respiratory infection. Journal of Allergy and Clinical Immunology2011;127(5):1294-6. ">Majak 2011</a>), the UK (<a href="./references#CD011511-bbs2-0015" title="MartineauAR , MacLaughlinBD , HooperRL , BarnesNC , JolliffeDA , ChoudhuryAB , et al. Double-blind multi-centre randomised controlled trial of vitamin D3 supplementation in adults with inhaled corticosteroid-treated asthma (ViDiAs). Thorax2014;69:A51-2. MartineauAR , MacLaughlinBD , HooperRL , BarnesNC , JolliffeDA , GreillerCL , et al. Double-blind randomised placebo-controlled trial of bolus-dose vitamin D3 supplementation in adults with asthma (ViDiAs). Thorax2015;70(5):451-7. ">Martineau 2015</a>), Spain (<a href="./references#CD011511-bbs2-0002" title="Andújar-EspinosaR , Aparicio-VicenteM , Ruiz-LópezFJ , Salinero-GonzálezL . Influence of vitamin D supplementation on the quality of life of asthma patients: Findings from ACVID randomised clinical trial. Respiratory Medicine2021;185:106484. [DOI: 10.1016/j.rmed.2021.106484]Andújar-EspinosaR , Salinero-GonzálezL , Illán-GómezF , Castilla-MartínezM , Hu-YangC , Ruiz-LópezFJ . Effect of vitamin D supplementation on asthma control in patients with vitamin D deficiency: the ACVID randomised clinical trial. Thorax2021;76(2):126–33. [DOI: 10.1136/thoraxjnl-2019-213936]">Andújar‐Espinosa 2021</a>), New Zealand (<a href="./references#CD011511-bbs2-0003" title="CamargoC , ToopL , SluyterJ , LawesCM , WaayerD , KhawKT , et al. Effect of monthly vitamin D supplementation on preventing exacerbations of asthma or chronic obstructive pulmonary disease in older adults: post hoc analysis of a randomized controlled trial. Nutrients2021;13:521. [DOI: 10.3390/nu13020521]SluyterJ , CamargoCA , WaayerD , LawesCM , ToopL , KhawKT , et al. Effect of monthly, high-dose, long-term vitamin D on lung function: a randomized controlled trial. Nutrients2017;9:1353. [DOI: 10.3390/nu9121353]">Camargo 2021</a>), China (<a href="./references#CD011511-bbs2-0010" title="JiangC , YiR , NaH , LinS . A randomized controlled study of Vitamin D3 supplementation on childhood asthma control. Chongqing Medicine2017;46(32):4505-7. [DOI: 10.3969/j.issn.1671-8348.2017.32.011]">Jiang 2017</a>), Ireland (<a href="./references#CD011511-bbs2-0011" title="KerleyCP , HutchinsonK , CormicanL , FaulJ , GreallyP , CoghlanD , et al. Vitamin D3 for uncontrolled childhood asthma: A pilot study. Paediatric Allergy and Immunology2016;27:404-12. [PMID: 10.1111/pai.12547]">Kerley 2016</a>), Mexico (<a href="./references#CD011511-bbs2-0016" title="Ramos-MartínezE , López-VancellMR , Fernández de Córdova-AguirreJC , Rojas-SerranoJ , ChavarríaA , Velasco-MedinaA , et al. Reduction of respiratory infections in asthma patients supplemented with vitamin D is related to increased serum IL-10 and IFNγ levels and cathelicidin expression. Cytokine2018;108:239–46. ">Ramos‐Martínez 2018</a>), and the USA (<a href="./references#CD011511-bbs2-0004" title="CastroM , KingTS , KunselmanSJ , CabanaMD , DenlingerL , HolguinF , et al. Effect of vitamin D3 on asthma treatment failures in adults with symptomatic asthma and lower vitamin D levels: the VIDA randomized clinical trial. JAMA2014;311(20):2083-91. DenlingerLC , KingTS , CardetJC , CraigT , HolguinF , JacksonDJ , et al. Vitamin D supplementation and the risk of colds in patients with asthma. American Journal of Respiratory and Critical Care Medicine2016;193(6):634–41. DenlingerLC , KingTS , CardetJC , CraigTJ , HolguinF , KraftM , et al. Vitamin D supplementation and the risk of colds in patients with asthma. Journal of Allergy and Clinical Immunology2015;135:AB109. JiaoJ , KingTS , McKenzieM , BacharierLB , DixonAE , CodispotiCD , et al. Effects of vitamin D3 supplementation in adults with asthma complicated by sinonasal disease. American Journal of Respiratory and Critical Care Medicine2015;191:A4148. JiaoJ , KingTS , McKenzieM , BacharierLB , DixonAE , CodispotiCD , et al. Vitamin D3 therapy in patients with asthma complicated by sinonasal disease: secondary analysis of the Vitamin D Add-on Therapy Enhances Corticosteroid Responsiveness in Asthma trial. Journal of Allergy and Clinical Immunology2016;138(2):589-92. MooreWC , KingTS , BleeckerER , MeyersDA , PetersSP , WenzelSE . Sarp clinical clusters predict steroid responsiveness and risk of asthma exacerbations in the asthma net vida (vitamin D in asthma) trial. American Journal of Respiratory and Critical Care Medicine2015;191:A6055. ReidB , GirodetP , BoomerJS , Abdel-GadirA , ZhengK , WechslerME , et al. Vitamin D3 treatment of vitamin D insufficient asthmatics does not alter immune cell function. Journal of Allergy and Clinical Immunology2016;138(1):286-9. ">Castro 2014</a>; <a href="./references#CD011511-bbs2-0006" title="FornoE , BacharierLB , PhipatanakulW , GuilbertTW , CabanaMD , RossK , et al. Effect of vitamin D3 supplementation on severe asthma exacerbations in children with asthma and low vitamin D levels: The VDKA Randomized Clinical Trial. JAMA2020;324(8):752-60. HanYY , FornoE , BacharierLB , PhipatanakulW , GuilbertTW , CabanaMD , et al. Vitamin D supplementation, lung function and asthma control in children with asthma and low vitamin D levels. European Respiratory Journal2021;58(4):2100989. [DOI: 10.1183/13993003.00989-2021]N/a. Errors in flow diagram. JAMA2021;326(1):90. [DOI: 10.1001/jama.2021.9465.]RosserFJ , HanYY , FornoE , BacharierLB , PhipatanakulW , GuilbertTW , et al. Effect of vitamin D supplementation on total andallergen-specific IgE in children with asthma andlow vitamin D levels. Journal of Allergy and Clinical Immunology2021;149(1):440-4.E2. [PMID: 10.1016/j.jaci.2021.05.037]">Forno 2020</a>; <a href="./references#CD011511-bbs2-0012" title="LewisE , FernandezC , NellaA , HoppR , GallagherJC , CasaleTB . Relationship of 25-hydroxyvitamin D and asthma control in children. Annals of Allergy, Asthma and Immunology2012;108(4):281-2. LewisE , FernandezC , NellaAA , HoppR , CasaleT , GallagherC . The relationship of vitamin D and asthma in children. Journal of Allergy and Clinical Immunology2011;127(2):AB262. ">Lewis 2012</a>). The majority of participants had mild to moderate asthma, defined as requiring GINA step 4 treatment or below, and a minority had severe asthma. Where measured, mean/median baseline serum 25(OH)D concentration ranged from 28 nmol/L (<a href="./references#CD011511-bbs2-0007" title="JatKR , GoelN , GuptaN , ChandraPG , SudipD , RakeshL , et al. Efficacy of vitamin D supplementation in asthmatic childrenwith vitamin D deficiency: a randomized controlled trial(ESDAC trial). Pediatric Allergy and Immunology2021;32(3):479– 88. [DOI: 10.1111/pai.13415]">Jat 2020</a>) to 89 nmol/L (<a href="./references#CD011511-bbs2-0014" title="MajakP , Olszowiec-ChlebnaM , SmejdaK , StelmachI . Vitamin D supplementation in children may prevent asthma exacerbation triggered by acute respiratory infection. Journal of Allergy and Clinical Immunology2011;127(5):1294-6. ">Majak 2011</a>). A minority of participants had serum 25(OH)D concentrations in the profoundly deficient range (less than 25 nmol/L). </p> <p><b>Intervention</b> </p> <p>All studies but two (<a href="./references#CD011511-bbs2-0002" title="Andújar-EspinosaR , Aparicio-VicenteM , Ruiz-LópezFJ , Salinero-GonzálezL . Influence of vitamin D supplementation on the quality of life of asthma patients: Findings from ACVID randomised clinical trial. Respiratory Medicine2021;185:106484. [DOI: 10.1016/j.rmed.2021.106484]Andújar-EspinosaR , Salinero-GonzálezL , Illán-GómezF , Castilla-MartínezM , Hu-YangC , Ruiz-LópezFJ . Effect of vitamin D supplementation on asthma control in patients with vitamin D deficiency: the ACVID randomised clinical trial. Thorax2021;76(2):126–33. [DOI: 10.1136/thoraxjnl-2019-213936]">Andújar‐Espinosa 2021</a>; <a href="./references#CD011511-bbs2-0016" title="Ramos-MartínezE , López-VancellMR , Fernández de Córdova-AguirreJC , Rojas-SerranoJ , ChavarríaA , Velasco-MedinaA , et al. Reduction of respiratory infections in asthma patients supplemented with vitamin D is related to increased serum IL-10 and IFNγ levels and cathelicidin expression. Cytokine2018;108:239–46. ">Ramos‐Martínez 2018</a>) administered oral vitamin D<sub>3</sub> (cholecalciferol) to participants in the intervention arm. <a href="./references#CD011511-bbs2-0016" title="Ramos-MartínezE , López-VancellMR , Fernández de Córdova-AguirreJC , Rojas-SerranoJ , ChavarríaA , Velasco-MedinaA , et al. Reduction of respiratory infections in asthma patients supplemented with vitamin D is related to increased serum IL-10 and IFNγ levels and cathelicidin expression. Cytokine2018;108:239–46. ">Ramos‐Martínez 2018</a> instead administered oral calcitriol (1,25‐(OH)<sub>2</sub>D<sub>3</sub>) to participants in the intervention arm, at a dose of 0.25 μg/day. <a href="./references#CD011511-bbs2-0002" title="Andújar-EspinosaR , Aparicio-VicenteM , Ruiz-LópezFJ , Salinero-GonzálezL . Influence of vitamin D supplementation on the quality of life of asthma patients: Findings from ACVID randomised clinical trial. Respiratory Medicine2021;185:106484. [DOI: 10.1016/j.rmed.2021.106484]Andújar-EspinosaR , Salinero-GonzálezL , Illán-GómezF , Castilla-MartínezM , Hu-YangC , Ruiz-LópezFJ . Effect of vitamin D supplementation on asthma control in patients with vitamin D deficiency: the ACVID randomised clinical trial. Thorax2021;76(2):126–33. [DOI: 10.1136/thoraxjnl-2019-213936]">Andújar‐Espinosa 2021</a> administered oral calcidiol, at a dose of 16,000 IU per week. There was considerable heterogeneity in vitamin D dosage regimens employed. Twelve studies exclusively used daily dosing regimens (<a href="./references#CD011511-bbs2-0001" title="AglipayM , BirkenC , DaiD , ParkinP , MaguireJ . 70 high dose vitamin D for the prevention of wheezing in preschoolers: a secondary analysis of a randomized clinical trial. Paediatrics and Child Health2019;24(S2):e27-8. [DOI: 10.1093/pch/pxz066.069]AglipayM , BirkenCS , ParkinPC , LoebMB , ThorpeK , ChenY , et al. TARGet Kids! Collaboration. Effect of high-dose vs standard-dose wintertime vitamin D supplementation on viral upper respiratory tract infections in young healthy children. JAMA2017;318(3):245-54. [DOI: 10.1001/jama.2017.8708.]">Aglipay 2019</a>; <a href="./references#CD011511-bbs2-0006" title="FornoE , BacharierLB , PhipatanakulW , GuilbertTW , CabanaMD , RossK , et al. Effect of vitamin D3 supplementation on severe asthma exacerbations in children with asthma and low vitamin D levels: The VDKA Randomized Clinical Trial. JAMA2020;324(8):752-60. HanYY , FornoE , BacharierLB , PhipatanakulW , GuilbertTW , CabanaMD , et al. Vitamin D supplementation, lung function and asthma control in children with asthma and low vitamin D levels. European Respiratory Journal2021;58(4):2100989. [DOI: 10.1183/13993003.00989-2021]N/a. Errors in flow diagram. JAMA2021;326(1):90. [DOI: 10.1001/jama.2021.9465.]RosserFJ , HanYY , FornoE , BacharierLB , PhipatanakulW , GuilbertTW , et al. Effect of vitamin D supplementation on total andallergen-specific IgE in children with asthma andlow vitamin D levels. Journal of Allergy and Clinical Immunology2021;149(1):440-4.E2. [PMID: 10.1016/j.jaci.2021.05.037]">Forno 2020</a>; <a href="./references#CD011511-bbs2-0007" title="JatKR , GoelN , GuptaN , ChandraPG , SudipD , RakeshL , et al. Efficacy of vitamin D supplementation in asthmatic childrenwith vitamin D deficiency: a randomized controlled trial(ESDAC trial). Pediatric Allergy and Immunology2021;32(3):479– 88. [DOI: 10.1111/pai.13415]">Jat 2020</a>; <a href="./references#CD011511-bbs2-0009" title="JerzynskaJ , StelmachW , RychlikB , LechańskaJ , PodleckaD , StelmachI . The clinical effect of vitamin D supplementation combined with grass-specific sublingual immunotherapy in children with allergic rhinitis. Allergy and Asthma Proceedings2016;37(2):105-14. [DOI: 10.2500/aap.2016.37.3921]">Jerzynska 2016</a>; <a href="./references#CD011511-bbs2-0010" title="JiangC , YiR , NaH , LinS . A randomized controlled study of Vitamin D3 supplementation on childhood asthma control. Chongqing Medicine2017;46(32):4505-7. [DOI: 10.3969/j.issn.1671-8348.2017.32.011]">Jiang 2017</a>; <a href="./references#CD011511-bbs2-0011" title="KerleyCP , HutchinsonK , CormicanL , FaulJ , GreallyP , CoghlanD , et al. Vitamin D3 for uncontrolled childhood asthma: A pilot study. Paediatric Allergy and Immunology2016;27:404-12. [PMID: 10.1111/pai.12547]">Kerley 2016</a>; <a href="./references#CD011511-bbs2-0012" title="LewisE , FernandezC , NellaA , HoppR , GallagherJC , CasaleTB . Relationship of 25-hydroxyvitamin D and asthma control in children. Annals of Allergy, Asthma and Immunology2012;108(4):281-2. LewisE , FernandezC , NellaAA , HoppR , CasaleT , GallagherC . The relationship of vitamin D and asthma in children. Journal of Allergy and Clinical Immunology2011;127(2):AB262. ">Lewis 2012</a>; <a href="./references#CD011511-bbs2-0014" title="MajakP , Olszowiec-ChlebnaM , SmejdaK , StelmachI . Vitamin D supplementation in children may prevent asthma exacerbation triggered by acute respiratory infection. Journal of Allergy and Clinical Immunology2011;127(5):1294-6. ">Majak 2011</a>; <a href="./references#CD011511-bbs2-0016" title="Ramos-MartínezE , López-VancellMR , Fernández de Córdova-AguirreJC , Rojas-SerranoJ , ChavarríaA , Velasco-MedinaA , et al. Reduction of respiratory infections in asthma patients supplemented with vitamin D is related to increased serum IL-10 and IFNγ levels and cathelicidin expression. Cytokine2018;108:239–46. ">Ramos‐Martínez 2018</a>; <a href="./references#CD011511-bbs2-0017" title="TachimotoH , MezawaH , SegawaT , AkiyamaN , IdaH , UrashimaM . Improved control of childhood asthma with low-dose, short-term vitamin D supplementation: a randomized, double-blind, placebo-controlled trial. Allergy2016;71(7):1001-9. ">Tachimoto 2016</a>; <a href="./references#CD011511-bbs2-0018" title="ThakurC , KumarJ , KumarP , GoyalJP , SinghK , GuptaA . Vitamin‐D supplementation as an adjunct to standard treatmentof asthma in children: a randomized controlled trial (ViDASTA Trial). Pediatric Pulmonology2021;56:1427–33. [DOI: 10.1002/ppul.25287]">Thakur 2021</a>; <a href="./references#CD011511-bbs2-0019" title="UrashimaM , SegawaT , OkazakiM , KuriharaM , WadaY , IdaH . Randomized trial of vitamin D supplementation to prevent seasonal influenza A in school children. American Journal of Clinical Nutrition2010;91(5):1255-60. ">Urashima 2010</a>). Of the other studies, two used weekly dosing (<a href="./references#CD011511-bbs2-0002" title="Andújar-EspinosaR , Aparicio-VicenteM , Ruiz-LópezFJ , Salinero-GonzálezL . Influence of vitamin D supplementation on the quality of life of asthma patients: Findings from ACVID randomised clinical trial. Respiratory Medicine2021;185:106484. [DOI: 10.1016/j.rmed.2021.106484]Andújar-EspinosaR , Salinero-GonzálezL , Illán-GómezF , Castilla-MartínezM , Hu-YangC , Ruiz-LópezFJ . Effect of vitamin D supplementation on asthma control in patients with vitamin D deficiency: the ACVID randomised clinical trial. Thorax2021;76(2):126–33. [DOI: 10.1136/thoraxjnl-2019-213936]">Andújar‐Espinosa 2021</a>, <a href="./references#CD011511-bbs2-0013" title="MajakP , JerzyiskaJ , SmejdaK , StelmachI , TimlerD , StelmachW . Correlation of vitamin D with Foxp3 induction and steroid-sparing effect of immunotherapy in asthmatic children. Annals of Allergy, Asthma and Immunology2012;109(5):329-35. MajakP , RychlikB , StelmachI . The effect of oral steroids with and without vitamin D3 on early efficacy of immunotherapy in asthmatic children. Clinical and Experimental Allergy2009;39(12):1830-41. ">Majak 2009</a>), one used monthly dosing (<a href="./references#CD011511-bbs2-0020" title="YadavM , MittalK . Effect of vitamin D supplementation on moderate to severe bronchial asthma. Indian Journal of Pediatrics2014;81(7):650-4. ">Yadav 2014</a>), one used two‐monthly dosing (<a href="./references#CD011511-bbs2-0015" title="MartineauAR , MacLaughlinBD , HooperRL , BarnesNC , JolliffeDA , ChoudhuryAB , et al. Double-blind multi-centre randomised controlled trial of vitamin D3 supplementation in adults with inhaled corticosteroid-treated asthma (ViDiAs). Thorax2014;69:A51-2. MartineauAR , MacLaughlinBD , HooperRL , BarnesNC , JolliffeDA , GreillerCL , et al. Double-blind randomised placebo-controlled trial of bolus-dose vitamin D3 supplementation in adults with asthma (ViDiAs). Thorax2015;70(5):451-7. ">Martineau 2015</a>), two gave a bolus dose at the start of the study, followed by daily dosing (<a href="./references#CD011511-bbs2-0004" title="CastroM , KingTS , KunselmanSJ , CabanaMD , DenlingerL , HolguinF , et al. Effect of vitamin D3 on asthma treatment failures in adults with symptomatic asthma and lower vitamin D levels: the VIDA randomized clinical trial. JAMA2014;311(20):2083-91. DenlingerLC , KingTS , CardetJC , CraigT , HolguinF , JacksonDJ , et al. Vitamin D supplementation and the risk of colds in patients with asthma. American Journal of Respiratory and Critical Care Medicine2016;193(6):634–41. DenlingerLC , KingTS , CardetJC , CraigTJ , HolguinF , KraftM , et al. Vitamin D supplementation and the risk of colds in patients with asthma. Journal of Allergy and Clinical Immunology2015;135:AB109. JiaoJ , KingTS , McKenzieM , BacharierLB , DixonAE , CodispotiCD , et al. Effects of vitamin D3 supplementation in adults with asthma complicated by sinonasal disease. American Journal of Respiratory and Critical Care Medicine2015;191:A4148. JiaoJ , KingTS , McKenzieM , BacharierLB , DixonAE , CodispotiCD , et al. Vitamin D3 therapy in patients with asthma complicated by sinonasal disease: secondary analysis of the Vitamin D Add-on Therapy Enhances Corticosteroid Responsiveness in Asthma trial. Journal of Allergy and Clinical Immunology2016;138(2):589-92. MooreWC , KingTS , BleeckerER , MeyersDA , PetersSP , WenzelSE . Sarp clinical clusters predict steroid responsiveness and risk of asthma exacerbations in the asthma net vida (vitamin D in asthma) trial. American Journal of Respiratory and Critical Care Medicine2015;191:A6055. ReidB , GirodetP , BoomerJS , Abdel-GadirA , ZhengK , WechslerME , et al. Vitamin D3 treatment of vitamin D insufficient asthmatics does not alter immune cell function. Journal of Allergy and Clinical Immunology2016;138(1):286-9. ">Castro 2014</a>; <a href="./references#CD011511-bbs2-0008" title="JensenM , MailhotG , AlosN , RousseauE , WhiteJ , KhamessanA , et al. Vitamin D intervention in preschoolers with viral-induced asthma (DIVA): a pilot randomised controlled trial. American Journal of Respiratory and Critical Care Medicine2015;191:A3360. JensenME , MailhotG , AlosN , RousseauE , WhiteJ , KhamessanA , et al. Vitamin D intervention in preschoolers with viral-induced asthma (DIVA): a pilot randomised controlled trial. Trials2016;17:353. [DOI: 10.1186/s13063-016-1483-1]">Jensen 2016</a>), one gave a bolus dose followed by monthly dosing (<a href="./references#CD011511-bbs2-0003" title="CamargoC , ToopL , SluyterJ , LawesCM , WaayerD , KhawKT , et al. Effect of monthly vitamin D supplementation on preventing exacerbations of asthma or chronic obstructive pulmonary disease in older adults: post hoc analysis of a randomized controlled trial. Nutrients2021;13:521. [DOI: 10.3390/nu13020521]SluyterJ , CamargoCA , WaayerD , LawesCM , ToopL , KhawKT , et al. Effect of monthly, high-dose, long-term vitamin D on lung function: a randomized controlled trial. Nutrients2017;9:1353. [DOI: 10.3390/nu9121353]">Camargo 2021</a>), and one administered a bolus at baseline and a bolus at 3.5 months (<a href="./references#CD011511-bbs2-0005" title="DucharmeFM , JensenM , MailhotG , AlosN , WhiteJ , RousseauE , et al. Impact of two oral doses of 100,000 IU of vitamin D3 in preschoolers with viral induced asthma: a pilot randomised controlled trial. Trials2019;20(1):138. [DOI: 10.1186/s13063-019-3184-z]">Ducharme 2019</a>). </p> <p>One study administered low‐dose vitamin D (400 IU/day) to participants in both the control and intervention arms; participants in the intervention arm of this study received an additional bolus of 100,000 IU vitamin D at the start of the study (<a href="./references#CD011511-bbs2-0008" title="JensenM , MailhotG , AlosN , RousseauE , WhiteJ , KhamessanA , et al. Vitamin D intervention in preschoolers with viral-induced asthma (DIVA): a pilot randomised controlled trial. American Journal of Respiratory and Critical Care Medicine2015;191:A3360. JensenME , MailhotG , AlosN , RousseauE , WhiteJ , KhamessanA , et al. Vitamin D intervention in preschoolers with viral-induced asthma (DIVA): a pilot randomised controlled trial. Trials2016;17:353. [DOI: 10.1186/s13063-016-1483-1]">Jensen 2016</a>). Another study administered low‐dose vitamin D (400 IU/day) to participants in the control arm, and high‐dose vitamin D (2000 IU/day) to participants in the intervention arm (<a href="./references#CD011511-bbs2-0001" title="AglipayM , BirkenC , DaiD , ParkinP , MaguireJ . 70 high dose vitamin D for the prevention of wheezing in preschoolers: a secondary analysis of a randomized clinical trial. Paediatrics and Child Health2019;24(S2):e27-8. [DOI: 10.1093/pch/pxz066.069]AglipayM , BirkenCS , ParkinPC , LoebMB , ThorpeK , ChenY , et al. TARGet Kids! Collaboration. Effect of high-dose vs standard-dose wintertime vitamin D supplementation on viral upper respiratory tract infections in young healthy children. JAMA2017;318(3):245-54. [DOI: 10.1001/jama.2017.8708.]">Aglipay 2019</a>). One study also administered an additional grass pollen extract to both intervention and control arms (<a href="./references#CD011511-bbs2-0009" title="JerzynskaJ , StelmachW , RychlikB , LechańskaJ , PodleckaD , StelmachI . The clinical effect of vitamin D supplementation combined with grass-specific sublingual immunotherapy in children with allergic rhinitis. Allergy and Asthma Proceedings2016;37(2):105-14. [DOI: 10.2500/aap.2016.37.3921]">Jerzynska 2016</a>). For the 14 trials in which vitamin D was given daily (with or without additional bolus doses) (<a href="./references#CD011511-bbs2-0001" title="AglipayM , BirkenC , DaiD , ParkinP , MaguireJ . 70 high dose vitamin D for the prevention of wheezing in preschoolers: a secondary analysis of a randomized clinical trial. Paediatrics and Child Health2019;24(S2):e27-8. [DOI: 10.1093/pch/pxz066.069]AglipayM , BirkenCS , ParkinPC , LoebMB , ThorpeK , ChenY , et al. TARGet Kids! Collaboration. Effect of high-dose vs standard-dose wintertime vitamin D supplementation on viral upper respiratory tract infections in young healthy children. JAMA2017;318(3):245-54. [DOI: 10.1001/jama.2017.8708.]">Aglipay 2019</a>; <a href="./references#CD011511-bbs2-0004" title="CastroM , KingTS , KunselmanSJ , CabanaMD , DenlingerL , HolguinF , et al. Effect of vitamin D3 on asthma treatment failures in adults with symptomatic asthma and lower vitamin D levels: the VIDA randomized clinical trial. JAMA2014;311(20):2083-91. DenlingerLC , KingTS , CardetJC , CraigT , HolguinF , JacksonDJ , et al. Vitamin D supplementation and the risk of colds in patients with asthma. American Journal of Respiratory and Critical Care Medicine2016;193(6):634–41. DenlingerLC , KingTS , CardetJC , CraigTJ , HolguinF , KraftM , et al. Vitamin D supplementation and the risk of colds in patients with asthma. Journal of Allergy and Clinical Immunology2015;135:AB109. JiaoJ , KingTS , McKenzieM , BacharierLB , DixonAE , CodispotiCD , et al. Effects of vitamin D3 supplementation in adults with asthma complicated by sinonasal disease. American Journal of Respiratory and Critical Care Medicine2015;191:A4148. JiaoJ , KingTS , McKenzieM , BacharierLB , DixonAE , CodispotiCD , et al. Vitamin D3 therapy in patients with asthma complicated by sinonasal disease: secondary analysis of the Vitamin D Add-on Therapy Enhances Corticosteroid Responsiveness in Asthma trial. Journal of Allergy and Clinical Immunology2016;138(2):589-92. MooreWC , KingTS , BleeckerER , MeyersDA , PetersSP , WenzelSE . Sarp clinical clusters predict steroid responsiveness and risk of asthma exacerbations in the asthma net vida (vitamin D in asthma) trial. American Journal of Respiratory and Critical Care Medicine2015;191:A6055. ReidB , GirodetP , BoomerJS , Abdel-GadirA , ZhengK , WechslerME , et al. Vitamin D3 treatment of vitamin D insufficient asthmatics does not alter immune cell function. Journal of Allergy and Clinical Immunology2016;138(1):286-9. ">Castro 2014</a>; <a href="./references#CD011511-bbs2-0006" title="FornoE , BacharierLB , PhipatanakulW , GuilbertTW , CabanaMD , RossK , et al. Effect of vitamin D3 supplementation on severe asthma exacerbations in children with asthma and low vitamin D levels: The VDKA Randomized Clinical Trial. JAMA2020;324(8):752-60. HanYY , FornoE , BacharierLB , PhipatanakulW , GuilbertTW , CabanaMD , et al. Vitamin D supplementation, lung function and asthma control in children with asthma and low vitamin D levels. European Respiratory Journal2021;58(4):2100989. [DOI: 10.1183/13993003.00989-2021]N/a. Errors in flow diagram. JAMA2021;326(1):90. [DOI: 10.1001/jama.2021.9465.]RosserFJ , HanYY , FornoE , BacharierLB , PhipatanakulW , GuilbertTW , et al. Effect of vitamin D supplementation on total andallergen-specific IgE in children with asthma andlow vitamin D levels. Journal of Allergy and Clinical Immunology2021;149(1):440-4.E2. [PMID: 10.1016/j.jaci.2021.05.037]">Forno 2020</a>; <a href="./references#CD011511-bbs2-0007" title="JatKR , GoelN , GuptaN , ChandraPG , SudipD , RakeshL , et al. Efficacy of vitamin D supplementation in asthmatic childrenwith vitamin D deficiency: a randomized controlled trial(ESDAC trial). Pediatric Allergy and Immunology2021;32(3):479– 88. [DOI: 10.1111/pai.13415]">Jat 2020</a>; <a href="./references#CD011511-bbs2-0008" title="JensenM , MailhotG , AlosN , RousseauE , WhiteJ , KhamessanA , et al. Vitamin D intervention in preschoolers with viral-induced asthma (DIVA): a pilot randomised controlled trial. American Journal of Respiratory and Critical Care Medicine2015;191:A3360. JensenME , MailhotG , AlosN , RousseauE , WhiteJ , KhamessanA , et al. Vitamin D intervention in preschoolers with viral-induced asthma (DIVA): a pilot randomised controlled trial. Trials2016;17:353. [DOI: 10.1186/s13063-016-1483-1]">Jensen 2016</a>; <a href="./references#CD011511-bbs2-0009" title="JerzynskaJ , StelmachW , RychlikB , LechańskaJ , PodleckaD , StelmachI . The clinical effect of vitamin D supplementation combined with grass-specific sublingual immunotherapy in children with allergic rhinitis. Allergy and Asthma Proceedings2016;37(2):105-14. [DOI: 10.2500/aap.2016.37.3921]">Jerzynska 2016</a>; <a href="./references#CD011511-bbs2-0010" title="JiangC , YiR , NaH , LinS . A randomized controlled study of Vitamin D3 supplementation on childhood asthma control. Chongqing Medicine2017;46(32):4505-7. [DOI: 10.3969/j.issn.1671-8348.2017.32.011]">Jiang 2017</a>; <a href="./references#CD011511-bbs2-0011" title="KerleyCP , HutchinsonK , CormicanL , FaulJ , GreallyP , CoghlanD , et al. Vitamin D3 for uncontrolled childhood asthma: A pilot study. Paediatric Allergy and Immunology2016;27:404-12. [PMID: 10.1111/pai.12547]">Kerley 2016</a>; <a href="./references#CD011511-bbs2-0012" title="LewisE , FernandezC , NellaA , HoppR , GallagherJC , CasaleTB . Relationship of 25-hydroxyvitamin D and asthma control in children. Annals of Allergy, Asthma and Immunology2012;108(4):281-2. LewisE , FernandezC , NellaAA , HoppR , CasaleT , GallagherC . The relationship of vitamin D and asthma in children. Journal of Allergy and Clinical Immunology2011;127(2):AB262. ">Lewis 2012</a>; <a href="./references#CD011511-bbs2-0014" title="MajakP , Olszowiec-ChlebnaM , SmejdaK , StelmachI . Vitamin D supplementation in children may prevent asthma exacerbation triggered by acute respiratory infection. Journal of Allergy and Clinical Immunology2011;127(5):1294-6. ">Majak 2011</a>; <a href="./references#CD011511-bbs2-0016" title="Ramos-MartínezE , López-VancellMR , Fernández de Córdova-AguirreJC , Rojas-SerranoJ , ChavarríaA , Velasco-MedinaA , et al. Reduction of respiratory infections in asthma patients supplemented with vitamin D is related to increased serum IL-10 and IFNγ levels and cathelicidin expression. Cytokine2018;108:239–46. ">Ramos‐Martínez 2018</a>; <a href="./references#CD011511-bbs2-0017" title="TachimotoH , MezawaH , SegawaT , AkiyamaN , IdaH , UrashimaM . Improved control of childhood asthma with low-dose, short-term vitamin D supplementation: a randomized, double-blind, placebo-controlled trial. Allergy2016;71(7):1001-9. ">Tachimoto 2016</a>; <a href="./references#CD011511-bbs2-0018" title="ThakurC , KumarJ , KumarP , GoyalJP , SinghK , GuptaA . Vitamin‐D supplementation as an adjunct to standard treatmentof asthma in children: a randomized controlled trial (ViDASTA Trial). Pediatric Pulmonology2021;56:1427–33. [DOI: 10.1002/ppul.25287]">Thakur 2021</a>; <a href="./references#CD011511-bbs2-0019" title="UrashimaM , SegawaT , OkazakiM , KuriharaM , WadaY , IdaH . Randomized trial of vitamin D supplementation to prevent seasonal influenza A in school children. American Journal of Clinical Nutrition2010;91(5):1255-60. ">Urashima 2010</a>), the median daily dose was 1000 IU/day, ranging from 400 IU/day (<a href="./references#CD011511-bbs2-0008" title="JensenM , MailhotG , AlosN , RousseauE , WhiteJ , KhamessanA , et al. Vitamin D intervention in preschoolers with viral-induced asthma (DIVA): a pilot randomised controlled trial. American Journal of Respiratory and Critical Care Medicine2015;191:A3360. JensenME , MailhotG , AlosN , RousseauE , WhiteJ , KhamessanA , et al. Vitamin D intervention in preschoolers with viral-induced asthma (DIVA): a pilot randomised controlled trial. Trials2016;17:353. [DOI: 10.1186/s13063-016-1483-1]">Jensen 2016</a>) to 4000 IU/day (<a href="./references#CD011511-bbs2-0004" title="CastroM , KingTS , KunselmanSJ , CabanaMD , DenlingerL , HolguinF , et al. Effect of vitamin D3 on asthma treatment failures in adults with symptomatic asthma and lower vitamin D levels: the VIDA randomized clinical trial. JAMA2014;311(20):2083-91. DenlingerLC , KingTS , CardetJC , CraigT , HolguinF , JacksonDJ , et al. Vitamin D supplementation and the risk of colds in patients with asthma. American Journal of Respiratory and Critical Care Medicine2016;193(6):634–41. DenlingerLC , KingTS , CardetJC , CraigTJ , HolguinF , KraftM , et al. Vitamin D supplementation and the risk of colds in patients with asthma. Journal of Allergy and Clinical Immunology2015;135:AB109. JiaoJ , KingTS , McKenzieM , BacharierLB , DixonAE , CodispotiCD , et al. Effects of vitamin D3 supplementation in adults with asthma complicated by sinonasal disease. American Journal of Respiratory and Critical Care Medicine2015;191:A4148. JiaoJ , KingTS , McKenzieM , BacharierLB , DixonAE , CodispotiCD , et al. Vitamin D3 therapy in patients with asthma complicated by sinonasal disease: secondary analysis of the Vitamin D Add-on Therapy Enhances Corticosteroid Responsiveness in Asthma trial. Journal of Allergy and Clinical Immunology2016;138(2):589-92. MooreWC , KingTS , BleeckerER , MeyersDA , PetersSP , WenzelSE . Sarp clinical clusters predict steroid responsiveness and risk of asthma exacerbations in the asthma net vida (vitamin D in asthma) trial. American Journal of Respiratory and Critical Care Medicine2015;191:A6055. ReidB , GirodetP , BoomerJS , Abdel-GadirA , ZhengK , WechslerME , et al. Vitamin D3 treatment of vitamin D insufficient asthmatics does not alter immune cell function. Journal of Allergy and Clinical Immunology2016;138(1):286-9. ">Castro 2014</a>; <a href="./references#CD011511-bbs2-0006" title="FornoE , BacharierLB , PhipatanakulW , GuilbertTW , CabanaMD , RossK , et al. Effect of vitamin D3 supplementation on severe asthma exacerbations in children with asthma and low vitamin D levels: The VDKA Randomized Clinical Trial. JAMA2020;324(8):752-60. HanYY , FornoE , BacharierLB , PhipatanakulW , GuilbertTW , CabanaMD , et al. Vitamin D supplementation, lung function and asthma control in children with asthma and low vitamin D levels. European Respiratory Journal2021;58(4):2100989. [DOI: 10.1183/13993003.00989-2021]N/a. Errors in flow diagram. JAMA2021;326(1):90. [DOI: 10.1001/jama.2021.9465.]RosserFJ , HanYY , FornoE , BacharierLB , PhipatanakulW , GuilbertTW , et al. Effect of vitamin D supplementation on total andallergen-specific IgE in children with asthma andlow vitamin D levels. Journal of Allergy and Clinical Immunology2021;149(1):440-4.E2. [PMID: 10.1016/j.jaci.2021.05.037]">Forno 2020</a>). </p> <p>Where serum 25(OH)D concentration was assessed, the intervention resulted in an inter‐arm difference in follow‐up concentration on at least one follow‐up time point in 12 studies (<a href="./references#CD011511-bbs2-0002" title="Andújar-EspinosaR , Aparicio-VicenteM , Ruiz-LópezFJ , Salinero-GonzálezL . Influence of vitamin D supplementation on the quality of life of asthma patients: Findings from ACVID randomised clinical trial. Respiratory Medicine2021;185:106484. [DOI: 10.1016/j.rmed.2021.106484]Andújar-EspinosaR , Salinero-GonzálezL , Illán-GómezF , Castilla-MartínezM , Hu-YangC , Ruiz-LópezFJ . Effect of vitamin D supplementation on asthma control in patients with vitamin D deficiency: the ACVID randomised clinical trial. Thorax2021;76(2):126–33. [DOI: 10.1136/thoraxjnl-2019-213936]">Andújar‐Espinosa 2021</a>; <a href="./references#CD011511-bbs2-0003" title="CamargoC , ToopL , SluyterJ , LawesCM , WaayerD , KhawKT , et al. Effect of monthly vitamin D supplementation on preventing exacerbations of asthma or chronic obstructive pulmonary disease in older adults: post hoc analysis of a randomized controlled trial. Nutrients2021;13:521. [DOI: 10.3390/nu13020521]SluyterJ , CamargoCA , WaayerD , LawesCM , ToopL , KhawKT , et al. Effect of monthly, high-dose, long-term vitamin D on lung function: a randomized controlled trial. Nutrients2017;9:1353. [DOI: 10.3390/nu9121353]">Camargo 2021</a>; <a href="./references#CD011511-bbs2-0004" title="CastroM , KingTS , KunselmanSJ , CabanaMD , DenlingerL , HolguinF , et al. Effect of vitamin D3 on asthma treatment failures in adults with symptomatic asthma and lower vitamin D levels: the VIDA randomized clinical trial. JAMA2014;311(20):2083-91. DenlingerLC , KingTS , CardetJC , CraigT , HolguinF , JacksonDJ , et al. Vitamin D supplementation and the risk of colds in patients with asthma. American Journal of Respiratory and Critical Care Medicine2016;193(6):634–41. DenlingerLC , KingTS , CardetJC , CraigTJ , HolguinF , KraftM , et al. Vitamin D supplementation and the risk of colds in patients with asthma. Journal of Allergy and Clinical Immunology2015;135:AB109. JiaoJ , KingTS , McKenzieM , BacharierLB , DixonAE , CodispotiCD , et al. Effects of vitamin D3 supplementation in adults with asthma complicated by sinonasal disease. American Journal of Respiratory and Critical Care Medicine2015;191:A4148. JiaoJ , KingTS , McKenzieM , BacharierLB , DixonAE , CodispotiCD , et al. Vitamin D3 therapy in patients with asthma complicated by sinonasal disease: secondary analysis of the Vitamin D Add-on Therapy Enhances Corticosteroid Responsiveness in Asthma trial. Journal of Allergy and Clinical Immunology2016;138(2):589-92. MooreWC , KingTS , BleeckerER , MeyersDA , PetersSP , WenzelSE . Sarp clinical clusters predict steroid responsiveness and risk of asthma exacerbations in the asthma net vida (vitamin D in asthma) trial. American Journal of Respiratory and Critical Care Medicine2015;191:A6055. ReidB , GirodetP , BoomerJS , Abdel-GadirA , ZhengK , WechslerME , et al. Vitamin D3 treatment of vitamin D insufficient asthmatics does not alter immune cell function. Journal of Allergy and Clinical Immunology2016;138(1):286-9. ">Castro 2014</a>; <a href="./references#CD011511-bbs2-0005" title="DucharmeFM , JensenM , MailhotG , AlosN , WhiteJ , RousseauE , et al. Impact of two oral doses of 100,000 IU of vitamin D3 in preschoolers with viral induced asthma: a pilot randomised controlled trial. Trials2019;20(1):138. [DOI: 10.1186/s13063-019-3184-z]">Ducharme 2019</a>; <a href="./references#CD011511-bbs2-0006" title="FornoE , BacharierLB , PhipatanakulW , GuilbertTW , CabanaMD , RossK , et al. Effect of vitamin D3 supplementation on severe asthma exacerbations in children with asthma and low vitamin D levels: The VDKA Randomized Clinical Trial. JAMA2020;324(8):752-60. HanYY , FornoE , BacharierLB , PhipatanakulW , GuilbertTW , CabanaMD , et al. Vitamin D supplementation, lung function and asthma control in children with asthma and low vitamin D levels. European Respiratory Journal2021;58(4):2100989. [DOI: 10.1183/13993003.00989-2021]N/a. Errors in flow diagram. JAMA2021;326(1):90. [DOI: 10.1001/jama.2021.9465.]RosserFJ , HanYY , FornoE , BacharierLB , PhipatanakulW , GuilbertTW , et al. Effect of vitamin D supplementation on total andallergen-specific IgE in children with asthma andlow vitamin D levels. Journal of Allergy and Clinical Immunology2021;149(1):440-4.E2. [PMID: 10.1016/j.jaci.2021.05.037]">Forno 2020</a>; <a href="./references#CD011511-bbs2-0007" title="JatKR , GoelN , GuptaN , ChandraPG , SudipD , RakeshL , et al. Efficacy of vitamin D supplementation in asthmatic childrenwith vitamin D deficiency: a randomized controlled trial(ESDAC trial). Pediatric Allergy and Immunology2021;32(3):479– 88. [DOI: 10.1111/pai.13415]">Jat 2020</a>; <a href="./references#CD011511-bbs2-0008" title="JensenM , MailhotG , AlosN , RousseauE , WhiteJ , KhamessanA , et al. Vitamin D intervention in preschoolers with viral-induced asthma (DIVA): a pilot randomised controlled trial. American Journal of Respiratory and Critical Care Medicine2015;191:A3360. JensenME , MailhotG , AlosN , RousseauE , WhiteJ , KhamessanA , et al. Vitamin D intervention in preschoolers with viral-induced asthma (DIVA): a pilot randomised controlled trial. Trials2016;17:353. [DOI: 10.1186/s13063-016-1483-1]">Jensen 2016</a>; <a href="./references#CD011511-bbs2-0009" title="JerzynskaJ , StelmachW , RychlikB , LechańskaJ , PodleckaD , StelmachI . The clinical effect of vitamin D supplementation combined with grass-specific sublingual immunotherapy in children with allergic rhinitis. Allergy and Asthma Proceedings2016;37(2):105-14. [DOI: 10.2500/aap.2016.37.3921]">Jerzynska 2016</a>; <a href="./references#CD011511-bbs2-0011" title="KerleyCP , HutchinsonK , CormicanL , FaulJ , GreallyP , CoghlanD , et al. Vitamin D3 for uncontrolled childhood asthma: A pilot study. Paediatric Allergy and Immunology2016;27:404-12. [PMID: 10.1111/pai.12547]">Kerley 2016</a>; <a href="./references#CD011511-bbs2-0015" title="MartineauAR , MacLaughlinBD , HooperRL , BarnesNC , JolliffeDA , ChoudhuryAB , et al. Double-blind multi-centre randomised controlled trial of vitamin D3 supplementation in adults with inhaled corticosteroid-treated asthma (ViDiAs). Thorax2014;69:A51-2. MartineauAR , MacLaughlinBD , HooperRL , BarnesNC , JolliffeDA , GreillerCL , et al. Double-blind randomised placebo-controlled trial of bolus-dose vitamin D3 supplementation in adults with asthma (ViDiAs). Thorax2015;70(5):451-7. ">Martineau 2015</a>; <a href="./references#CD011511-bbs2-0017" title="TachimotoH , MezawaH , SegawaT , AkiyamaN , IdaH , UrashimaM . Improved control of childhood asthma with low-dose, short-term vitamin D supplementation: a randomized, double-blind, placebo-controlled trial. Allergy2016;71(7):1001-9. ">Tachimoto 2016</a>; <a href="./references#CD011511-bbs2-0018" title="ThakurC , KumarJ , KumarP , GoyalJP , SinghK , GuptaA . Vitamin‐D supplementation as an adjunct to standard treatmentof asthma in children: a randomized controlled trial (ViDASTA Trial). Pediatric Pulmonology2021;56:1427–33. [DOI: 10.1002/ppul.25287]">Thakur 2021</a>), but not in three others (<a href="./references#CD011511-bbs2-0012" title="LewisE , FernandezC , NellaA , HoppR , GallagherJC , CasaleTB . Relationship of 25-hydroxyvitamin D and asthma control in children. Annals of Allergy, Asthma and Immunology2012;108(4):281-2. LewisE , FernandezC , NellaAA , HoppR , CasaleT , GallagherC . The relationship of vitamin D and asthma in children. Journal of Allergy and Clinical Immunology2011;127(2):AB262. ">Lewis 2012</a>; <a href="./references#CD011511-bbs2-0013" title="MajakP , JerzyiskaJ , SmejdaK , StelmachI , TimlerD , StelmachW . Correlation of vitamin D with Foxp3 induction and steroid-sparing effect of immunotherapy in asthmatic children. Annals of Allergy, Asthma and Immunology2012;109(5):329-35. MajakP , RychlikB , StelmachI . The effect of oral steroids with and without vitamin D3 on early efficacy of immunotherapy in asthmatic children. Clinical and Experimental Allergy2009;39(12):1830-41. ">Majak 2009</a>; <a href="./references#CD011511-bbs2-0014" title="MajakP , Olszowiec-ChlebnaM , SmejdaK , StelmachI . Vitamin D supplementation in children may prevent asthma exacerbation triggered by acute respiratory infection. Journal of Allergy and Clinical Immunology2011;127(5):1294-6. ">Majak 2011</a>). </p> <p><b>Outcomes</b> </p> <p>Seventeen trials reported asthma exacerbation as an outcome measure (<a href="./references#CD011511-bbs2-0001" title="AglipayM , BirkenC , DaiD , ParkinP , MaguireJ . 70 high dose vitamin D for the prevention of wheezing in preschoolers: a secondary analysis of a randomized clinical trial. Paediatrics and Child Health2019;24(S2):e27-8. [DOI: 10.1093/pch/pxz066.069]AglipayM , BirkenCS , ParkinPC , LoebMB , ThorpeK , ChenY , et al. TARGet Kids! Collaboration. Effect of high-dose vs standard-dose wintertime vitamin D supplementation on viral upper respiratory tract infections in young healthy children. JAMA2017;318(3):245-54. [DOI: 10.1001/jama.2017.8708.]">Aglipay 2019</a>; <a href="./references#CD011511-bbs2-0002" title="Andújar-EspinosaR , Aparicio-VicenteM , Ruiz-LópezFJ , Salinero-GonzálezL . Influence of vitamin D supplementation on the quality of life of asthma patients: Findings from ACVID randomised clinical trial. Respiratory Medicine2021;185:106484. [DOI: 10.1016/j.rmed.2021.106484]Andújar-EspinosaR , Salinero-GonzálezL , Illán-GómezF , Castilla-MartínezM , Hu-YangC , Ruiz-LópezFJ . Effect of vitamin D supplementation on asthma control in patients with vitamin D deficiency: the ACVID randomised clinical trial. Thorax2021;76(2):126–33. [DOI: 10.1136/thoraxjnl-2019-213936]">Andújar‐Espinosa 2021</a>; <a href="./references#CD011511-bbs2-0003" title="CamargoC , ToopL , SluyterJ , LawesCM , WaayerD , KhawKT , et al. Effect of monthly vitamin D supplementation on preventing exacerbations of asthma or chronic obstructive pulmonary disease in older adults: post hoc analysis of a randomized controlled trial. Nutrients2021;13:521. [DOI: 10.3390/nu13020521]SluyterJ , CamargoCA , WaayerD , LawesCM , ToopL , KhawKT , et al. Effect of monthly, high-dose, long-term vitamin D on lung function: a randomized controlled trial. Nutrients2017;9:1353. [DOI: 10.3390/nu9121353]">Camargo 2021</a>; <a href="./references#CD011511-bbs2-0004" title="CastroM , KingTS , KunselmanSJ , CabanaMD , DenlingerL , HolguinF , et al. Effect of vitamin D3 on asthma treatment failures in adults with symptomatic asthma and lower vitamin D levels: the VIDA randomized clinical trial. JAMA2014;311(20):2083-91. DenlingerLC , KingTS , CardetJC , CraigT , HolguinF , JacksonDJ , et al. Vitamin D supplementation and the risk of colds in patients with asthma. American Journal of Respiratory and Critical Care Medicine2016;193(6):634–41. DenlingerLC , KingTS , CardetJC , CraigTJ , HolguinF , KraftM , et al. Vitamin D supplementation and the risk of colds in patients with asthma. Journal of Allergy and Clinical Immunology2015;135:AB109. JiaoJ , KingTS , McKenzieM , BacharierLB , DixonAE , CodispotiCD , et al. Effects of vitamin D3 supplementation in adults with asthma complicated by sinonasal disease. American Journal of Respiratory and Critical Care Medicine2015;191:A4148. JiaoJ , KingTS , McKenzieM , BacharierLB , DixonAE , CodispotiCD , et al. Vitamin D3 therapy in patients with asthma complicated by sinonasal disease: secondary analysis of the Vitamin D Add-on Therapy Enhances Corticosteroid Responsiveness in Asthma trial. Journal of Allergy and Clinical Immunology2016;138(2):589-92. MooreWC , KingTS , BleeckerER , MeyersDA , PetersSP , WenzelSE . Sarp clinical clusters predict steroid responsiveness and risk of asthma exacerbations in the asthma net vida (vitamin D in asthma) trial. American Journal of Respiratory and Critical Care Medicine2015;191:A6055. ReidB , GirodetP , BoomerJS , Abdel-GadirA , ZhengK , WechslerME , et al. Vitamin D3 treatment of vitamin D insufficient asthmatics does not alter immune cell function. Journal of Allergy and Clinical Immunology2016;138(1):286-9. ">Castro 2014</a>; <a href="./references#CD011511-bbs2-0005" title="DucharmeFM , JensenM , MailhotG , AlosN , WhiteJ , RousseauE , et al. Impact of two oral doses of 100,000 IU of vitamin D3 in preschoolers with viral induced asthma: a pilot randomised controlled trial. Trials2019;20(1):138. [DOI: 10.1186/s13063-019-3184-z]">Ducharme 2019</a>; <a href="./references#CD011511-bbs2-0006" title="FornoE , BacharierLB , PhipatanakulW , GuilbertTW , CabanaMD , RossK , et al. Effect of vitamin D3 supplementation on severe asthma exacerbations in children with asthma and low vitamin D levels: The VDKA Randomized Clinical Trial. JAMA2020;324(8):752-60. HanYY , FornoE , BacharierLB , PhipatanakulW , GuilbertTW , CabanaMD , et al. Vitamin D supplementation, lung function and asthma control in children with asthma and low vitamin D levels. European Respiratory Journal2021;58(4):2100989. [DOI: 10.1183/13993003.00989-2021]N/a. Errors in flow diagram. JAMA2021;326(1):90. [DOI: 10.1001/jama.2021.9465.]RosserFJ , HanYY , FornoE , BacharierLB , PhipatanakulW , GuilbertTW , et al. Effect of vitamin D supplementation on total andallergen-specific IgE in children with asthma andlow vitamin D levels. Journal of Allergy and Clinical Immunology2021;149(1):440-4.E2. [PMID: 10.1016/j.jaci.2021.05.037]">Forno 2020</a>; <a href="./references#CD011511-bbs2-0007" title="JatKR , GoelN , GuptaN , ChandraPG , SudipD , RakeshL , et al. Efficacy of vitamin D supplementation in asthmatic childrenwith vitamin D deficiency: a randomized controlled trial(ESDAC trial). Pediatric Allergy and Immunology2021;32(3):479– 88. [DOI: 10.1111/pai.13415]">Jat 2020</a>; <a href="./references#CD011511-bbs2-0008" title="JensenM , MailhotG , AlosN , RousseauE , WhiteJ , KhamessanA , et al. Vitamin D intervention in preschoolers with viral-induced asthma (DIVA): a pilot randomised controlled trial. American Journal of Respiratory and Critical Care Medicine2015;191:A3360. JensenME , MailhotG , AlosN , RousseauE , WhiteJ , KhamessanA , et al. Vitamin D intervention in preschoolers with viral-induced asthma (DIVA): a pilot randomised controlled trial. Trials2016;17:353. [DOI: 10.1186/s13063-016-1483-1]">Jensen 2016</a>; <a href="./references#CD011511-bbs2-0009" title="JerzynskaJ , StelmachW , RychlikB , LechańskaJ , PodleckaD , StelmachI . The clinical effect of vitamin D supplementation combined with grass-specific sublingual immunotherapy in children with allergic rhinitis. Allergy and Asthma Proceedings2016;37(2):105-14. [DOI: 10.2500/aap.2016.37.3921]">Jerzynska 2016</a>; <a href="./references#CD011511-bbs2-0011" title="KerleyCP , HutchinsonK , CormicanL , FaulJ , GreallyP , CoghlanD , et al. Vitamin D3 for uncontrolled childhood asthma: A pilot study. Paediatric Allergy and Immunology2016;27:404-12. [PMID: 10.1111/pai.12547]">Kerley 2016</a>; <a href="./references#CD011511-bbs2-0013" title="MajakP , JerzyiskaJ , SmejdaK , StelmachI , TimlerD , StelmachW . Correlation of vitamin D with Foxp3 induction and steroid-sparing effect of immunotherapy in asthmatic children. Annals of Allergy, Asthma and Immunology2012;109(5):329-35. MajakP , RychlikB , StelmachI . The effect of oral steroids with and without vitamin D3 on early efficacy of immunotherapy in asthmatic children. Clinical and Experimental Allergy2009;39(12):1830-41. ">Majak 2009</a>; <a href="./references#CD011511-bbs2-0014" title="MajakP , Olszowiec-ChlebnaM , SmejdaK , StelmachI . Vitamin D supplementation in children may prevent asthma exacerbation triggered by acute respiratory infection. Journal of Allergy and Clinical Immunology2011;127(5):1294-6. ">Majak 2011</a>; <a href="./references#CD011511-bbs2-0015" title="MartineauAR , MacLaughlinBD , HooperRL , BarnesNC , JolliffeDA , ChoudhuryAB , et al. Double-blind multi-centre randomised controlled trial of vitamin D3 supplementation in adults with inhaled corticosteroid-treated asthma (ViDiAs). Thorax2014;69:A51-2. MartineauAR , MacLaughlinBD , HooperRL , BarnesNC , JolliffeDA , GreillerCL , et al. Double-blind randomised placebo-controlled trial of bolus-dose vitamin D3 supplementation in adults with asthma (ViDiAs). Thorax2015;70(5):451-7. ">Martineau 2015</a>; <a href="./references#CD011511-bbs2-0017" title="TachimotoH , MezawaH , SegawaT , AkiyamaN , IdaH , UrashimaM . Improved control of childhood asthma with low-dose, short-term vitamin D supplementation: a randomized, double-blind, placebo-controlled trial. Allergy2016;71(7):1001-9. ">Tachimoto 2016</a>; <a href="./references#CD011511-bbs2-0018" title="ThakurC , KumarJ , KumarP , GoyalJP , SinghK , GuptaA . Vitamin‐D supplementation as an adjunct to standard treatmentof asthma in children: a randomized controlled trial (ViDASTA Trial). Pediatric Pulmonology2021;56:1427–33. [DOI: 10.1002/ppul.25287]">Thakur 2021</a>; <a href="./references#CD011511-bbs2-0019" title="UrashimaM , SegawaT , OkazakiM , KuriharaM , WadaY , IdaH . Randomized trial of vitamin D supplementation to prevent seasonal influenza A in school children. American Journal of Clinical Nutrition2010;91(5):1255-60. ">Urashima 2010</a>; <a href="./references#CD011511-bbs2-0020" title="YadavM , MittalK . Effect of vitamin D supplementation on moderate to severe bronchial asthma. Indian Journal of Pediatrics2014;81(7):650-4. ">Yadav 2014</a>). Definitions of exacerbation varied significantly between trials. Fifteen trials reported data on exacerbations requiring treatment with systemic corticosteroids (<a href="./references#CD011511-bbs2-0002" title="Andújar-EspinosaR , Aparicio-VicenteM , Ruiz-LópezFJ , Salinero-GonzálezL . Influence of vitamin D supplementation on the quality of life of asthma patients: Findings from ACVID randomised clinical trial. Respiratory Medicine2021;185:106484. [DOI: 10.1016/j.rmed.2021.106484]Andújar-EspinosaR , Salinero-GonzálezL , Illán-GómezF , Castilla-MartínezM , Hu-YangC , Ruiz-LópezFJ . Effect of vitamin D supplementation on asthma control in patients with vitamin D deficiency: the ACVID randomised clinical trial. Thorax2021;76(2):126–33. [DOI: 10.1136/thoraxjnl-2019-213936]">Andújar‐Espinosa 2021</a>; <a href="./references#CD011511-bbs2-0003" title="CamargoC , ToopL , SluyterJ , LawesCM , WaayerD , KhawKT , et al. Effect of monthly vitamin D supplementation on preventing exacerbations of asthma or chronic obstructive pulmonary disease in older adults: post hoc analysis of a randomized controlled trial. Nutrients2021;13:521. [DOI: 10.3390/nu13020521]SluyterJ , CamargoCA , WaayerD , LawesCM , ToopL , KhawKT , et al. Effect of monthly, high-dose, long-term vitamin D on lung function: a randomized controlled trial. Nutrients2017;9:1353. [DOI: 10.3390/nu9121353]">Camargo 2021</a>; <a href="./references#CD011511-bbs2-0004" title="CastroM , KingTS , KunselmanSJ , CabanaMD , DenlingerL , HolguinF , et al. Effect of vitamin D3 on asthma treatment failures in adults with symptomatic asthma and lower vitamin D levels: the VIDA randomized clinical trial. JAMA2014;311(20):2083-91. DenlingerLC , KingTS , CardetJC , CraigT , HolguinF , JacksonDJ , et al. Vitamin D supplementation and the risk of colds in patients with asthma. American Journal of Respiratory and Critical Care Medicine2016;193(6):634–41. DenlingerLC , KingTS , CardetJC , CraigTJ , HolguinF , KraftM , et al. Vitamin D supplementation and the risk of colds in patients with asthma. Journal of Allergy and Clinical Immunology2015;135:AB109. JiaoJ , KingTS , McKenzieM , BacharierLB , DixonAE , CodispotiCD , et al. Effects of vitamin D3 supplementation in adults with asthma complicated by sinonasal disease. American Journal of Respiratory and Critical Care Medicine2015;191:A4148. JiaoJ , KingTS , McKenzieM , BacharierLB , DixonAE , CodispotiCD , et al. Vitamin D3 therapy in patients with asthma complicated by sinonasal disease: secondary analysis of the Vitamin D Add-on Therapy Enhances Corticosteroid Responsiveness in Asthma trial. Journal of Allergy and Clinical Immunology2016;138(2):589-92. MooreWC , KingTS , BleeckerER , MeyersDA , PetersSP , WenzelSE . Sarp clinical clusters predict steroid responsiveness and risk of asthma exacerbations in the asthma net vida (vitamin D in asthma) trial. American Journal of Respiratory and Critical Care Medicine2015;191:A6055. ReidB , GirodetP , BoomerJS , Abdel-GadirA , ZhengK , WechslerME , et al. Vitamin D3 treatment of vitamin D insufficient asthmatics does not alter immune cell function. Journal of Allergy and Clinical Immunology2016;138(1):286-9. ">Castro 2014</a>; <a href="./references#CD011511-bbs2-0005" title="DucharmeFM , JensenM , MailhotG , AlosN , WhiteJ , RousseauE , et al. Impact of two oral doses of 100,000 IU of vitamin D3 in preschoolers with viral induced asthma: a pilot randomised controlled trial. Trials2019;20(1):138. [DOI: 10.1186/s13063-019-3184-z]">Ducharme 2019</a>; <a href="./references#CD011511-bbs2-0006" title="FornoE , BacharierLB , PhipatanakulW , GuilbertTW , CabanaMD , RossK , et al. Effect of vitamin D3 supplementation on severe asthma exacerbations in children with asthma and low vitamin D levels: The VDKA Randomized Clinical Trial. JAMA2020;324(8):752-60. HanYY , FornoE , BacharierLB , PhipatanakulW , GuilbertTW , CabanaMD , et al. Vitamin D supplementation, lung function and asthma control in children with asthma and low vitamin D levels. European Respiratory Journal2021;58(4):2100989. [DOI: 10.1183/13993003.00989-2021]N/a. Errors in flow diagram. JAMA2021;326(1):90. [DOI: 10.1001/jama.2021.9465.]RosserFJ , HanYY , FornoE , BacharierLB , PhipatanakulW , GuilbertTW , et al. Effect of vitamin D supplementation on total andallergen-specific IgE in children with asthma andlow vitamin D levels. Journal of Allergy and Clinical Immunology2021;149(1):440-4.E2. [PMID: 10.1016/j.jaci.2021.05.037]">Forno 2020</a>; <a href="./references#CD011511-bbs2-0007" title="JatKR , GoelN , GuptaN , ChandraPG , SudipD , RakeshL , et al. Efficacy of vitamin D supplementation in asthmatic childrenwith vitamin D deficiency: a randomized controlled trial(ESDAC trial). Pediatric Allergy and Immunology2021;32(3):479– 88. [DOI: 10.1111/pai.13415]">Jat 2020</a>; <a href="./references#CD011511-bbs2-0008" title="JensenM , MailhotG , AlosN , RousseauE , WhiteJ , KhamessanA , et al. Vitamin D intervention in preschoolers with viral-induced asthma (DIVA): a pilot randomised controlled trial. American Journal of Respiratory and Critical Care Medicine2015;191:A3360. JensenME , MailhotG , AlosN , RousseauE , WhiteJ , KhamessanA , et al. Vitamin D intervention in preschoolers with viral-induced asthma (DIVA): a pilot randomised controlled trial. Trials2016;17:353. [DOI: 10.1186/s13063-016-1483-1]">Jensen 2016</a>; <a href="./references#CD011511-bbs2-0009" title="JerzynskaJ , StelmachW , RychlikB , LechańskaJ , PodleckaD , StelmachI . The clinical effect of vitamin D supplementation combined with grass-specific sublingual immunotherapy in children with allergic rhinitis. Allergy and Asthma Proceedings2016;37(2):105-14. [DOI: 10.2500/aap.2016.37.3921]">Jerzynska 2016</a>; <a href="./references#CD011511-bbs2-0011" title="KerleyCP , HutchinsonK , CormicanL , FaulJ , GreallyP , CoghlanD , et al. Vitamin D3 for uncontrolled childhood asthma: A pilot study. Paediatric Allergy and Immunology2016;27:404-12. [PMID: 10.1111/pai.12547]">Kerley 2016</a>; <a href="./references#CD011511-bbs2-0013" title="MajakP , JerzyiskaJ , SmejdaK , StelmachI , TimlerD , StelmachW . Correlation of vitamin D with Foxp3 induction and steroid-sparing effect of immunotherapy in asthmatic children. Annals of Allergy, Asthma and Immunology2012;109(5):329-35. MajakP , RychlikB , StelmachI . The effect of oral steroids with and without vitamin D3 on early efficacy of immunotherapy in asthmatic children. Clinical and Experimental Allergy2009;39(12):1830-41. ">Majak 2009</a>; <a href="./references#CD011511-bbs2-0014" title="MajakP , Olszowiec-ChlebnaM , SmejdaK , StelmachI . Vitamin D supplementation in children may prevent asthma exacerbation triggered by acute respiratory infection. Journal of Allergy and Clinical Immunology2011;127(5):1294-6. ">Majak 2011</a>; <a href="./references#CD011511-bbs2-0015" title="MartineauAR , MacLaughlinBD , HooperRL , BarnesNC , JolliffeDA , ChoudhuryAB , et al. Double-blind multi-centre randomised controlled trial of vitamin D3 supplementation in adults with inhaled corticosteroid-treated asthma (ViDiAs). Thorax2014;69:A51-2. MartineauAR , MacLaughlinBD , HooperRL , BarnesNC , JolliffeDA , GreillerCL , et al. Double-blind randomised placebo-controlled trial of bolus-dose vitamin D3 supplementation in adults with asthma (ViDiAs). Thorax2015;70(5):451-7. ">Martineau 2015</a>; <a href="./references#CD011511-bbs2-0017" title="TachimotoH , MezawaH , SegawaT , AkiyamaN , IdaH , UrashimaM . Improved control of childhood asthma with low-dose, short-term vitamin D supplementation: a randomized, double-blind, placebo-controlled trial. Allergy2016;71(7):1001-9. ">Tachimoto 2016</a>; <a href="./references#CD011511-bbs2-0018" title="ThakurC , KumarJ , KumarP , GoyalJP , SinghK , GuptaA . Vitamin‐D supplementation as an adjunct to standard treatmentof asthma in children: a randomized controlled trial (ViDASTA Trial). Pediatric Pulmonology2021;56:1427–33. [DOI: 10.1002/ppul.25287]">Thakur 2021</a>; <a href="./references#CD011511-bbs2-0019" title="UrashimaM , SegawaT , OkazakiM , KuriharaM , WadaY , IdaH . Randomized trial of vitamin D supplementation to prevent seasonal influenza A in school children. American Journal of Clinical Nutrition2010;91(5):1255-60. ">Urashima 2010</a>). </p> </section> <section id="CD011511-sec-0044"> <h4 class="title">Excluded studies</h4> <p>We excluded 35 studies with reasons. See <a href="./references#CD011511-sec-0112" title="">Characteristics of excluded studies</a> for full details. </p> </section> </section> <section id="CD011511-sec-0045"> <h3 class="title">Risk of bias in included studies</h3> <p>An overview of risk of bias judgements is shown in <a href="#CD011511-fig-0002">Figure 2</a>. </p> <div class="figure" id="CD011511-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD011511-fig-0002" src="/cdsr/doi/10.1002/14651858.CD011511.pub3/media/CDSR/CD011511/image_n/nCD011511-FIG-02.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> </div> <section id="CD011511-sec-0046"> <h4 class="title">Allocation</h4> <p>Three studies did not report the method of sequence generation (<a href="./references#CD011511-bbs2-0011" title="KerleyCP , HutchinsonK , CormicanL , FaulJ , GreallyP , CoghlanD , et al. Vitamin D3 for uncontrolled childhood asthma: A pilot study. Paediatric Allergy and Immunology2016;27:404-12. [PMID: 10.1111/pai.12547]">Kerley 2016</a>; <a href="./references#CD011511-bbs2-0012" title="LewisE , FernandezC , NellaA , HoppR , GallagherJC , CasaleTB . Relationship of 25-hydroxyvitamin D and asthma control in children. Annals of Allergy, Asthma and Immunology2012;108(4):281-2. LewisE , FernandezC , NellaAA , HoppR , CasaleT , GallagherC . The relationship of vitamin D and asthma in children. Journal of Allergy and Clinical Immunology2011;127(2):AB262. ">Lewis 2012</a>; <a href="./references#CD011511-bbs2-0020" title="YadavM , MittalK . Effect of vitamin D supplementation on moderate to severe bronchial asthma. Indian Journal of Pediatrics2014;81(7):650-4. ">Yadav 2014</a>), and two studies did not report the method of allocation concealment (<a href="./references#CD011511-bbs2-0012" title="LewisE , FernandezC , NellaA , HoppR , GallagherJC , CasaleTB . Relationship of 25-hydroxyvitamin D and asthma control in children. Annals of Allergy, Asthma and Immunology2012;108(4):281-2. LewisE , FernandezC , NellaAA , HoppR , CasaleT , GallagherC . The relationship of vitamin D and asthma in children. Journal of Allergy and Clinical Immunology2011;127(2):AB262. ">Lewis 2012</a>; <a href="./references#CD011511-bbs2-0014" title="MajakP , Olszowiec-ChlebnaM , SmejdaK , StelmachI . Vitamin D supplementation in children may prevent asthma exacerbation triggered by acute respiratory infection. Journal of Allergy and Clinical Immunology2011;127(5):1294-6. ">Majak 2011</a>). We have therefore classified the risk of selection bias for these studies as 'unclear'. One study (<a href="./references#CD011511-bbs2-0010" title="JiangC , YiR , NaH , LinS . A randomized controlled study of Vitamin D3 supplementation on childhood asthma control. Chongqing Medicine2017;46(32):4505-7. [DOI: 10.3969/j.issn.1671-8348.2017.32.011]">Jiang 2017</a>) stated that investigators were divided into planning and dispensing, and those in charge of planning did not disclose the experimental and placebo medications to the dispenser and participants. We classified this as high risk of bias, as it suggested that those in charge of allocating participants may not have been blinded. We assessed the risk of selection bias for the remaining studies as low. </p> </section> <section id="CD011511-sec-0047"> <h4 class="title">Blinding</h4> <p>Participants and study personnel, including those who administered the intervention, were effectively blinded to allocation for all studies with the possible exception of Jiang and colleagues, as outlined above (<a href="./references#CD011511-bbs2-0010" title="JiangC , YiR , NaH , LinS . A randomized controlled study of Vitamin D3 supplementation on childhood asthma control. Chongqing Medicine2017;46(32):4505-7. [DOI: 10.3969/j.issn.1671-8348.2017.32.011]">Jiang 2017</a>). Accordingly, we assessed the risk of performance and detection bias as low for all studies except for <a href="./references#CD011511-bbs2-0010" title="JiangC , YiR , NaH , LinS . A randomized controlled study of Vitamin D3 supplementation on childhood asthma control. Chongqing Medicine2017;46(32):4505-7. [DOI: 10.3969/j.issn.1671-8348.2017.32.011]">Jiang 2017</a>. We classified this study as being at high risk of bias for blinding participants and study personnel, and unclear risk of bias for blinding of outcome assessment. </p> </section> <section id="CD011511-sec-0048"> <h4 class="title">Incomplete outcome data</h4> <p>One‐third of participants (10 out of 30) in the study by Lewis and colleagues were lost to follow‐up (<a href="./references#CD011511-bbs2-0012" title="LewisE , FernandezC , NellaA , HoppR , GallagherJC , CasaleTB . Relationship of 25-hydroxyvitamin D and asthma control in children. Annals of Allergy, Asthma and Immunology2012;108(4):281-2. LewisE , FernandezC , NellaAA , HoppR , CasaleT , GallagherC . The relationship of vitamin D and asthma in children. Journal of Allergy and Clinical Immunology2011;127(2):AB262. ">Lewis 2012</a>); we have therefore assessed the risk of attrition bias as high for this study. The study by Yadav and colleagues reports that 18 out of 100 participants were lost to follow‐up, but follow‐up data for 100 participants were presented for the final follow‐up visit (<a href="./references#CD011511-bbs2-0020" title="YadavM , MittalK . Effect of vitamin D supplementation on moderate to severe bronchial asthma. Indian Journal of Pediatrics2014;81(7):650-4. ">Yadav 2014</a>). This discrepancy led us to assess the risk of attrition bias as being high for this study. </p> <p>We also assessed <a href="./references#CD011511-bbs2-0011" title="KerleyCP , HutchinsonK , CormicanL , FaulJ , GreallyP , CoghlanD , et al. Vitamin D3 for uncontrolled childhood asthma: A pilot study. Paediatric Allergy and Immunology2016;27:404-12. [PMID: 10.1111/pai.12547]">Kerley 2016</a> as being at unclear risk of attrition bias, as there was a high rate of loss to follow‐up (12 of 51 participants, 7 prior to randomisation and 5 postrandomisation) but similar rates of loss to follow‐up between arms (7 out of 24 intervention arm, 5 out of 27 control arm). We assessed the risk of attrition bias for the remaining studies as low. </p> </section> <section id="CD011511-sec-0049"> <h4 class="title">Selective reporting</h4> <p>The study by Ducharme and colleagues reported different primary and secondary outcomes to those prespecified in the study protocol as a result of premature trial cessation due to partial funding (<a href="./references#CD011511-bbs2-0005" title="DucharmeFM , JensenM , MailhotG , AlosN , WhiteJ , RousseauE , et al. Impact of two oral doses of 100,000 IU of vitamin D3 in preschoolers with viral induced asthma: a pilot randomised controlled trial. Trials2019;20(1):138. [DOI: 10.1186/s13063-019-3184-z]">Ducharme 2019</a>). However, the study presented and explained this clearly. We therefore assessed the risk of reporting bias as unclear. The study by Kerley and colleagues reported its primary outcome prespecified in the trial protocol, but did not report two secondary outcomes; height velocity and a parental diary of child asthma symptoms (<a href="./references#CD011511-bbs2-0011" title="KerleyCP , HutchinsonK , CormicanL , FaulJ , GreallyP , CoghlanD , et al. Vitamin D3 for uncontrolled childhood asthma: A pilot study. Paediatric Allergy and Immunology2016;27:404-12. [PMID: 10.1111/pai.12547]">Kerley 2016</a>). These were not outcomes assessed by our review, but this discrepancy led us to assess the risk of reporting bias as unclear. </p> <p>We found no evidence of selective reporting for any of the remaining studies and have therefore assessed the risk of reporting bias as low. </p> </section> <section id="CD011511-sec-0050"> <h4 class="title">Other potential sources of bias</h4> <p>The study by Camargo and colleagues defined an asthma exacerbation as “any prescription of oral corticosteroids more than 20 days apart for a short period”, yet participants may have been prescribed oral corticosteroids for other reasons, including rescue packs to treat future exacerbations (<a href="./references#CD011511-bbs2-0003" title="CamargoC , ToopL , SluyterJ , LawesCM , WaayerD , KhawKT , et al. Effect of monthly vitamin D supplementation on preventing exacerbations of asthma or chronic obstructive pulmonary disease in older adults: post hoc analysis of a randomized controlled trial. Nutrients2021;13:521. [DOI: 10.3390/nu13020521]SluyterJ , CamargoCA , WaayerD , LawesCM , ToopL , KhawKT , et al. Effect of monthly, high-dose, long-term vitamin D on lung function: a randomized controlled trial. Nutrients2017;9:1353. [DOI: 10.3390/nu9121353]">Camargo 2021</a>). Investigators sought to minimise this by excluding participants with conditions other than asthma in which systemic corticosteroids may be indicated (e.g. autoimmune disease), but there may still have been residual non‐asthma causes of steroid prescriptions. However, this risk was unlikely to differ between intervention and control arms in a way that systematically biases results. Therefore, we assessed this study as being at unclear risk of misclassification bias. In the study by Yadav and colleagues, we noted a change in classification of asthma severity between the six‐month time point and earlier time points (<a href="./references#CD011511-bbs2-0020" title="YadavM , MittalK . Effect of vitamin D supplementation on moderate to severe bronchial asthma. Indian Journal of Pediatrics2014;81(7):650-4. ">Yadav 2014</a>). This suggested a high risk of misclassification bias operating at the final follow‐up time point. We assessed the study by Jiang and colleagues (<a href="./references#CD011511-bbs2-0010" title="JiangC , YiR , NaH , LinS . A randomized controlled study of Vitamin D3 supplementation on childhood asthma control. Chongqing Medicine2017;46(32):4505-7. [DOI: 10.3969/j.issn.1671-8348.2017.32.011]">Jiang 2017</a>) as being at unclear risk of other bias, as only participants who completed the trial were analysed in baseline outcomes, with baseline characteristics of those lost to follow‐up not presented. Lastly, the study by Thakur and colleagues found baseline cACT scores differed significantly between treatment and placebo groups (<a href="./references#CD011511-bbs2-0018" title="ThakurC , KumarJ , KumarP , GoyalJP , SinghK , GuptaA . Vitamin‐D supplementation as an adjunct to standard treatmentof asthma in children: a randomized controlled trial (ViDASTA Trial). Pediatric Pulmonology2021;56:1427–33. [DOI: 10.1002/ppul.25287]">Thakur 2021</a>). However, this meta‐analysis considers the change in cACT from baseline to end‐study, minimising potential for bias to operate. We therefore classified this study as being at unclear risk of other bias. We identified no other potential sources of bias for the remaining included trials. </p> </section> </section> <section id="CD011511-sec-0051"> <h3 class="title" id="CD011511-sec-0051">Effects of interventions</h3> <p>See: <a href="./full#CD011511-tbl-0001"><b>Summary of findings 1</b> Summary of findings table ‐ Vitamin D compared to placebo for the management of asthma</a> </p> <p>See: <a href="./full#CD011511-tbl-0001">summary of findings Table 1</a>. This review was based on a published protocol, <a href="./references#CD011511-bbs2-0100" title="MartineauA , WilliamsonA , SheikhA , GriffithsCJ . Intervention protocol: vitamin D for the management of asthma (2021). figshare.com/articles/journal_contribution/Intervention_Protocol_Vitamin_D_for_the_management_of_asthma_2021_/16926430. [DOI: 10.6084/m9.figshare.16926430.v1]">Martineau 2021</a>. </p> <section id="CD011511-sec-0052"> <h4 class="title">Vitamin D versus placebo: all eligible trials</h4> <p>Twenty trials with a total of 2225 participants (1155 children and 1070 adults) contributed to this comparison for at least one outcome. Fifteen trials contributed to this comparison for analysis of the primary outcome of exacerbations requiring systemic corticosteroids; 14 contributed data on whether vitamin D administration influenced the proportion of participants experiencing one or more asthma exacerbations treated with systemic corticosteroids (<a href="./references#CD011511-fig-0007" title="">Analysis 1.1</a>), with one further study contributing evidence on the rate of asthma exacerbations treated with systemic corticosteroids (<a href="./references#CD011511-fig-0008" title="">Analysis 1.2</a>). </p> <section id="CD011511-sec-0053"> <h5 class="title">Primary outcome</h5> <section id="CD011511-sec-0054"> <h6 class="title">Incidence of severe asthma exacerbations, defined as those treated with systemic corticosteroids</h6> <section id="CD011511-sec-0055"> <p><b>Analyses including all participants</b></p> <p>Administration of vitamin D did not reduce or increase the proportion of participants experiencing one or more asthma exacerbations treated with systemic corticosteroids (OR 1.04, 95% CI 0.81 to 1.34; I<sup>2</sup> = 0%; 14 studies, 1778 participants; high‐quality evidence; <a href="./references#CD011511-fig-0007" title="">Analysis 1.1</a>). There was low heterogeneity across studies for this outcome, with I<sup>2</sup> = 0%. A funnel plot of included studies for this outcome is presented in <a href="#CD011511-fig-0003">Figure 3</a>. This appears approximately symmetrical, with no evidence of small‐study or publication bias. </p> <div class="figure" id="CD011511-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="Forest plot of comparison: vitamin D versus placebo (all studies), outcome 1.1: proportion of participants experiencing one or more asthma exacerbations treated with systemic corticosteroids" data-id="CD011511-fig-0003" src="/cdsr/doi/10.1002/14651858.CD011511.pub3/media/CDSR/CD011511/image_n/nCD011511-FIG-03.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: vitamin D versus placebo (all studies), outcome 1.1: proportion of participants experiencing one or more asthma exacerbations treated with systemic corticosteroids </p> </div> </div> </div> <p>We also found no evidence that vitamin D administration affected the rate of asthma exacerbations treated with systemic corticosteroids (rate ratio 0.86, 95% CI 0.62 to 1.19; I<sup>2</sup> = 60%; 10 studies, 1599 participants; high‐quality evidence; <a href="./references#CD011511-fig-0008" title="">Analysis 1.2</a>). A funnel plot of included studies for this outcome is presented in <a href="#CD011511-fig-0004">Figure 4</a>. </p> <div class="figure" id="CD011511-fig-0004"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 4</div> </div> <hr class="top"/><img alt="Funnel plot of comparison 1: Vitamin D versus placebo (all studies), outcome 1.2 Rate ratio, exacerbation requiring corticosteroids" data-id="CD011511-fig-0004" src="/cdsr/doi/10.1002/14651858.CD011511.pub3/media/CDSR/CD011511/image_n/nCD011511-FIG-04.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Funnel plot of comparison 1: Vitamin D versus placebo (all studies), outcome 1.2 Rate ratio, exacerbation requiring corticosteroids </p> </div> </div> </div> <p>Finally, we found no evidence to suggest a benefit of vitamin D for the outcome of time to first exacerbation treated with systemic corticosteroids (hazard ratio 0.82, 95% CI 0.59 to 1.15; I<sup>2</sup> = 22%; 3 studies, 850 participants; high‐quality evidence; <a href="./references#CD011511-fig-0009" title="">Analysis 1.3</a>). </p> </section> <section id="CD011511-sec-0056"> <p><b>Subgroup analyses</b></p> <p>We conducted four prespecified subgroup analyses for our primary outcome.</p> <p>First, we stratified by participant baseline vitamin D status (<a href="./references#CD011511-fig-0010" title="">Analysis 1.4</a>; serum 25(OH)D &lt; 25 nmol/L versus 25 to 49.9 nmol/L versus 50 to 74.9 nmol/L versus ≥ 75 nmol/L). Vitamin D administration did not influence the proportion of participants experiencing one or more asthma exacerbations treated with systemic corticosteroids in any of these subgroups; baseline &lt; 25 nmol/L (OR 0.78, 95% CI 0.15 to 3.96; I<sup>2</sup> = 63%; 4 studies, 198 participants; low‐quality evidence), 25 to 49.9 nmol/L (OR 0.91, 95% CI 0.57 to 1.44; I<sup>2</sup> = 0%; 8 studies, 515 participants; low‐quality evidence), 50 to 74.9 nmol/L (OR 1.16, 95% CI 0.60 to 2.25; I<sup>2</sup> = 29%; 7 studies, 419 participants; low‐quality evidence), or ≥ 75 nmol/L (OR 0.98, 95% CI 0.49 to 1.95; I<sup>2</sup> = 0%; 5 studies, 142 participants; low‐quality evidence). However, we note only a limited number of studies provided data stratified by baseline vitamin D status, and thus downgraded this evidence by two levels due to imprecision. Testing for heterogeneity across subgroups revealed no evidence of a significant difference in outcomes (Chi² = 0.44, df = 3 (P = 0.93), I² = 0%) (<a href="./references#CD011511-bbs2-0067" title="BorensteinM , HigginsJP . Meta-analysis and subgroups. Prevention Science2013;14:134–43. [DOI: 10.1007/s11121-013-0377-7]">Borenstein 2013</a>). We could not analyse the outcomes rate of exacerbations and time to first exacerbation by baseline vitamin D subgroup due to lack of access to individual participant data for relevant trials. </p> <p>Second, we conducted subgroup analyses based on the dose and form of vitamin D administered. We converted studies which provided only regular bolus doses of oral vitamin D<sub>3</sub> into their daily equivalent and then stratified results into two prespecified categories (<a href="./references#CD011511-fig-0011" title="">Analysis 1.5</a>; daily vitamin D dose ≤ 2000 IU versus &gt; 2000 IU). Some studies combined bolus and daily dosing strategies and could not be classified; they were excluded from this subgroup analysis (<a href="./references#CD011511-bbs2-0003" title="CamargoC , ToopL , SluyterJ , LawesCM , WaayerD , KhawKT , et al. Effect of monthly vitamin D supplementation on preventing exacerbations of asthma or chronic obstructive pulmonary disease in older adults: post hoc analysis of a randomized controlled trial. Nutrients2021;13:521. [DOI: 10.3390/nu13020521]SluyterJ , CamargoCA , WaayerD , LawesCM , ToopL , KhawKT , et al. Effect of monthly, high-dose, long-term vitamin D on lung function: a randomized controlled trial. Nutrients2017;9:1353. [DOI: 10.3390/nu9121353]">Camargo 2021</a>; <a href="./references#CD011511-bbs2-0004" title="CastroM , KingTS , KunselmanSJ , CabanaMD , DenlingerL , HolguinF , et al. Effect of vitamin D3 on asthma treatment failures in adults with symptomatic asthma and lower vitamin D levels: the VIDA randomized clinical trial. JAMA2014;311(20):2083-91. DenlingerLC , KingTS , CardetJC , CraigT , HolguinF , JacksonDJ , et al. Vitamin D supplementation and the risk of colds in patients with asthma. American Journal of Respiratory and Critical Care Medicine2016;193(6):634–41. DenlingerLC , KingTS , CardetJC , CraigTJ , HolguinF , KraftM , et al. Vitamin D supplementation and the risk of colds in patients with asthma. Journal of Allergy and Clinical Immunology2015;135:AB109. JiaoJ , KingTS , McKenzieM , BacharierLB , DixonAE , CodispotiCD , et al. Effects of vitamin D3 supplementation in adults with asthma complicated by sinonasal disease. American Journal of Respiratory and Critical Care Medicine2015;191:A4148. JiaoJ , KingTS , McKenzieM , BacharierLB , DixonAE , CodispotiCD , et al. Vitamin D3 therapy in patients with asthma complicated by sinonasal disease: secondary analysis of the Vitamin D Add-on Therapy Enhances Corticosteroid Responsiveness in Asthma trial. Journal of Allergy and Clinical Immunology2016;138(2):589-92. MooreWC , KingTS , BleeckerER , MeyersDA , PetersSP , WenzelSE . Sarp clinical clusters predict steroid responsiveness and risk of asthma exacerbations in the asthma net vida (vitamin D in asthma) trial. American Journal of Respiratory and Critical Care Medicine2015;191:A6055. ReidB , GirodetP , BoomerJS , Abdel-GadirA , ZhengK , WechslerME , et al. Vitamin D3 treatment of vitamin D insufficient asthmatics does not alter immune cell function. Journal of Allergy and Clinical Immunology2016;138(1):286-9. ">Castro 2014</a>; <a href="./references#CD011511-bbs2-0008" title="JensenM , MailhotG , AlosN , RousseauE , WhiteJ , KhamessanA , et al. Vitamin D intervention in preschoolers with viral-induced asthma (DIVA): a pilot randomised controlled trial. American Journal of Respiratory and Critical Care Medicine2015;191:A3360. JensenME , MailhotG , AlosN , RousseauE , WhiteJ , KhamessanA , et al. Vitamin D intervention in preschoolers with viral-induced asthma (DIVA): a pilot randomised controlled trial. Trials2016;17:353. [DOI: 10.1186/s13063-016-1483-1]">Jensen 2016</a>). Vitamin D supplementation had no significant effect on the proportion of participants experiencing one or more asthma exacerbations treated with systemic corticosteroids in the lower dose subgroup (OR 1.13, 95% CI 0.75 to 1.69; I<sup>2</sup> = 0%; 10 studies, 942 participants; low‐quality evidence). Only one study provided regular doses of vitamin D<sub>3</sub> greater than 2000 IU (<a href="./references#CD011511-bbs2-0006" title="FornoE , BacharierLB , PhipatanakulW , GuilbertTW , CabanaMD , RossK , et al. Effect of vitamin D3 supplementation on severe asthma exacerbations in children with asthma and low vitamin D levels: The VDKA Randomized Clinical Trial. JAMA2020;324(8):752-60. HanYY , FornoE , BacharierLB , PhipatanakulW , GuilbertTW , CabanaMD , et al. Vitamin D supplementation, lung function and asthma control in children with asthma and low vitamin D levels. European Respiratory Journal2021;58(4):2100989. [DOI: 10.1183/13993003.00989-2021]N/a. Errors in flow diagram. JAMA2021;326(1):90. [DOI: 10.1001/jama.2021.9465.]RosserFJ , HanYY , FornoE , BacharierLB , PhipatanakulW , GuilbertTW , et al. Effect of vitamin D supplementation on total andallergen-specific IgE in children with asthma andlow vitamin D levels. Journal of Allergy and Clinical Immunology2021;149(1):440-4.E2. [PMID: 10.1016/j.jaci.2021.05.037]">Forno 2020</a>); it also reported no significant effect (OR 1.15, 95% CI 0.63 to 2.07; I<sup>2</sup> = 0%; 1 study, 192 participants; low‐quality evidence). Testing for heterogeneity across subgroups found no significant difference between groups (Chi² = 0.00, df = 1 (P = 0.97), I² = 0%). </p> <p><a href="./references#CD011511-bbs2-0002" title="Andújar-EspinosaR , Aparicio-VicenteM , Ruiz-LópezFJ , Salinero-GonzálezL . Influence of vitamin D supplementation on the quality of life of asthma patients: Findings from ACVID randomised clinical trial. Respiratory Medicine2021;185:106484. [DOI: 10.1016/j.rmed.2021.106484]Andújar-EspinosaR , Salinero-GonzálezL , Illán-GómezF , Castilla-MartínezM , Hu-YangC , Ruiz-LópezFJ . Effect of vitamin D supplementation on asthma control in patients with vitamin D deficiency: the ACVID randomised clinical trial. Thorax2021;76(2):126–33. [DOI: 10.1136/thoraxjnl-2019-213936]">Andújar‐Espinosa 2021</a> administered oral calcidiol (25[OH]D<sub>3</sub>) at a dose of 266 µg (one 1.5 mL ampoule) per week, and reported on the rate of asthma exacerbations treated with systemic corticosteroids. All other studies reporting on this outcome considered administered oral vitamin D<sub>3</sub> (cholecalciferol) to participants in the intervention arm. When this analysis was stratified, we found that administration of oral vitamin D<sub>3</sub> did not significantly influence the rate of severe exacerbations (rate ratio 0.93, 95% CI 0.68 to 1.28; I<sup>2</sup> = 54%; 9 studies, 1487 participants; low‐quality evidence; <a href="./references#CD011511-fig-0012" title="">Analysis 1.6</a>). Oral calcidiol did significantly reduce the rate of exacerbations (rate ratio 0.43, 95% CI 0.22 to 0.82; 1 study, 112 participants; low‐quality evidence). The formal test for subgroup differences was significant (Chi² = 4.42, df = 1 (P = 0.04), I² = 77%). We could not carry out subgroup analyses on the proportion of participants experiencing at least one severe exacerbation and time to first severe exacerbation based on the form of vitamin D administered, as only studies administering oral cholecalciferol reported on these outcomes. </p> <p>Third, we stratified our primary outcome by frequency of dosing regimen. Two categories were used; daily dosing versus intermittent bolus dosing at monthly or greater than monthly frequency (<a href="./references#CD011511-fig-0013" title="">Analysis 1.7</a>). One further study reporting on the primary outcome followed a dosing regimen of 1000 IU weekly (Majak 2009), but this study reported no events in either arm and thus an OR was not estimable for this dosing regimen category. We found that vitamin D did not influence the proportion of participants experiencing one or more asthma exacerbations treated with systemic corticosteroids when administered daily (OR 1.23, 95% CI 0.91 to 1.66; I<sup>2</sup> = 0%; 10 studies, 1201 participants; moderate‐quality evidence), or when administered using intermittent bolus doses (OR 1.09, 95% CI 0.68 to 1.77; I<sup>2</sup> = 31%; 3 studies, 511 participants; moderate‐quality evidence). The formal test for subgroup differences found no significant difference in the effect of allocation between groups (Chi² = 0.16, df =1 (P = 0.69), I<sup>2</sup> = 0%). </p> <p>Fourth, we stratified our primary outcome by the mean age of participants, in three categories; &lt; 5 years versus 5 to 16 years versus &gt; 16 years (<a href="./references#CD011511-fig-0014" title="">Analysis 1.8</a>). Vitamin D supplementation had no significant effect on the proportion of participants experiencing one or more asthma exacerbations treated with systemic corticosteroids in the subgroup of children &lt; 5 years (OR 2.15, 95% CI 0.82 to 5.64; I<sup>2</sup> = 0%; 2 studies, 69 participants; moderate‐quality evidence), the subgroup of children aged 5 to 16 years (OR 1.28, 95% CI 0.83 to 1.97; I<sup>2</sup> = 0%; 9 studies, 837 participants; moderate‐quality evidence), or the subgroup aged over 16 years (OR 0.85, 95% CI 0.58 to 1.24; I<sup>2</sup> = 31%; 3 studies, 872 participants; moderate‐quality evidence). The formal test for subgroup differences found no significant difference in the effect of allocation between groups (Chi² = 4.13, df =2 (P = 0.13), I<sup>2</sup> = 51.5%). </p> <p>Lack of access to individual participant data precluded conduct of prespecified subgroup analyses for the outcome of severe asthma exacerbation according to asthma severity, concomitant asthma treatment, body mass index, and genetic variation in the vitamin D pathway. </p> </section> <section id="CD011511-sec-0057"> <p><b>Sensitivity analysis excluding trials at high risk of bias</b></p> <p>We assessed three trials as being at high risk of bias (<a href="./references#CD011511-bbs2-0010" title="JiangC , YiR , NaH , LinS . A randomized controlled study of Vitamin D3 supplementation on childhood asthma control. Chongqing Medicine2017;46(32):4505-7. [DOI: 10.3969/j.issn.1671-8348.2017.32.011]">Jiang 2017</a>; <a href="./references#CD011511-bbs2-0012" title="LewisE , FernandezC , NellaA , HoppR , GallagherJC , CasaleTB . Relationship of 25-hydroxyvitamin D and asthma control in children. Annals of Allergy, Asthma and Immunology2012;108(4):281-2. LewisE , FernandezC , NellaAA , HoppR , CasaleT , GallagherC . The relationship of vitamin D and asthma in children. Journal of Allergy and Clinical Immunology2011;127(2):AB262. ">Lewis 2012</a>; <a href="./references#CD011511-bbs2-0020" title="YadavM , MittalK . Effect of vitamin D supplementation on moderate to severe bronchial asthma. Indian Journal of Pediatrics2014;81(7):650-4. ">Yadav 2014</a>). None of these contributed data relating to incidence of exacerbation treated with systemic corticosteroids or exacerbation precipitating emergency department attendance or hospitalisation, or both. We assessed a further five trials which contributed to the primary outcome as being at unclear risk of bias (<a href="./references#CD011511-bbs2-0003" title="CamargoC , ToopL , SluyterJ , LawesCM , WaayerD , KhawKT , et al. Effect of monthly vitamin D supplementation on preventing exacerbations of asthma or chronic obstructive pulmonary disease in older adults: post hoc analysis of a randomized controlled trial. Nutrients2021;13:521. [DOI: 10.3390/nu13020521]SluyterJ , CamargoCA , WaayerD , LawesCM , ToopL , KhawKT , et al. Effect of monthly, high-dose, long-term vitamin D on lung function: a randomized controlled trial. Nutrients2017;9:1353. [DOI: 10.3390/nu9121353]">Camargo 2021</a>; <a href="./references#CD011511-bbs2-0005" title="DucharmeFM , JensenM , MailhotG , AlosN , WhiteJ , RousseauE , et al. Impact of two oral doses of 100,000 IU of vitamin D3 in preschoolers with viral induced asthma: a pilot randomised controlled trial. Trials2019;20(1):138. [DOI: 10.1186/s13063-019-3184-z]">Ducharme 2019</a>; <a href="./references#CD011511-bbs2-0011" title="KerleyCP , HutchinsonK , CormicanL , FaulJ , GreallyP , CoghlanD , et al. Vitamin D3 for uncontrolled childhood asthma: A pilot study. Paediatric Allergy and Immunology2016;27:404-12. [PMID: 10.1111/pai.12547]">Kerley 2016</a>; <a href="./references#CD011511-bbs2-0014" title="MajakP , Olszowiec-ChlebnaM , SmejdaK , StelmachI . Vitamin D supplementation in children may prevent asthma exacerbation triggered by acute respiratory infection. Journal of Allergy and Clinical Immunology2011;127(5):1294-6. ">Majak 2011</a>; <a href="./references#CD011511-bbs2-0018" title="ThakurC , KumarJ , KumarP , GoyalJP , SinghK , GuptaA . Vitamin‐D supplementation as an adjunct to standard treatmentof asthma in children: a randomized controlled trial (ViDASTA Trial). Pediatric Pulmonology2021;56:1427–33. [DOI: 10.1002/ppul.25287]">Thakur 2021</a>). Excluding these trials in a sensitivity analysis, the overall finding remained null (OR 0.96, 95% CI 0.71 to 1.30; I<sup>2</sup> = 0%; 9 studies, 1365 participants; high‐quality evidence; <a href="./references#CD011511-fig-0015" title="">Analysis 1.9</a>). One trial assessed as being at high risk of bias reported effects of vitamin D on the proportion of participants experiencing at least one study‐defined exacerbation (<a href="./references#CD011511-bbs2-0020" title="YadavM , MittalK . Effect of vitamin D supplementation on moderate to severe bronchial asthma. Indian Journal of Pediatrics2014;81(7):650-4. ">Yadav 2014</a>). When we excluded this trial in a sensitivity analysis, the overall finding was still null (OR 0.90, 95% CI 0.62 to 1.30; I<sup>2</sup> = 42%; 11 studies, 1439 participants; high‐quality evidence; <a href="./references#CD011511-fig-0016" title="">Analysis 1.10</a>). </p> </section> <section id="CD011511-sec-0058"> <p><b>Sensitivity analyses using fixed‐effect models</b></p> <p>Sensitivity analyses using fixed‐effect models to evaluate the effect of vitamin D on risk of severe asthma exacerbation all yielded null results (<a href="#CD011511-tbl-0002">Table 1</a>). The proportion of participants experiencing one or more asthma exacerbations treated with systemic corticosteroids measured by risk difference also returned a null result (RD 0.00, 95% CI ‐0.02 to 0.03; I<sup>2</sup> = 0%; 14 studies, 1778 participants; <a href="./references#CD011511-fig-0017" title="">Analysis 1.11</a>). </p> <div class="table" id="CD011511-tbl-0002"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Sensitivity analysis: random‐effects versus fixed‐effect models</span></div> <tbody> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Analysis</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Random‐effects model</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Fixed‐effect model</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>People with one or more exacerbations requiring systemic corticosteroids</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>(OR 1.04, 95% CI 0.81 to 1.34)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>(OR 1.04, 95% CI 0.81 to 1.34)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>People with one or more exacerbations requiring systemic corticosteroids (risk difference)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>(RD 0.00, 95% CI ‐0.02 to 0.03)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>(RD 0.00, 95% CI ‐0.02 to 0.03)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>FEV1, % predicted</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>(MD 0.20, 95% CI ‐1.24 to 1.63)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>(MD 0.34, 95% CI ‐0.81 to 1.48)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>End‐study C‐ACT/ACT score (0 to 27)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MD 0.23 (‐0.26 to 0.73)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MD 0.20 (‐0.21 to 0.60)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>People with fatal asthma exacerbation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No events occurred (RD 0.00, 95% CI ‐0.01 to 0.01)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No events occurred (RD 0.00, 95% CI ‐0.01 to 0.01)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>People with 1 or more serious adverse event due to any cause</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>(OR 0.89, 95% CI 0.56 to 1.41)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>(OR 0.89, 95% CI 0.57 to 1.38)</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>Abbreviations: C‐ACT/ACT, Childhood Asthma Control Test/ Asthma Control Test; CI, confidence interval; FEV1, forced expiratory volume in one second ; MD, mean difference; OR, odds ratio; RD, risk difference. </p> </div> </div> </section> </section> </section> <section id="CD011511-sec-0059"> <h5 class="title">Secondary outcomes</h5> <section id="CD011511-sec-0060"> <h6 class="title">Incidence of asthma exacerbations precipitating emergency department visit or requiring hospitalisation or both </h6> <p>Administration of vitamin D did not reduce or increase the proportion of participants experiencing at least one asthma exacerbation precipitating an emergency department visit or hospital admission, or both (OR 0.56, 95% CI 0.26 to 1.21; I<sup>2</sup> = 33%; 9 studies, 1070 participants; moderate‐quality evidence; <a href="./references#CD011511-fig-0018" title="">Analysis 1.12</a>). </p> </section> <section id="CD011511-sec-0061"> <h6 class="title">End‐study cACT or ACT score</h6> <p>We saw no effect of vitamin D on asthma control scores. Different studies used the cACT for participants under 12 years (scale 0 to 27, 27 representing optimal control) or the ACT for 12 years and over (scale 0 to 25, 25 representing optimal control). As outlined in <a href="#CD011511-sec-0015">Methods</a>, we used a linear scale transformation to convert ACT scores to the cACT scale for direct comparison. End‐study mean difference between arms was not significant (MD 0.23 higher in vitamin D arm, 95% CI ‐0.26 to 0.73; I<sup>2</sup> = 29%; 7 studies, 1271 participants; moderate‐quality evidence; <a href="./references#CD011511-fig-0019" title="">Analysis 1.13</a>). The standard minimally important difference for this score is three (<a href="./references#CD011511-bbs2-0109" title="SchatzM , KosinskiM , YarlasAS , HanlonJ , WatsonME , JhingranP . The minimally important difference of the Asthma Control Test. Journal of Allergy and Clinical Immunology2009;124(4):719-723. [DOI: 10.1016/j.jaci.2009.06.053]">Schatz 2009</a>). </p> <p>Two other studies provided data on the change in ACT scores within arms rather than end‐study scores (<a href="./references#CD011511-bbs2-0010" title="JiangC , YiR , NaH , LinS . A randomized controlled study of Vitamin D3 supplementation on childhood asthma control. Chongqing Medicine2017;46(32):4505-7. [DOI: 10.3969/j.issn.1671-8348.2017.32.011]">Jiang 2017</a>; <a href="./references#CD011511-bbs2-0011" title="KerleyCP , HutchinsonK , CormicanL , FaulJ , GreallyP , CoghlanD , et al. Vitamin D3 for uncontrolled childhood asthma: A pilot study. Paediatric Allergy and Immunology2016;27:404-12. [PMID: 10.1111/pai.12547]">Kerley 2016</a>), which we have summarised narratively as they could not be meta‐analysed with the other eight studies above. <a href="./references#CD011511-bbs2-0010" title="JiangC , YiR , NaH , LinS . A randomized controlled study of Vitamin D3 supplementation on childhood asthma control. Chongqing Medicine2017;46(32):4505-7. [DOI: 10.3969/j.issn.1671-8348.2017.32.011]">Jiang 2017</a> showed a mean increase of 0.325 (SD 0.80) from baseline in the intervention arm and a mean decrease of ‐0.025 (SD 0.79) in the placebo arm, with a mean difference of 0.35 (standard error 0.17). <a href="./references#CD011511-bbs2-0011" title="KerleyCP , HutchinsonK , CormicanL , FaulJ , GreallyP , CoghlanD , et al. Vitamin D3 for uncontrolled childhood asthma: A pilot study. Paediatric Allergy and Immunology2016;27:404-12. [PMID: 10.1111/pai.12547]">Kerley 2016</a> presented outcomes as median (IQR), with a median change in ACT score of 2 (‐2 to 4) in the intervention arm and 3.5 (0 to 5) in the control arm (P = 0.34). </p> </section> <section id="CD011511-sec-0062"> <h6 class="title">End‐study % predicted FEV1</h6> <p>There was no overall effect of vitamin D on end‐study % predicted FEV1 (MD 0.20 higher in vitamin D arm, 95% CI ‐1.24 to 1.63; I<sup>2</sup> = 25%; 11 studies, 1286 participants; high‐quality evidence; <a href="./references#CD011511-fig-0020" title="">Analysis 1.14</a>). A funnel plot of included studies for this outcome is presented in <a href="#CD011511-fig-0005">Figure 5</a>, which is approximately symmetrical aside from one large study (<a href="./references#CD011511-bbs2-0003" title="CamargoC , ToopL , SluyterJ , LawesCM , WaayerD , KhawKT , et al. Effect of monthly vitamin D supplementation on preventing exacerbations of asthma or chronic obstructive pulmonary disease in older adults: post hoc analysis of a randomized controlled trial. Nutrients2021;13:521. [DOI: 10.3390/nu13020521]SluyterJ , CamargoCA , WaayerD , LawesCM , ToopL , KhawKT , et al. Effect of monthly, high-dose, long-term vitamin D on lung function: a randomized controlled trial. Nutrients2017;9:1353. [DOI: 10.3390/nu9121353]">Camargo 2021</a>), and shows no evidence of small‐study bias. Two other trials investigated FEV1 as an outcome measure in a different format, which we have reported narratively. <a href="./references#CD011511-bbs2-0010" title="JiangC , YiR , NaH , LinS . A randomized controlled study of Vitamin D3 supplementation on childhood asthma control. Chongqing Medicine2017;46(32):4505-7. [DOI: 10.3969/j.issn.1671-8348.2017.32.011]">Jiang 2017</a> reported the end‐study proportion of participants with FEV1 &lt; 80% predicted, with no significant difference (14 out of 43 in intervention arm versus 15 out of 40 in control arm). <a href="./references#CD011511-bbs2-0011" title="KerleyCP , HutchinsonK , CormicanL , FaulJ , GreallyP , CoghlanD , et al. Vitamin D3 for uncontrolled childhood asthma: A pilot study. Paediatric Allergy and Immunology2016;27:404-12. [PMID: 10.1111/pai.12547]">Kerley 2016</a> reported no significant change in % predicted FEV1 within arms, with a median (IQR) change of ‐4 (‐6.3 to ‐1) in the intervention arm and 2.5 (‐4.3 to 6.5) in the control arm (P = 0.06). </p> <div class="figure" id="CD011511-fig-0005"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 5</div> </div> <hr class="top"/><img alt="Funnel plot of comparison: Vitamin D versus placebo (all studies), outcome: 1.11 End‐study FEV1, % predicted" data-id="CD011511-fig-0005" src="/cdsr/doi/10.1002/14651858.CD011511.pub3/media/CDSR/CD011511/image_n/nCD011511-FIG-05.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Funnel plot of comparison: Vitamin D versus placebo (all studies), outcome: 1.11 End‐study FEV1, % predicted </p> </div> </div> </div> </section> <section id="CD011511-sec-0063"> <h6 class="title">Incidence of any serious adverse event, any cause</h6> <p>Administration of vitamin D did not influence the proportion of participants experiencing one or more serious adverse events of any cause (OR 0.89, 95% CI 0.56 to 1.41; I<sup>2</sup> = 0%; 12 studies, 1556 participants; high‐quality evidence; <a href="./references#CD011511-fig-0021" title="">Analysis 1.15</a>). One other study reported the rate of adverse events rather than the number of participants experiencing one or more such events (<a href="./references#CD011511-bbs2-0007" title="JatKR , GoelN , GuptaN , ChandraPG , SudipD , RakeshL , et al. Efficacy of vitamin D supplementation in asthmatic childrenwith vitamin D deficiency: a randomized controlled trial(ESDAC trial). Pediatric Allergy and Immunology2021;32(3):479– 88. [DOI: 10.1111/pai.13415]">Jat 2020</a>), and found that one participant in the intervention arm experienced altered sensorium, which was not defined further, and one in the placebo arm experienced a seizure. </p> </section> <section id="CD011511-sec-0064"> <h6 class="title">Incidence of adverse reactions attributed to administration of vitamin D or its metabolites</h6> <p>Two trials reported occurrences of hypercalciuria, an event that is recognised as a potential adverse reaction to vitamin D. In the study by Jensen and colleagues, this event arose in one participant in the intervention arm and one participant in the control arm (<a href="./references#CD011511-bbs2-0008" title="JensenM , MailhotG , AlosN , RousseauE , WhiteJ , KhamessanA , et al. Vitamin D intervention in preschoolers with viral-induced asthma (DIVA): a pilot randomised controlled trial. American Journal of Respiratory and Critical Care Medicine2015;191:A3360. JensenME , MailhotG , AlosN , RousseauE , WhiteJ , KhamessanA , et al. Vitamin D intervention in preschoolers with viral-induced asthma (DIVA): a pilot randomised controlled trial. Trials2016;17:353. [DOI: 10.1186/s13063-016-1483-1]">Jensen 2016</a>). This trial involved administration of 400 IU vitamin D<sub>3</sub> to both study arms, and an initial 100,000 IU bolus for the intervention arm. In <a href="./references#CD011511-bbs2-0005" title="DucharmeFM , JensenM , MailhotG , AlosN , WhiteJ , RousseauE , et al. Impact of two oral doses of 100,000 IU of vitamin D3 in preschoolers with viral induced asthma: a pilot randomised controlled trial. Trials2019;20(1):138. [DOI: 10.1186/s13063-019-3184-z]">Ducharme 2019</a>, at least one participant in the intervention arm experienced borderline hypercalciuria (Ca:Cr 1.02) following treatment with vitamin D, but we could not ascertain the total number of events in either arm from the trial report. </p> <p>Camargo and colleagues reported 11 participants with adverse reactions potentially attributable to vitamin D (<a href="./references#CD011511-bbs2-0003" title="CamargoC , ToopL , SluyterJ , LawesCM , WaayerD , KhawKT , et al. Effect of monthly vitamin D supplementation on preventing exacerbations of asthma or chronic obstructive pulmonary disease in older adults: post hoc analysis of a randomized controlled trial. Nutrients2021;13:521. [DOI: 10.3390/nu13020521]SluyterJ , CamargoCA , WaayerD , LawesCM , ToopL , KhawKT , et al. Effect of monthly, high-dose, long-term vitamin D on lung function: a randomized controlled trial. Nutrients2017;9:1353. [DOI: 10.3390/nu9121353]">Camargo 2021</a>). Two participants in the intervention arm experienced hypervitaminosis D (defined as 25(OH)D &gt; 220 nmol/L) and six experienced kidney stones, whilst three participants in the control arm experienced kidney stones. Andújar‐Espinosa and colleagues reported five participants experiencing gastrointestinal symptoms (<a href="./references#CD011511-bbs2-0002" title="Andújar-EspinosaR , Aparicio-VicenteM , Ruiz-LópezFJ , Salinero-GonzálezL . Influence of vitamin D supplementation on the quality of life of asthma patients: Findings from ACVID randomised clinical trial. Respiratory Medicine2021;185:106484. [DOI: 10.1016/j.rmed.2021.106484]Andújar-EspinosaR , Salinero-GonzálezL , Illán-GómezF , Castilla-MartínezM , Hu-YangC , Ruiz-LópezFJ . Effect of vitamin D supplementation on asthma control in patients with vitamin D deficiency: the ACVID randomised clinical trial. Thorax2021;76(2):126–33. [DOI: 10.1136/thoraxjnl-2019-213936]">Andújar‐Espinosa 2021</a>); three in the intervention arm and two in the control arm. Jat and colleagues reported that one participant from the control arm withdrew from the study due to mild itch (<a href="./references#CD011511-bbs2-0007" title="JatKR , GoelN , GuptaN , ChandraPG , SudipD , RakeshL , et al. Efficacy of vitamin D supplementation in asthmatic childrenwith vitamin D deficiency: a randomized controlled trial(ESDAC trial). Pediatric Allergy and Immunology2021;32(3):479– 88. [DOI: 10.1111/pai.13415]">Jat 2020</a>). Jerzynska and colleagues narratively reported sublingual itching, headaches, and stomachaches occurring in both arms, without incidence detail specific to the asthma cohort (<a href="./references#CD011511-bbs2-0009" title="JerzynskaJ , StelmachW , RychlikB , LechańskaJ , PodleckaD , StelmachI . The clinical effect of vitamin D supplementation combined with grass-specific sublingual immunotherapy in children with allergic rhinitis. Allergy and Asthma Proceedings2016;37(2):105-14. [DOI: 10.2500/aap.2016.37.3921]">Jerzynska 2016</a>). No other studies reported any adverse reactions potentially attributable to vitamin D. </p> </section> <section id="CD011511-sec-0065"> <h6 class="title">Incidence of fatal asthma exacerbation</h6> <p>No participant in any of the included trials suffered a fatal asthma exacerbation, therefore the effect of the intervention on this outcome could not be evaluated (risk difference 0.00, 95% CI ‐0.01 to 0.01; I<sup>2</sup> = 0%; 16 studies, 1976 participants; low‐quality evidence; <a href="./references#CD011511-fig-0022" title="">Analysis 1.16</a>). </p> </section> <section id="CD011511-sec-0066"> <h6 class="title">Incidence of asthma exacerbation as defined in primary trials</h6> <p>The definitions of asthma exacerbations used in individual trials are summarised in <a href="#CD011511-tbl-0003">Table 2</a>. Administration of vitamin D did not significantly affect the proportion of participants experiencing at least one study‐defined exacerbation, though there was considerable heterogeneity in study definitions of exacerbation (OR 0.77, 95% CI 0.51 to 1.17; I<sup>2</sup> = 57%; 12 studies, 1539 participants; high‐quality evidence; <a href="./references#CD011511-fig-0023" title="">Analysis 1.17</a>). A further study reported no difference between placebo and vitamin D groups (30.4% vs 35.5%; P = 0.431) but did not report absolute numbers (<a href="./references#CD011511-bbs2-0007" title="JatKR , GoelN , GuptaN , ChandraPG , SudipD , RakeshL , et al. Efficacy of vitamin D supplementation in asthmatic childrenwith vitamin D deficiency: a randomized controlled trial(ESDAC trial). Pediatric Allergy and Immunology2021;32(3):479– 88. [DOI: 10.1111/pai.13415]">Jat 2020</a>). The funnel plot, shown in <a href="#CD011511-fig-0006">Figure 6</a>, was approximately symmetric. </p> <div class="table" id="CD011511-tbl-0003"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Definitions of asthma exacerbation used in primary trials</span></div> <tbody> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Study</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Definition</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011511-bbs2-0001" title="AglipayM , BirkenC , DaiD , ParkinP , MaguireJ . 70 high dose vitamin D for the prevention of wheezing in preschoolers: a secondary analysis of a randomized clinical trial. Paediatrics and Child Health2019;24(S2):e27-8. [DOI: 10.1093/pch/pxz066.069]AglipayM , BirkenCS , ParkinPC , LoebMB , ThorpeK , ChenY , et al. TARGet Kids! Collaboration. Effect of high-dose vs standard-dose wintertime vitamin D supplementation on viral upper respiratory tract infections in young healthy children. JAMA2017;318(3):245-54. [DOI: 10.1001/jama.2017.8708.]">Aglipay 2019</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Wheezing episode in children with asthma reported in parent completed symptom checklist, based on the International Study of Asthma and Allergies in Childhood </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011511-bbs2-0003" title="CamargoC , ToopL , SluyterJ , LawesCM , WaayerD , KhawKT , et al. Effect of monthly vitamin D supplementation on preventing exacerbations of asthma or chronic obstructive pulmonary disease in older adults: post hoc analysis of a randomized controlled trial. Nutrients2021;13:521. [DOI: 10.3390/nu13020521]SluyterJ , CamargoCA , WaayerD , LawesCM , ToopL , KhawKT , et al. Effect of monthly, high-dose, long-term vitamin D on lung function: a randomized controlled trial. Nutrients2017;9:1353. [DOI: 10.3390/nu9121353]">Camargo 2021</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Any prescription of oral corticosteroids more than 20 days apart for a short period (e.g. several days) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011511-bbs2-0004" title="CastroM , KingTS , KunselmanSJ , CabanaMD , DenlingerL , HolguinF , et al. Effect of vitamin D3 on asthma treatment failures in adults with symptomatic asthma and lower vitamin D levels: the VIDA randomized clinical trial. JAMA2014;311(20):2083-91. DenlingerLC , KingTS , CardetJC , CraigT , HolguinF , JacksonDJ , et al. Vitamin D supplementation and the risk of colds in patients with asthma. American Journal of Respiratory and Critical Care Medicine2016;193(6):634–41. DenlingerLC , KingTS , CardetJC , CraigTJ , HolguinF , KraftM , et al. Vitamin D supplementation and the risk of colds in patients with asthma. Journal of Allergy and Clinical Immunology2015;135:AB109. JiaoJ , KingTS , McKenzieM , BacharierLB , DixonAE , CodispotiCD , et al. Effects of vitamin D3 supplementation in adults with asthma complicated by sinonasal disease. American Journal of Respiratory and Critical Care Medicine2015;191:A4148. JiaoJ , KingTS , McKenzieM , BacharierLB , DixonAE , CodispotiCD , et al. Vitamin D3 therapy in patients with asthma complicated by sinonasal disease: secondary analysis of the Vitamin D Add-on Therapy Enhances Corticosteroid Responsiveness in Asthma trial. Journal of Allergy and Clinical Immunology2016;138(2):589-92. MooreWC , KingTS , BleeckerER , MeyersDA , PetersSP , WenzelSE . Sarp clinical clusters predict steroid responsiveness and risk of asthma exacerbations in the asthma net vida (vitamin D in asthma) trial. American Journal of Respiratory and Critical Care Medicine2015;191:A6055. ReidB , GirodetP , BoomerJS , Abdel-GadirA , ZhengK , WechslerME , et al. Vitamin D3 treatment of vitamin D insufficient asthmatics does not alter immune cell function. Journal of Allergy and Clinical Immunology2016;138(1):286-9. ">Castro 2014</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Meeting criteria for treatment failure and 1 or more of the following:</p> <p> <ul id="CD011511-list-0009"> <li> <p>failure to respond to rescue algorithm within 48 hours;</p> </li> <li> <p>FEV1 of less than 50% of baseline measurement on 2 consecutive measurements;</p> </li> <li> <p>FEV1 of less than 40% of predicted level on 2 consecutive measurements;</p> </li> <li> <p>use of 16 puffs/day or more of as‐needed levalbuterol for 48 hours;</p> </li> <li> <p>experiencing an exacerbation of asthma according to physician opinion;</p> </li> <li> <p>use of oral or parenteral corticosteroids due to asthma.</p> </li> </ul> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011511-bbs2-0005" title="DucharmeFM , JensenM , MailhotG , AlosN , WhiteJ , RousseauE , et al. Impact of two oral doses of 100,000 IU of vitamin D3 in preschoolers with viral induced asthma: a pilot randomised controlled trial. Trials2019;20(1):138. [DOI: 10.1186/s13063-019-3184-z]">Ducharme 2019</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Exacerbation requiring rescue oral corticosteroids</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011511-bbs2-0006" title="FornoE , BacharierLB , PhipatanakulW , GuilbertTW , CabanaMD , RossK , et al. Effect of vitamin D3 supplementation on severe asthma exacerbations in children with asthma and low vitamin D levels: The VDKA Randomized Clinical Trial. JAMA2020;324(8):752-60. HanYY , FornoE , BacharierLB , PhipatanakulW , GuilbertTW , CabanaMD , et al. Vitamin D supplementation, lung function and asthma control in children with asthma and low vitamin D levels. European Respiratory Journal2021;58(4):2100989. [DOI: 10.1183/13993003.00989-2021]N/a. Errors in flow diagram. JAMA2021;326(1):90. [DOI: 10.1001/jama.2021.9465.]RosserFJ , HanYY , FornoE , BacharierLB , PhipatanakulW , GuilbertTW , et al. Effect of vitamin D supplementation on total andallergen-specific IgE in children with asthma andlow vitamin D levels. Journal of Allergy and Clinical Immunology2021;149(1):440-4.E2. [PMID: 10.1016/j.jaci.2021.05.037]">Forno 2020</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Either:</p> <p> <ul id="CD011511-list-0010"> <li> <p>use of systemic corticosteroids for at least 3 days; or</p> </li> <li> <p>hospitalisation or emergency department visit because of asthma, requiring systemic corticosteroids </p> </li> </ul> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011511-bbs2-0008" title="JensenM , MailhotG , AlosN , RousseauE , WhiteJ , KhamessanA , et al. Vitamin D intervention in preschoolers with viral-induced asthma (DIVA): a pilot randomised controlled trial. American Journal of Respiratory and Critical Care Medicine2015;191:A3360. JensenME , MailhotG , AlosN , RousseauE , WhiteJ , KhamessanA , et al. Vitamin D intervention in preschoolers with viral-induced asthma (DIVA): a pilot randomised controlled trial. Trials2016;17:353. [DOI: 10.1186/s13063-016-1483-1]">Jensen 2016</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Exacerbation requiring rescue oral corticosteroids, documented in medical or pharmacy records or both </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011511-bbs2-0009" title="JerzynskaJ , StelmachW , RychlikB , LechańskaJ , PodleckaD , StelmachI . The clinical effect of vitamin D supplementation combined with grass-specific sublingual immunotherapy in children with allergic rhinitis. Allergy and Asthma Proceedings2016;37(2):105-14. [DOI: 10.2500/aap.2016.37.3921]">Jerzynska 2016</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Exacerbation not defined in study manuscript, individual participant data defined as requiring steroid course </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011511-bbs2-0011" title="KerleyCP , HutchinsonK , CormicanL , FaulJ , GreallyP , CoghlanD , et al. Vitamin D3 for uncontrolled childhood asthma: A pilot study. Paediatric Allergy and Immunology2016;27:404-12. [PMID: 10.1111/pai.12547]">Kerley 2016</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Exacerbation not defined in study manuscript, individual participant data defined as requiring steroid course </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011511-bbs2-0012" title="LewisE , FernandezC , NellaA , HoppR , GallagherJC , CasaleTB . Relationship of 25-hydroxyvitamin D and asthma control in children. Annals of Allergy, Asthma and Immunology2012;108(4):281-2. LewisE , FernandezC , NellaAA , HoppR , CasaleT , GallagherC . The relationship of vitamin D and asthma in children. Journal of Allergy and Clinical Immunology2011;127(2):AB262. ">Lewis 2012</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Exacerbation not defined or reported in study manuscript</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011511-bbs2-0013" title="MajakP , JerzyiskaJ , SmejdaK , StelmachI , TimlerD , StelmachW . Correlation of vitamin D with Foxp3 induction and steroid-sparing effect of immunotherapy in asthmatic children. Annals of Allergy, Asthma and Immunology2012;109(5):329-35. MajakP , RychlikB , StelmachI . The effect of oral steroids with and without vitamin D3 on early efficacy of immunotherapy in asthmatic children. Clinical and Experimental Allergy2009;39(12):1830-41. ">Majak 2009</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Exacerbation not defined or reported in study manuscript; authors confirmed that no exacerbations requiring systemic corticosteroid treatment occurred in the study </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011511-bbs2-0014" title="MajakP , Olszowiec-ChlebnaM , SmejdaK , StelmachI . Vitamin D supplementation in children may prevent asthma exacerbation triggered by acute respiratory infection. Journal of Allergy and Clinical Immunology2011;127(5):1294-6. ">Majak 2011</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Reported but not defined in study manuscript; authors confirmed that no exacerbations requiring systemic corticosteroid treatment occurred in the study </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011511-bbs2-0015" title="MartineauAR , MacLaughlinBD , HooperRL , BarnesNC , JolliffeDA , ChoudhuryAB , et al. Double-blind multi-centre randomised controlled trial of vitamin D3 supplementation in adults with inhaled corticosteroid-treated asthma (ViDiAs). Thorax2014;69:A51-2. MartineauAR , MacLaughlinBD , HooperRL , BarnesNC , JolliffeDA , GreillerCL , et al. Double-blind randomised placebo-controlled trial of bolus-dose vitamin D3 supplementation in adults with asthma (ViDiAs). Thorax2015;70(5):451-7. ">Martineau 2015</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Deterioration in asthma resulting in (A) treatment with oral corticosteroids, or (B) hospital admission or emergency department treatment, or (C) decrease in the morning PEFR to more than 25% below the mean run‐in value on 2 or more consecutive days </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011511-bbs2-0017" title="TachimotoH , MezawaH , SegawaT , AkiyamaN , IdaH , UrashimaM . Improved control of childhood asthma with low-dose, short-term vitamin D supplementation: a randomized, double-blind, placebo-controlled trial. Allergy2016;71(7):1001-9. ">Tachimoto 2016</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Worsening of asthma symptoms prompting a need for a change in asthma treatment (from authors) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011511-bbs2-0018" title="ThakurC , KumarJ , KumarP , GoyalJP , SinghK , GuptaA . Vitamin‐D supplementation as an adjunct to standard treatmentof asthma in children: a randomized controlled trial (ViDASTA Trial). Pediatric Pulmonology2021;56:1427–33. [DOI: 10.1002/ppul.25287]">Thakur 2021</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Reported but not defined in study manuscript</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011511-bbs2-0019" title="UrashimaM , SegawaT , OkazakiM , KuriharaM , WadaY , IdaH . Randomized trial of vitamin D supplementation to prevent seasonal influenza A in school children. American Journal of Clinical Nutrition2010;91(5):1255-60. ">Urashima 2010</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Asthma attack that included wheezing, improved by inhalation of a beta‐stimulant in participants who already had a diagnosis of asthma; authors confirmed that no exacerbations requiring systemic corticosteroid treatment occurred in the study </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011511-bbs2-0020" title="YadavM , MittalK . Effect of vitamin D supplementation on moderate to severe bronchial asthma. Indian Journal of Pediatrics2014;81(7):650-4. ">Yadav 2014</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Reported but not defined in study manuscript</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>FEV1, forced expiratory volume in one second; PEFR, peak expiratory flow rate.</p> </div> </div> <div class="figure" id="CD011511-fig-0006"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 6</div> </div> <hr class="top"/><img alt="Funnel plot of comparison: 1 Vitamin D versus placebo (all studies), outcome: 1.9 People with one or more study‐defined exacerbations" data-id="CD011511-fig-0006" src="/cdsr/doi/10.1002/14651858.CD011511.pub3/media/CDSR/CD011511/image_n/nCD011511-FIG-06.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Funnel plot of comparison: 1 Vitamin D versus placebo (all studies), outcome: 1.9 People with one or more study‐defined exacerbations </p> </div> </div> </div> </section> <section id="CD011511-sec-0067"> <h6 class="title">End‐study % lower airway eosinophils</h6> <p>Vitamin D did not influence mean end‐study % eosinophil count in the lower airway (MD ‐0.38, 95% CI ‐1.92 to 1.15; I<sup>2</sup> = 43%; 3 studies, 525 participants; moderate‐quality evidence; <a href="./references#CD011511-fig-0024" title="">Analysis 1.18</a>). One further study narratively reported no significant effect of vitamin D on mean end‐study % eosinophils (<a href="./references#CD011511-bbs2-0011" title="KerleyCP , HutchinsonK , CormicanL , FaulJ , GreallyP , CoghlanD , et al. Vitamin D3 for uncontrolled childhood asthma: A pilot study. Paediatric Allergy and Immunology2016;27:404-12. [PMID: 10.1111/pai.12547]">Kerley 2016</a>). However, another study reported only the absolute volume of end‐study eosinophils following administration of calcitriol, and found that this active form of vitamin D did reduce the outcome (vitamin D arm 0.77 ± 1.3 x 10<sup>3</sup>/μl, control arm 1.29 ± 2.5 x 10<sup>3</sup>/μl) (<a href="./references#CD011511-bbs2-0016" title="Ramos-MartínezE , López-VancellMR , Fernández de Córdova-AguirreJC , Rojas-SerranoJ , ChavarríaA , Velasco-MedinaA , et al. Reduction of respiratory infections in asthma patients supplemented with vitamin D is related to increased serum IL-10 and IFNγ levels and cathelicidin expression. Cytokine2018;108:239–46. ">Ramos‐Martínez 2018</a>). </p> </section> <section id="CD011511-sec-0068"> <h6 class="title">End‐study log10 total IgE, IU/ml</h6> <p>Three trials reported data on end‐study log total IgE levels (IU/ml), showing no significant effects of vitamin D administration (MD 0.07 higher in vitamin D arm, 95% CI ‐0.13 to 0.26; I<sup>2</sup> = 0%; 3 studies, 366 participants; high‐quality evidence; <a href="./references#CD011511-fig-0025" title="">Analysis 1.19</a>) (<a href="./references#CD011511-bbs2-0002" title="Andújar-EspinosaR , Aparicio-VicenteM , Ruiz-LópezFJ , Salinero-GonzálezL . Influence of vitamin D supplementation on the quality of life of asthma patients: Findings from ACVID randomised clinical trial. Respiratory Medicine2021;185:106484. [DOI: 10.1016/j.rmed.2021.106484]Andújar-EspinosaR , Salinero-GonzálezL , Illán-GómezF , Castilla-MartínezM , Hu-YangC , Ruiz-LópezFJ . Effect of vitamin D supplementation on asthma control in patients with vitamin D deficiency: the ACVID randomised clinical trial. Thorax2021;76(2):126–33. [DOI: 10.1136/thoraxjnl-2019-213936]">Andújar‐Espinosa 2021</a>; <a href="./references#CD011511-bbs2-0006" title="FornoE , BacharierLB , PhipatanakulW , GuilbertTW , CabanaMD , RossK , et al. Effect of vitamin D3 supplementation on severe asthma exacerbations in children with asthma and low vitamin D levels: The VDKA Randomized Clinical Trial. JAMA2020;324(8):752-60. HanYY , FornoE , BacharierLB , PhipatanakulW , GuilbertTW , CabanaMD , et al. Vitamin D supplementation, lung function and asthma control in children with asthma and low vitamin D levels. European Respiratory Journal2021;58(4):2100989. [DOI: 10.1183/13993003.00989-2021]N/a. Errors in flow diagram. JAMA2021;326(1):90. [DOI: 10.1001/jama.2021.9465.]RosserFJ , HanYY , FornoE , BacharierLB , PhipatanakulW , GuilbertTW , et al. Effect of vitamin D supplementation on total andallergen-specific IgE in children with asthma andlow vitamin D levels. Journal of Allergy and Clinical Immunology2021;149(1):440-4.E2. [PMID: 10.1016/j.jaci.2021.05.037]">Forno 2020</a>; <a href="./references#CD011511-bbs2-0016" title="Ramos-MartínezE , López-VancellMR , Fernández de Córdova-AguirreJC , Rojas-SerranoJ , ChavarríaA , Velasco-MedinaA , et al. Reduction of respiratory infections in asthma patients supplemented with vitamin D is related to increased serum IL-10 and IFNγ levels and cathelicidin expression. Cytokine2018;108:239–46. ">Ramos‐Martínez 2018</a>). Two further trials reported no significant effect on IgE levels, but did not present data on this outcome (<a href="./references#CD011511-bbs2-0011" title="KerleyCP , HutchinsonK , CormicanL , FaulJ , GreallyP , CoghlanD , et al. Vitamin D3 for uncontrolled childhood asthma: A pilot study. Paediatric Allergy and Immunology2016;27:404-12. [PMID: 10.1111/pai.12547]">Kerley 2016</a>; <a href="./references#CD011511-bbs2-0017" title="TachimotoH , MezawaH , SegawaT , AkiyamaN , IdaH , UrashimaM . Improved control of childhood asthma with low-dose, short-term vitamin D supplementation: a randomized, double-blind, placebo-controlled trial. Allergy2016;71(7):1001-9. ">Tachimoto 2016</a>). </p> <p><a href="./references#CD011511-bbs2-0011" title="KerleyCP , HutchinsonK , CormicanL , FaulJ , GreallyP , CoghlanD , et al. Vitamin D3 for uncontrolled childhood asthma: A pilot study. Paediatric Allergy and Immunology2016;27:404-12. [PMID: 10.1111/pai.12547]">Kerley 2016</a> also found that vitamin D had no effect on total IgA, IL10 or LL37 biomarkers. Another trial conducted in adults investigated the effects of vitamin D on concentrations of inflammatory markers in induced sputum supernatants. Martineau and colleagues reported that administration of vitamin D had no effect on supernatant concentrations of a panel of 17 inflammatory markers whose concentrations were detectable, measured at 2 and 12 months (<a href="./references#CD011511-bbs2-0015" title="MartineauAR , MacLaughlinBD , HooperRL , BarnesNC , JolliffeDA , ChoudhuryAB , et al. Double-blind multi-centre randomised controlled trial of vitamin D3 supplementation in adults with inhaled corticosteroid-treated asthma (ViDiAs). Thorax2014;69:A51-2. MartineauAR , MacLaughlinBD , HooperRL , BarnesNC , JolliffeDA , GreillerCL , et al. Double-blind randomised placebo-controlled trial of bolus-dose vitamin D3 supplementation in adults with asthma (ViDiAs). Thorax2015;70(5):451-7. ">Martineau 2015</a>). Castro and colleagues investigated the effects of vitamin D on function of myeloid cells and CD4+ T cells in peripheral blood but found no effect on this outcome (<a href="./references#CD011511-bbs2-0004" title="CastroM , KingTS , KunselmanSJ , CabanaMD , DenlingerL , HolguinF , et al. Effect of vitamin D3 on asthma treatment failures in adults with symptomatic asthma and lower vitamin D levels: the VIDA randomized clinical trial. JAMA2014;311(20):2083-91. DenlingerLC , KingTS , CardetJC , CraigT , HolguinF , JacksonDJ , et al. Vitamin D supplementation and the risk of colds in patients with asthma. American Journal of Respiratory and Critical Care Medicine2016;193(6):634–41. DenlingerLC , KingTS , CardetJC , CraigTJ , HolguinF , KraftM , et al. Vitamin D supplementation and the risk of colds in patients with asthma. Journal of Allergy and Clinical Immunology2015;135:AB109. JiaoJ , KingTS , McKenzieM , BacharierLB , DixonAE , CodispotiCD , et al. Effects of vitamin D3 supplementation in adults with asthma complicated by sinonasal disease. American Journal of Respiratory and Critical Care Medicine2015;191:A4148. JiaoJ , KingTS , McKenzieM , BacharierLB , DixonAE , CodispotiCD , et al. Vitamin D3 therapy in patients with asthma complicated by sinonasal disease: secondary analysis of the Vitamin D Add-on Therapy Enhances Corticosteroid Responsiveness in Asthma trial. Journal of Allergy and Clinical Immunology2016;138(2):589-92. MooreWC , KingTS , BleeckerER , MeyersDA , PetersSP , WenzelSE . Sarp clinical clusters predict steroid responsiveness and risk of asthma exacerbations in the asthma net vida (vitamin D in asthma) trial. American Journal of Respiratory and Critical Care Medicine2015;191:A6055. ReidB , GirodetP , BoomerJS , Abdel-GadirA , ZhengK , WechslerME , et al. Vitamin D3 treatment of vitamin D insufficient asthmatics does not alter immune cell function. Journal of Allergy and Clinical Immunology2016;138(1):286-9. ">Castro 2014</a>). Ramos‐Martínez and colleagues found end‐study serum concentrations of IL‐10 and INF‐γ were higher in the intervention than the control arm (difference in means IL‐10 24.92 pg/ml, INF‐γ 53.33 pg/ml), while end‐study IL‐5, IL‐9, and IL‐13 were lower in the intervention arm (difference in means IL‐5 33.72 pg/ml, IL‐9 36.92 pg/ml, IL‐13 181.45 pg/ml) (<a href="./references#CD011511-bbs2-0016" title="Ramos-MartínezE , López-VancellMR , Fernández de Córdova-AguirreJC , Rojas-SerranoJ , ChavarríaA , Velasco-MedinaA , et al. Reduction of respiratory infections in asthma patients supplemented with vitamin D is related to increased serum IL-10 and IFNγ levels and cathelicidin expression. Cytokine2018;108:239–46. ">Ramos‐Martínez 2018</a>). </p> </section> <section id="CD011511-sec-0069"> <h6 class="title">End‐study % predicted FVC</h6> <p>Vitamin D did not influence mean end‐study FVC (MD 1.84 higher in vitamin D arm, 95% CI ‐3.60 to 7.29; I<sup>2</sup> = 73%; 4 studies, 476 participants; moderate‐quality evidence; <a href="./references#CD011511-fig-0026" title="">Analysis 1.20</a>). Two further studies reported FVC data in a different format, which we have presented narratively. <a href="./references#CD011511-bbs2-0010" title="JiangC , YiR , NaH , LinS . A randomized controlled study of Vitamin D3 supplementation on childhood asthma control. Chongqing Medicine2017;46(32):4505-7. [DOI: 10.3969/j.issn.1671-8348.2017.32.011]">Jiang 2017</a> reported end‐study proportion of participants with FVC &lt; 80% predicted, with no significant difference (13 out of 43 in intervention arm versus 11 out of 40 in control arm). <a href="./references#CD011511-bbs2-0011" title="KerleyCP , HutchinsonK , CormicanL , FaulJ , GreallyP , CoghlanD , et al. Vitamin D3 for uncontrolled childhood asthma: A pilot study. Paediatric Allergy and Immunology2016;27:404-12. [PMID: 10.1111/pai.12547]">Kerley 2016</a> reported no significant change in FVC % predicted within arms, with a median (IQR) change of ‐2.5 (‐8.3 to 3) in the intervention arm and 0 (‐5 to 4.5) in the control arm (P = 0.36). </p> </section> <section id="CD011511-sec-0070"> <h6 class="title">End‐study PEFR</h6> <p>Vitamin D did not influence mean end‐study PEFR (MD 4.84 higher in vitamin D arm, 95% CI ‐8.95 to 18.62; I<sup>2</sup> = 79%; 3 studies, 476 participants; moderate‐quality evidence; <a href="./references#CD011511-fig-0027" title="">Analysis 1.21</a>). One further study presented PEFR in graphical form only, with end‐study mean of approximately 185 L/min for the vitamin D arm and 165 L/min for the control arm, but did not report standard deviations (<a href="./references#CD011511-bbs2-0020" title="YadavM , MittalK . Effect of vitamin D supplementation on moderate to severe bronchial asthma. Indian Journal of Pediatrics2014;81(7):650-4. ">Yadav 2014</a>). </p> </section> <section id="CD011511-sec-0071"> <h6 class="title">Proportion of participants withdrawing from the trial</h6> <p>We saw no difference in the proportion of participants withdrawing from trials between intervention and control arms (OR 1.05, 95% CI 0.77 to 1.43; I<sup>2</sup> = 0%; 20 studies, 2225 participants; high‐quality evidence; <a href="./references#CD011511-fig-0028" title="">Analysis 1.22</a>). </p> <section id="CD011511-sec-0072"> <p><b>Sensitivity analysis excluding trials at high risk of bias</b></p> <p>All three trials assessed as being at high risk of bias reported effects of vitamin D on the proportion of participants withdrawing from the trial (<a href="./references#CD011511-bbs2-0010" title="JiangC , YiR , NaH , LinS . A randomized controlled study of Vitamin D3 supplementation on childhood asthma control. Chongqing Medicine2017;46(32):4505-7. [DOI: 10.3969/j.issn.1671-8348.2017.32.011]">Jiang 2017</a>; <a href="./references#CD011511-bbs2-0012" title="LewisE , FernandezC , NellaA , HoppR , GallagherJC , CasaleTB . Relationship of 25-hydroxyvitamin D and asthma control in children. Annals of Allergy, Asthma and Immunology2012;108(4):281-2. LewisE , FernandezC , NellaAA , HoppR , CasaleT , GallagherC . The relationship of vitamin D and asthma in children. Journal of Allergy and Clinical Immunology2011;127(2):AB262. ">Lewis 2012</a>; <a href="./references#CD011511-bbs2-0020" title="YadavM , MittalK . Effect of vitamin D supplementation on moderate to severe bronchial asthma. Indian Journal of Pediatrics2014;81(7):650-4. ">Yadav 2014</a>). When these trials were excluded, the effect of vitamin D on this outcome remained null (OR 1.11, 95% CI 0.80 to 1.53; I<sup>2</sup> = 0%; 17 studies, 2003 participants; <a href="./references#CD011511-fig-0029" title="">Analysis 1.23</a>). </p> </section> </section> </section> <section id="CD011511-sec-0073"> <h5 class="title">Narrative outcomes</h5> <section id="CD011511-sec-0074"> <h6 class="title">Time off school or work</h6> <p>One trial conducted in adults investigated the outcome of work absence due to asthma exacerbation or upper respiratory infection (<a href="./references#CD011511-bbs2-0015" title="MartineauAR , MacLaughlinBD , HooperRL , BarnesNC , JolliffeDA , ChoudhuryAB , et al. Double-blind multi-centre randomised controlled trial of vitamin D3 supplementation in adults with inhaled corticosteroid-treated asthma (ViDiAs). Thorax2014;69:A51-2. MartineauAR , MacLaughlinBD , HooperRL , BarnesNC , JolliffeDA , GreillerCL , et al. Double-blind randomised placebo-controlled trial of bolus-dose vitamin D3 supplementation in adults with asthma (ViDiAs). Thorax2015;70(5):451-7. ">Martineau 2015</a>). Allocation to vitamin D did not influence such work absence when measured as time to first event (adjusted HR 0.77, 95% CI 0.53 to 1.10), event rate (adjusted RR 0.86, 95% CI 0.50 to 1.46), or proportion of participants with at least one such absence (adjusted OR 0.77, 95% CI 0.45 to 1.30). One trial conducted in children did find an effect on the outcome of time off school due to asthma symptoms (<a href="./references#CD011511-bbs2-0011" title="KerleyCP , HutchinsonK , CormicanL , FaulJ , GreallyP , CoghlanD , et al. Vitamin D3 for uncontrolled childhood asthma: A pilot study. Paediatric Allergy and Immunology2016;27:404-12. [PMID: 10.1111/pai.12547]">Kerley 2016</a>). Vitamin D supplementation was associated with a median of one (IQR 0 to 5) school day missed over the 15 weeks follow‐up, compared with a median of five days (IQR 2 to 10) for the control arm (P = 0.04). Meta‐analysis across these two trials was not possible due to results being presented in different formats. </p> </section> <section id="CD011511-sec-0075"> <h6 class="title">Beta2‐agonist inhaler use</h6> <p>One trial conducted in adults investigated the effects of vitamin D on the number of uses of inhaled relief medication per 24 hours (<a href="./references#CD011511-bbs2-0015" title="MartineauAR , MacLaughlinBD , HooperRL , BarnesNC , JolliffeDA , ChoudhuryAB , et al. Double-blind multi-centre randomised controlled trial of vitamin D3 supplementation in adults with inhaled corticosteroid-treated asthma (ViDiAs). Thorax2014;69:A51-2. MartineauAR , MacLaughlinBD , HooperRL , BarnesNC , JolliffeDA , GreillerCL , et al. Double-blind randomised placebo-controlled trial of bolus-dose vitamin D3 supplementation in adults with asthma (ViDiAs). Thorax2015;70(5):451-7. ">Martineau 2015</a>). Allocation to vitamin D did not influence this outcome at 12 months (adjusted ratio of geometric means 1.00, 95% CI 0.77 to 1.28). Another trial assessed the effects of vitamin D on the intensity of beta2‐agonist use per episode, measured as the cumulative number of puffs (<a href="./references#CD011511-bbs2-0005" title="DucharmeFM , JensenM , MailhotG , AlosN , WhiteJ , RousseauE , et al. Impact of two oral doses of 100,000 IU of vitamin D3 in preschoolers with viral induced asthma: a pilot randomised controlled trial. Trials2019;20(1):138. [DOI: 10.1186/s13063-019-3184-z]">Ducharme 2019</a>). Allocation to vitamin D did not influence this outcome, with a mean difference of 1.4 fewer puffs required per episode in participants randomised to intervention versus placebo (95% CI ‐13.5 to 10.7, P &gt; 0.05). </p> </section> <section id="CD011511-sec-0076"> <h6 class="title">End‐study asthma quality of life</h6> <p>Five trials investigated the effects of vitamin D on respiratory quality of life. Andújar‐Espinosa and colleagues reported a significant improvement in Asthma Quality of Life Questionnaire (AQLQ) score (MD 0.70 higher in vitamin D arm, 95% CI 0.15 to 1.25) (<a href="./references#CD011511-bbs2-0002" title="Andújar-EspinosaR , Aparicio-VicenteM , Ruiz-LópezFJ , Salinero-GonzálezL . Influence of vitamin D supplementation on the quality of life of asthma patients: Findings from ACVID randomised clinical trial. Respiratory Medicine2021;185:106484. [DOI: 10.1016/j.rmed.2021.106484]Andújar-EspinosaR , Salinero-GonzálezL , Illán-GómezF , Castilla-MartínezM , Hu-YangC , Ruiz-LópezFJ . Effect of vitamin D supplementation on asthma control in patients with vitamin D deficiency: the ACVID randomised clinical trial. Thorax2021;76(2):126–33. [DOI: 10.1136/thoraxjnl-2019-213936]">Andújar‐Espinosa 2021</a>). The minimum clinically important difference for this score is 0.5 points (<a href="./references#CD011511-bbs2-0090" title="JuniperEF , SvenssonK , MorkAC , StahlE . Modification of the asthma quality of life questionnaire (standardised) for patients 12 years and older. Health Quality Life Outcomes2005;3:58. [DOI: 10.1186/1477-7525-3-58]">Juniper 2005</a>). Conversely, Kerley and colleagues stated that vitamin D administration had no significant effect on AQLQ scores in the text of their paper, though they did not present the associated data (<a href="./references#CD011511-bbs2-0011" title="KerleyCP , HutchinsonK , CormicanL , FaulJ , GreallyP , CoghlanD , et al. Vitamin D3 for uncontrolled childhood asthma: A pilot study. Paediatric Allergy and Immunology2016;27:404-12. [PMID: 10.1111/pai.12547]">Kerley 2016</a>). A supplementary analysis by Forno and colleagues also reported that vitamin D administration had no significant effect on AQLQ scores, presenting this result as a multivariate regression coefficient of 0.12 (95% CI ‐0.27 to 0.51) (<a href="./references#CD011511-bbs2-0006" title="FornoE , BacharierLB , PhipatanakulW , GuilbertTW , CabanaMD , RossK , et al. Effect of vitamin D3 supplementation on severe asthma exacerbations in children with asthma and low vitamin D levels: The VDKA Randomized Clinical Trial. JAMA2020;324(8):752-60. HanYY , FornoE , BacharierLB , PhipatanakulW , GuilbertTW , CabanaMD , et al. Vitamin D supplementation, lung function and asthma control in children with asthma and low vitamin D levels. European Respiratory Journal2021;58(4):2100989. [DOI: 10.1183/13993003.00989-2021]N/a. Errors in flow diagram. JAMA2021;326(1):90. [DOI: 10.1001/jama.2021.9465.]RosserFJ , HanYY , FornoE , BacharierLB , PhipatanakulW , GuilbertTW , et al. Effect of vitamin D supplementation on total andallergen-specific IgE in children with asthma andlow vitamin D levels. Journal of Allergy and Clinical Immunology2021;149(1):440-4.E2. [PMID: 10.1016/j.jaci.2021.05.037]">Forno 2020</a>). Martineau and colleagues reported that administration of vitamin D modestly improved respiratory quality of life as evidenced by adjusted inter‐arm differences in total St George's Respiratory Questionnaire (SGRQ) score of ‐3.9 points at two months (P = 0.005), ‐3.7 points at six months (P = 0.038), and ‐3.3 points at 12 months (P = 0.060; P for allocation time interaction = 0.026). These differences were associated with statistically significant decreases in component scores for the impacts dimension of the SGRQ at two months (P = 0.05) and six months (P = 0.005; P for allocation‐time interaction = 0.030) (<a href="./references#CD011511-bbs2-0015" title="MartineauAR , MacLaughlinBD , HooperRL , BarnesNC , JolliffeDA , ChoudhuryAB , et al. Double-blind multi-centre randomised controlled trial of vitamin D3 supplementation in adults with inhaled corticosteroid-treated asthma (ViDiAs). Thorax2014;69:A51-2. MartineauAR , MacLaughlinBD , HooperRL , BarnesNC , JolliffeDA , GreillerCL , et al. Double-blind randomised placebo-controlled trial of bolus-dose vitamin D3 supplementation in adults with asthma (ViDiAs). Thorax2015;70(5):451-7. ">Martineau 2015</a>). Of note, the minimum clinically important difference for this score is around four points (<a href="./references#CD011511-bbs2-0089" title="JonesPW . St. George's Respiratory Questionnaire: MCID. COPD2005;2(1):75-9.">Jones 2005</a>). Castro and colleagues reported no effect of the intervention on the Asthma Bother Profile score: the adjusted mean change in score was ‐1.0 (95% CI ‐2.7 to 0.7) in the intervention arm versus ‐2.4 (95% CI ‐4.0 to ‐0.7) in the placebo arm; P = 0.16) (<a href="./references#CD011511-bbs2-0004" title="CastroM , KingTS , KunselmanSJ , CabanaMD , DenlingerL , HolguinF , et al. Effect of vitamin D3 on asthma treatment failures in adults with symptomatic asthma and lower vitamin D levels: the VIDA randomized clinical trial. JAMA2014;311(20):2083-91. DenlingerLC , KingTS , CardetJC , CraigT , HolguinF , JacksonDJ , et al. Vitamin D supplementation and the risk of colds in patients with asthma. American Journal of Respiratory and Critical Care Medicine2016;193(6):634–41. DenlingerLC , KingTS , CardetJC , CraigTJ , HolguinF , KraftM , et al. Vitamin D supplementation and the risk of colds in patients with asthma. Journal of Allergy and Clinical Immunology2015;135:AB109. JiaoJ , KingTS , McKenzieM , BacharierLB , DixonAE , CodispotiCD , et al. Effects of vitamin D3 supplementation in adults with asthma complicated by sinonasal disease. American Journal of Respiratory and Critical Care Medicine2015;191:A4148. JiaoJ , KingTS , McKenzieM , BacharierLB , DixonAE , CodispotiCD , et al. Vitamin D3 therapy in patients with asthma complicated by sinonasal disease: secondary analysis of the Vitamin D Add-on Therapy Enhances Corticosteroid Responsiveness in Asthma trial. Journal of Allergy and Clinical Immunology2016;138(2):589-92. MooreWC , KingTS , BleeckerER , MeyersDA , PetersSP , WenzelSE . Sarp clinical clusters predict steroid responsiveness and risk of asthma exacerbations in the asthma net vida (vitamin D in asthma) trial. American Journal of Respiratory and Critical Care Medicine2015;191:A6055. ReidB , GirodetP , BoomerJS , Abdel-GadirA , ZhengK , WechslerME , et al. Vitamin D3 treatment of vitamin D insufficient asthmatics does not alter immune cell function. Journal of Allergy and Clinical Immunology2016;138(1):286-9. ">Castro 2014</a>). Data from these different instruments were unsuitable for pooling and were therefore not meta‐analysed. </p> </section> <section id="CD011511-sec-0077"> <h6 class="title">End‐study FeNO</h6> <p>Two trials investigated the effects of vitamin D on FeNO. Martineau and colleagues reported that administration of vitamin D had no effect on mean FeNO concentrations at 12 months (ratio of geometric means −1.4, 95% CI −6.8 to 3.9) (<a href="./references#CD011511-bbs2-0015" title="MartineauAR , MacLaughlinBD , HooperRL , BarnesNC , JolliffeDA , ChoudhuryAB , et al. Double-blind multi-centre randomised controlled trial of vitamin D3 supplementation in adults with inhaled corticosteroid-treated asthma (ViDiAs). Thorax2014;69:A51-2. MartineauAR , MacLaughlinBD , HooperRL , BarnesNC , JolliffeDA , GreillerCL , et al. Double-blind randomised placebo-controlled trial of bolus-dose vitamin D3 supplementation in adults with asthma (ViDiAs). Thorax2015;70(5):451-7. ">Martineau 2015</a>). Thakur and colleagues similarly reported that administration of vitamin D had no effect on median FeNO concentrations at three months, with an end‐study median of 16 parts per billion (ppb) (IQR 10 to 24.5) in the intervention arm and a median of 10 ppb (IQR 8.3 to 21.8) in the control arm (P = 0.2) (<a href="./references#CD011511-bbs2-0018" title="ThakurC , KumarJ , KumarP , GoyalJP , SinghK , GuptaA . Vitamin‐D supplementation as an adjunct to standard treatmentof asthma in children: a randomized controlled trial (ViDASTA Trial). Pediatric Pulmonology2021;56:1427–33. [DOI: 10.1002/ppul.25287]">Thakur 2021</a>). The skewness of these results precluded a conversion from median to mean and standard deviation. </p> </section> <section id="CD011511-sec-0078"> <h6 class="title">End‐study airway reactivity (PC20)</h6> <p>Two trials investigated the effects of vitamin D on airway reactivity. Castro and colleagues reported that administration of vitamin D had no effect on the provocative concentration of methacholine at which FEV1 decreased by 20% (PC20): the adjusted mean change in log base 2 transformed PC20 (doubling dilutions) was 0.70 mg/ml (95% CI 0.38 to 1.03) in the intervention arm versus 0.74 mg/ml (95% CI 0.41 to 1.07) in the placebo arm; a difference in mean change of 0.04 mg/ml (P = 0.87) (<a href="./references#CD011511-bbs2-0004" title="CastroM , KingTS , KunselmanSJ , CabanaMD , DenlingerL , HolguinF , et al. Effect of vitamin D3 on asthma treatment failures in adults with symptomatic asthma and lower vitamin D levels: the VIDA randomized clinical trial. JAMA2014;311(20):2083-91. DenlingerLC , KingTS , CardetJC , CraigT , HolguinF , JacksonDJ , et al. Vitamin D supplementation and the risk of colds in patients with asthma. American Journal of Respiratory and Critical Care Medicine2016;193(6):634–41. DenlingerLC , KingTS , CardetJC , CraigTJ , HolguinF , KraftM , et al. Vitamin D supplementation and the risk of colds in patients with asthma. Journal of Allergy and Clinical Immunology2015;135:AB109. JiaoJ , KingTS , McKenzieM , BacharierLB , DixonAE , CodispotiCD , et al. Effects of vitamin D3 supplementation in adults with asthma complicated by sinonasal disease. American Journal of Respiratory and Critical Care Medicine2015;191:A4148. JiaoJ , KingTS , McKenzieM , BacharierLB , DixonAE , CodispotiCD , et al. Vitamin D3 therapy in patients with asthma complicated by sinonasal disease: secondary analysis of the Vitamin D Add-on Therapy Enhances Corticosteroid Responsiveness in Asthma trial. Journal of Allergy and Clinical Immunology2016;138(2):589-92. MooreWC , KingTS , BleeckerER , MeyersDA , PetersSP , WenzelSE . Sarp clinical clusters predict steroid responsiveness and risk of asthma exacerbations in the asthma net vida (vitamin D in asthma) trial. American Journal of Respiratory and Critical Care Medicine2015;191:A6055. ReidB , GirodetP , BoomerJS , Abdel-GadirA , ZhengK , WechslerME , et al. Vitamin D3 treatment of vitamin D insufficient asthmatics does not alter immune cell function. Journal of Allergy and Clinical Immunology2016;138(1):286-9. ">Castro 2014</a>). Jerzynska and colleagues also reported in text format that vitamin D administration had no significant effect on PC20, but did not present data for this outcome (<a href="./references#CD011511-bbs2-0009" title="JerzynskaJ , StelmachW , RychlikB , LechańskaJ , PodleckaD , StelmachI . The clinical effect of vitamin D supplementation combined with grass-specific sublingual immunotherapy in children with allergic rhinitis. Allergy and Asthma Proceedings2016;37(2):105-14. [DOI: 10.2500/aap.2016.37.3921]">Jerzynska 2016</a>). </p> </section> <section id="CD011511-sec-0079"> <h6 class="title">Costs from the perspective of healthcare providers</h6> <p>One trial conducted in adults investigated the effects of vitamin D on health economic outcomes. Martineau and colleagues reported that administration of vitamin D had no effect on total costs associated with asthma/upper respiratory infection over 12 months (adjusted mean difference GBP 66.78, 95% CI GBP ‐263.47 to GBP 397.03) (<a href="./references#CD011511-bbs2-0015" title="MartineauAR , MacLaughlinBD , HooperRL , BarnesNC , JolliffeDA , ChoudhuryAB , et al. Double-blind multi-centre randomised controlled trial of vitamin D3 supplementation in adults with inhaled corticosteroid-treated asthma (ViDiAs). Thorax2014;69:A51-2. MartineauAR , MacLaughlinBD , HooperRL , BarnesNC , JolliffeDA , GreillerCL , et al. Double-blind randomised placebo-controlled trial of bolus-dose vitamin D3 supplementation in adults with asthma (ViDiAs). Thorax2015;70(5):451-7. ">Martineau 2015</a>). </p> </section> </section> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD011511-sec-0080" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD011511-sec-0080"></div> <section id="CD011511-sec-0081"> <h3 class="title" id="CD011511-sec-0081">Summary of main results</h3> <p>This systematic review and meta‐analysis incorporated data from 1155 children and 1070 adults enrolled in 20 double‐blind randomised placebo‐controlled trials of vitamin D supplementation in participants with asthma. Overall, we found that administration of vitamin D had no significant effect on any primary or secondary outcomes considered, both in aggregate and in the majority of subgroup analyses conducted. This is in contrast to the findings reported in our previous Cochrane Review on this topic (<a href="./references#CD011511-bbs2-0117" title="MartineauAR , CatesCJ , UrashimaM , JensenM , GriffithsAP , NurmatovU , et al. Vitamin D for the management of asthma. Cochrane Database of Systematic Reviews2016, Issue 9. Art. No: CD011511. [DOI: 10.1002/14651858.CD011511.pub2]">Martineau 2016</a>). </p> <p>Fifteen studies contributed data to analyses of the primary outcome of asthma exacerbations requiring systemic corticosteroids (severe exacerbations). Administration of vitamin D had no effect on the proportion of participants experiencing one or more asthma exacerbations treated with systemic corticosteroids (OR 1.04, 95% CI 0.81 to 1.34; I<sup>2</sup> = 0%; 14 studies, 1778 participants; high‐quality evidence; <a href="./references#CD011511-fig-0007" title="">Analysis 1.1</a>). We note the lower bound of the 95% confidence interval of 0.81, such that we can state with 97.5% certainty that vitamin D supplementation leads to no more than a 19% reduction in the odds of experiencing one or more severe exacerbations. There was low heterogeneity across studies for this primary outcome, with I<sup>2</sup> = 0%. </p> <p>Administration of vitamin D did not influence the rate of severe asthma exacerbations (RR 0.86, 95% CI 0.62 to 1.19; I<sup>2</sup> = 60%; 10 studies, 1599 participants; <a href="./references#CD011511-fig-0008" title="">Analysis 1.2</a>). We note, however, that there was a high degree of heterogeneity across studies for this outcome, with I<sup>2</sup> = 60%. This heterogeneity may be due to differences in populations, such as variation in baseline vitamin D status, genetics, adherence to the intervention, or different background treatments. It may also arise due to differences in interventions, including the dose of vitamin D given and the dosing regimen. An additional possible factor is that this outcome includes data from the single study which administered calcidiol rather than vitamin D<sub>3</sub>, and reported a significant protective effect from this metabolite (<a href="./references#CD011511-bbs2-0002" title="Andújar-EspinosaR , Aparicio-VicenteM , Ruiz-LópezFJ , Salinero-GonzálezL . Influence of vitamin D supplementation on the quality of life of asthma patients: Findings from ACVID randomised clinical trial. Respiratory Medicine2021;185:106484. [DOI: 10.1016/j.rmed.2021.106484]Andújar-EspinosaR , Salinero-GonzálezL , Illán-GómezF , Castilla-MartínezM , Hu-YangC , Ruiz-LópezFJ . Effect of vitamin D supplementation on asthma control in patients with vitamin D deficiency: the ACVID randomised clinical trial. Thorax2021;76(2):126–33. [DOI: 10.1136/thoraxjnl-2019-213936]">Andújar‐Espinosa 2021</a>). Conversely, <a href="./references#CD011511-fig-0007" title="">Analysis 1.1</a> and <a href="./references#CD011511-fig-0009" title="">Analysis 1.3</a> could not include this study as it did not publish data on the relevant outcomes. Following the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> Chapter 10 (<a href="./references#CD011511-bbs2-0083" title="HigginsJP , ThomasJ , ChandlerJ , CumpstonM , LiT , PageMJ , WelchVA , editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.3 (updated February 2022). Cochrane, 2022. Available from training.cochrane.org/handbook.">Higgins 2022</a>), the random‐effects model used should account for any such heterogeneity. </p> <p>Vitamin D did not influence time to first severe asthma exacerbation (HR 0.82, 95% CI 0.59 to 1.19; I<sup>2</sup> = 22%; 3 studies, 850 participants; high‐quality evidence; <a href="./references#CD011511-fig-0009" title="">Analysis 1.3</a>). </p> <p>We also found that vitamin D was not associated with a significant difference in risk of asthma exacerbations in any subgroup considered, except for form of vitamin D administered. No effect of giving cholecalciferol was seen, but oral calcidiol did significantly reduce the rate of exacerbations in the single study which utilised this form of vitamin D (<a href="./references#CD011511-bbs2-0002" title="Andújar-EspinosaR , Aparicio-VicenteM , Ruiz-LópezFJ , Salinero-GonzálezL . Influence of vitamin D supplementation on the quality of life of asthma patients: Findings from ACVID randomised clinical trial. Respiratory Medicine2021;185:106484. [DOI: 10.1016/j.rmed.2021.106484]Andújar-EspinosaR , Salinero-GonzálezL , Illán-GómezF , Castilla-MartínezM , Hu-YangC , Ruiz-LópezFJ . Effect of vitamin D supplementation on asthma control in patients with vitamin D deficiency: the ACVID randomised clinical trial. Thorax2021;76(2):126–33. [DOI: 10.1136/thoraxjnl-2019-213936]">Andújar‐Espinosa 2021</a>). Further research is therefore warranted to investigate whether calcidiol has a significant effect on risk of asthma exacerbation. </p> </section> <section id="CD011511-sec-0082"> <h3 class="title" id="CD011511-sec-0082">Overall completeness and applicability of evidence</h3> <p>This review incorporated evidence from 20 trials, across a wide range of patient populations in terms of age, country, baseline vitamin D status, and vitamin D dosing regimens. We included papers published in both English and Chinese, and sought supplementary unpublished data from authors as per the published protocol where required (<a href="./references#CD011511-bbs2-0100" title="MartineauA , WilliamsonA , SheikhA , GriffithsCJ . Intervention protocol: vitamin D for the management of asthma (2021). figshare.com/articles/journal_contribution/Intervention_Protocol_Vitamin_D_for_the_management_of_asthma_2021_/16926430. [DOI: 10.6084/m9.figshare.16926430.v1]">Martineau 2021</a>). This was a result of rigorous search criteria using a range of Cochrane and other databases to maximise completeness of evidence. This large pool of studies increases the generalisability of our findings relative to other reviews (<a href="./references#CD011511-bbs2-0071" title="ChenZ , PengC , MeiJ , ZhuL , KongH . Vitamin D can safely reduce asthma exacerbations among corticosteroid-using children and adults with asthma: a systematic review and meta-analysis of randomized controlled trials. Nutrition Research2021;92:49-61. [DOI: 10.1016/j.nutres.2021.05.010]">Chen 2021</a>; <a href="./references#CD011511-bbs2-0075" title="FaresMM , AlkhaledLH , MrouehSM , AklEA . Vitamin D supplementation in children with asthma: a systematic review and meta-analysis. BMC Research Notes2015;8:23. [DOI: 10.1186/s13104-014-0961-3]">Fares 2015</a>; <a href="./references#CD011511-bbs2-0088" title="JolliffeDA , GreenbergL , HooperRL , GriffithsCJ , CamargoCA , KerleyCP , et al. Vitamin D supplementation to prevent asthmaexacerbations: a systematic review and meta-analysis of individual participant data. Lancet Respiratory Medicine2017;5(11):881-90. [DOI: 10.1016/ S2213-2600(17)30306-5]">Jolliffe 2017</a>; <a href="./references#CD011511-bbs2-0092" title="KumarJ , KumarP , GoyalJP , ThakurC , ChoudharyP , MeenaJ , et al. Vitamin D supplementation in childhood asthma: a systematic review and meta-analysis of randomised controlled trials. ERJ Open Research2022;8(2):662. [DOI: 10.1183/23120541.00662-2021]">Kumar 2022</a>; <a href="./references#CD011511-bbs2-0095" title="LuoJ , LiuD , Liu C-T. Can vitamin D supplementation in addition to asthma controllers improve clinical outcomes in patients with asthma? A meta-analysis. Medicine2015;94(50):e2185.">Luo 2015</a>; <a href="./references#CD011511-bbs2-0117" title="MartineauAR , CatesCJ , UrashimaM , JensenM , GriffithsAP , NurmatovU , et al. Vitamin D for the management of asthma. Cochrane Database of Systematic Reviews2016, Issue 9. Art. No: CD011511. [DOI: 10.1002/14651858.CD011511.pub2]">Martineau 2016</a>; <a href="./references#CD011511-bbs2-0102" title="NitzanI , MimouniFB , NunAB , KasirerY , MendlovicJ . Vitamin D and asthma: a systematic review of clinical trials. Current Nutrition Reports2022;11(2):311-17. [DOI: 10.1007/s13668-022-00411-6]">Nitzan 2022</a>; <a href="./references#CD011511-bbs2-0103" title="PojsupapS , IlirianiK , SampaioT , O’HearnK , KinR , KovesiT , et al. Efficacy of high-dose vitamin D in pediatric asthma: a systematic review and meta-analysis. Journal of Asthma2015;52:382-90. [DOI: 10.3109/02770903.2014.980509]">Pojsupap 2015</a>; <a href="./references#CD011511-bbs2-0106" title="RiverinBD , MaguireJL , LiP . Vitamin D supplementation for childhood asthma: a systematic review and meta-analysis. PLoS ONE2015;10(8):e0136841.">Riverin 2015</a>; <a href="./references#CD011511-bbs2-0114" title="XiaoL , XingC , YangZ , XuS , WangM , DuH , et al. Vitamin D supplementation for the prevention of childhood acute respiratory infections: a systematic review of randomised controlled trials. British Journal of Nutrition2015;114:1026-34.">Xiao 2015</a>). It allowed for subgroup analyses by baseline vitamin D status, vitamin D dose and form, dosing regimen, and age, with null findings from these subgroup analyses increasing the applicability of our conclusions for each of these groups. This is of particular note for the population with low baseline vitamin D, given that other studies postulated a potential relationship here (<a href="./references#CD011511-bbs2-0086" title="JanssensW , DecramerM , MathieuC , KorfH . Vitamin D and chronic obstructive pulmonary disease: hype or reality?Lancet Respiratory Medicine2013;1(10):804-12.">Janssens 2013</a>; <a href="./references#CD011511-bbs2-0099" title="MartineauAR , JamesWY , HooperRL , BarnesNC , JolliffeDA , GreillerCL , et al. Vitamin D3 supplementation in patients with chronic obstructive pulmonary disease (ViDiCO): a multicentre, double-blind, randomised controlled trial. Lancet Respiratory Medicine2015;3(2):120-30.">Martineau 2015a</a>). </p> <p>Nonetheless, this systematic review was limited to meta‐analysis of aggregate data from published manuscripts, augmented by specific unpublished data and individual participant data from authors where it was possible to obtain this. Despite strenuous attempts to obtain further data, for instance, outcomes stratified by baseline vitamin D status, only certain authors were able to provide this information. Therefore, fewer studies contributed data to subgroup analyses, and this may have constrained power leading to type 2 error. In particular, there was a paucity of data on the effects of vitamin D administration on asthma exacerbation risk in those who were profoundly vitamin D deficient (serum 25(OH)D &lt; 25 nmol/L), with only three studies contributing data to this subgroup (<a href="./references#CD011511-bbs2-0004" title="CastroM , KingTS , KunselmanSJ , CabanaMD , DenlingerL , HolguinF , et al. Effect of vitamin D3 on asthma treatment failures in adults with symptomatic asthma and lower vitamin D levels: the VIDA randomized clinical trial. JAMA2014;311(20):2083-91. DenlingerLC , KingTS , CardetJC , CraigT , HolguinF , JacksonDJ , et al. Vitamin D supplementation and the risk of colds in patients with asthma. American Journal of Respiratory and Critical Care Medicine2016;193(6):634–41. DenlingerLC , KingTS , CardetJC , CraigTJ , HolguinF , KraftM , et al. Vitamin D supplementation and the risk of colds in patients with asthma. Journal of Allergy and Clinical Immunology2015;135:AB109. JiaoJ , KingTS , McKenzieM , BacharierLB , DixonAE , CodispotiCD , et al. Effects of vitamin D3 supplementation in adults with asthma complicated by sinonasal disease. American Journal of Respiratory and Critical Care Medicine2015;191:A4148. JiaoJ , KingTS , McKenzieM , BacharierLB , DixonAE , CodispotiCD , et al. Vitamin D3 therapy in patients with asthma complicated by sinonasal disease: secondary analysis of the Vitamin D Add-on Therapy Enhances Corticosteroid Responsiveness in Asthma trial. Journal of Allergy and Clinical Immunology2016;138(2):589-92. MooreWC , KingTS , BleeckerER , MeyersDA , PetersSP , WenzelSE . Sarp clinical clusters predict steroid responsiveness and risk of asthma exacerbations in the asthma net vida (vitamin D in asthma) trial. American Journal of Respiratory and Critical Care Medicine2015;191:A6055. ReidB , GirodetP , BoomerJS , Abdel-GadirA , ZhengK , WechslerME , et al. Vitamin D3 treatment of vitamin D insufficient asthmatics does not alter immune cell function. Journal of Allergy and Clinical Immunology2016;138(1):286-9. ">Castro 2014</a>; <a href="./references#CD011511-bbs2-0007" title="JatKR , GoelN , GuptaN , ChandraPG , SudipD , RakeshL , et al. Efficacy of vitamin D supplementation in asthmatic childrenwith vitamin D deficiency: a randomized controlled trial(ESDAC trial). Pediatric Allergy and Immunology2021;32(3):479– 88. [DOI: 10.1111/pai.13415]">Jat 2020</a>; <a href="./references#CD011511-bbs2-0015" title="MartineauAR , MacLaughlinBD , HooperRL , BarnesNC , JolliffeDA , ChoudhuryAB , et al. Double-blind multi-centre randomised controlled trial of vitamin D3 supplementation in adults with inhaled corticosteroid-treated asthma (ViDiAs). Thorax2014;69:A51-2. MartineauAR , MacLaughlinBD , HooperRL , BarnesNC , JolliffeDA , GreillerCL , et al. Double-blind randomised placebo-controlled trial of bolus-dose vitamin D3 supplementation in adults with asthma (ViDiAs). Thorax2015;70(5):451-7. ">Martineau 2015</a>). Further research to clarify whether baseline vitamin D status modifies effects of vitamin D on exacerbation risk, including further individual participant data meta‐analysis, is needed before definitive clinical recommendations can be made regarding effects of vitamin D replacement in individuals with the lowest baseline vitamin D status. We were also limited to studies focused mainly on children and adults with mild to moderate asthma, defined as requiring GINA step 4 treatment or below. Thus, conclusions cannot reliably be drawn for people with severe asthma. </p> </section> <section id="CD011511-sec-0083"> <h3 class="title" id="CD011511-sec-0083">Quality of the evidence</h3> <p>This review followed rigorous prespecified selection criteria in a published protocol (<a href="./references#CD011511-bbs2-0100" title="MartineauA , WilliamsonA , SheikhA , GriffithsCJ . Intervention protocol: vitamin D for the management of asthma (2021). figshare.com/articles/journal_contribution/Intervention_Protocol_Vitamin_D_for_the_management_of_asthma_2021_/16926430. [DOI: 10.6084/m9.figshare.16926430.v1]">Martineau 2021</a>), restricted to double‐blind, placebo‐controlled trials. This gives confidence in the internal validity of our findings. </p> <p>Following a GRADE approach, we first considered the primary outcome of asthma exacerbations requiring systemic corticosteroids. We assessed the risk of bias as low or unclear in all studies contributing data to this outcome, with sensitivity analyses showing that the null findings remain consistent when studies with unclear risk of bias were excluded. The results showed high precision, with a 95% CI of 0.81 to 1.34 for the core outcome of the proportion of participants experiencing such an exacerbation. Results showed low heterogeneity for two of the three dimensions of this outcome, proportion experiencing one or more severe exacerbations (<a href="./references#CD011511-fig-0007" title="">Analysis 1.1</a>, I<sup>2</sup> = 0%) and time to first severe exacerbation (<a href="./references#CD011511-fig-0009" title="">Analysis 1.3</a>, I<sup>2</sup> = 22%). </p> <p>The third dimension of this primary outcome, the rate ratio of asthma exacerbations (<a href="./references#CD011511-fig-0008" title="">Analysis 1.2</a>), showed less precision (RR 0.86, 95% CI 0.62 to 1.19) and higher heterogeneity, with I<sup>2</sup> = 60%. However, the null findings in this dimension of the primary outcome were consistent with other expressions of this outcome (OR (<a href="./references#CD011511-fig-0007" title="">Analysis 1.1</a>) versus RR (<a href="./references#CD011511-fig-0008" title="">Analysis 1.2</a>) versus HR (<a href="./references#CD011511-fig-0009" title="">Analysis 1.3</a>)), and when different definitions of exacerbation were used (exacerbations treated with systemic corticosteroids (<a href="./references#CD011511-fig-0007" title="">Analysis 1.1</a>) versus those defined according to study protocols (<a href="./references#CD011511-fig-0023" title="">Analysis 1.17</a>)). The consistency of null findings across the three dimensions of this outcome increases our confidence in rating evidence as consistent for the outcome as a whole. The null effect identified was also consistent with null findings across a range of different secondary outcomes, enhancing our confidence in a true null result. We also assessed this evidence as direct rather than indirect, as a wide range of patient populations were studied and subgroup analyses were consistent with the overall null finding. </p> <p>We created funnel plots for the primary outcome as more than 10 studies contributed data. These showed no obvious asymmetry, suggesting no evidence of publication bias (<a href="#CD011511-fig-0003">Figure 3</a>; <a href="#CD011511-fig-0004">Figure 4</a>). Assessment for publication bias is discussed further under <a href="#CD011511-sec-0084">Potential biases in the review process</a>. We classified the evidence for this primary outcome as high quality. </p> <p>We downgraded the evidence for five secondary outcomes to moderate quality. The proportion of participants with one or more exacerbations precipitating an emergency department visit or requiring hospital admission, or both, showed less precision (OR 0.56, 95% CI 0.26 to 1.21) and included fewer studies than the primary outcome, so we downgraded by one level to moderate‐quality evidence. Four further outcomes with null findings showed heterogeneity of evidence: end‐study cACT score (MD 0.23, 95% CI ‐0.26 to 0.73; I<sup>2</sup> = 29%), end‐study % lower airway eosinophils (MD ‐0.38, 95% CI ‐1.92 to 1.15; I<sup>2</sup> = 43%), end study % predicted FVC (MD 1.84, 95% CI ‐3.60 to 7.29; I<sup>2</sup> = 73%), and end‐study PEFR (MD 4.84, 95% CI ‐8.95 to 18.62; I<sup>2</sup> = 79%). We downgraded the evidence in each case to moderate quality as a result. Finally, evidence regarding fatal exacerbations was downgraded two levels to 'low', as no such events occurred in any included study. </p> <p>We classified all remaining secondary outcomes as high‐quality evidence, with low risk of bias, high precision, direct evidence, consistency of findings, and no evidence of publication bias on funnel plots where analysed. </p> </section> <section id="CD011511-sec-0084"> <h3 class="title" id="CD011511-sec-0084">Potential biases in the review process</h3> <p>This review followed rigorous prespecified selection criteria, restricted to double‐blind, placebo‐controlled trials. We searched multiple databases for eligible studies using prespecified criteria, and this strategy led to identification of unpublished data which are included in this review. As outlined in the Methods, AW, AS, and CJG assessed the eligibility and risk of bias of the new study co‐authored by ARM (<a href="./references#CD011511-bbs2-0003" title="CamargoC , ToopL , SluyterJ , LawesCM , WaayerD , KhawKT , et al. Effect of monthly vitamin D supplementation on preventing exacerbations of asthma or chronic obstructive pulmonary disease in older adults: post hoc analysis of a randomized controlled trial. Nutrients2021;13:521. [DOI: 10.3390/nu13020521]SluyterJ , CamargoCA , WaayerD , LawesCM , ToopL , KhawKT , et al. Effect of monthly, high-dose, long-term vitamin D on lung function: a randomized controlled trial. Nutrients2017;9:1353. [DOI: 10.3390/nu9121353]">Camargo 2021</a>). As for any review of randomised controlled trials, publication bias may have favoured publication of trials reporting favourable results. However, we used funnel plots to screen for any such bias. </p> <p>Following Section 10.4.3 and Chapter 13 of the <i>Cochrane Handbook for Systematic Reviews of Interventions,</i><a href="./references#CD011511-bbs2-0083" title="HigginsJP , ThomasJ , ChandlerJ , CumpstonM , LiT , PageMJ , WelchVA , editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.3 (updated February 2022). Cochrane, 2022. Available from training.cochrane.org/handbook.">Higgins 2022</a>, we did not conduct formal statistical tests for funnel plot asymmetry due to risk of misleading results, especially for continuous outcomes. Instead, we followed the recommended approach and assessed for selective non‐reporting amongst eligible studies and trial protocols. </p> <p>The initial screening for eligible studies utilised a wide range of trials registers to identify any initiated, ongoing or completed but unpublished studies that met the eligibility criteria. We identified 11 ongoing eligible trials that had not yet published their findings (listed under <a href="./references#CD011511-bbs1-0003" title="">Ongoing studies</a>). We contacted the named authors in each case to request preliminary data, but either did not receive a response, or were informed that the data were not yet available. However, each trial protocol identified was only recently published (2016 or later), with a planned duration extending until the date of this systematic review or beyond. Thus, we have a low suspicion of selective non‐publication of findings that differ from our review conclusions. </p> <p>We also considered the seven studies identified as ongoing in the previous Cochrane Review on this topic (<a href="./references#CD011511-bbs2-0117" title="MartineauAR , CatesCJ , UrashimaM , JensenM , GriffithsAP , NurmatovU , et al. Vitamin D for the management of asthma. Cochrane Database of Systematic Reviews2016, Issue 9. Art. No: CD011511. [DOI: 10.1002/14651858.CD011511.pub2]">Martineau 2016</a>). Of these, three have now been published and incorporated into the current systematic review (<a href="./references#CD011511-bbs2-0001" title="AglipayM , BirkenC , DaiD , ParkinP , MaguireJ . 70 high dose vitamin D for the prevention of wheezing in preschoolers: a secondary analysis of a randomized clinical trial. Paediatrics and Child Health2019;24(S2):e27-8. [DOI: 10.1093/pch/pxz066.069]AglipayM , BirkenCS , ParkinPC , LoebMB , ThorpeK , ChenY , et al. TARGet Kids! Collaboration. Effect of high-dose vs standard-dose wintertime vitamin D supplementation on viral upper respiratory tract infections in young healthy children. JAMA2017;318(3):245-54. [DOI: 10.1001/jama.2017.8708.]">Aglipay 2019</a>; <a href="./references#CD011511-bbs2-0005" title="DucharmeFM , JensenM , MailhotG , AlosN , WhiteJ , RousseauE , et al. Impact of two oral doses of 100,000 IU of vitamin D3 in preschoolers with viral induced asthma: a pilot randomised controlled trial. Trials2019;20(1):138. [DOI: 10.1186/s13063-019-3184-z]">Ducharme 2019</a>; <a href="./references#CD011511-bbs2-0011" title="KerleyCP , HutchinsonK , CormicanL , FaulJ , GreallyP , CoghlanD , et al. Vitamin D3 for uncontrolled childhood asthma: A pilot study. Paediatric Allergy and Immunology2016;27:404-12. [PMID: 10.1111/pai.12547]">Kerley 2016</a>). One study is still listed as ongoing in the current systematic review, with a prespecified five‐year follow‐up period (<a href="./references#CD011511-bbs2-0057" title="GoldDR , LitonjuaAA , CareyVJ , MansonJE , BuringJE , LeeIM , et al. Lung VITAL: rationale, design, and baseline characteristics of an ancillary study evaluating the effects of vitamin D and/or marine omega-3 fatty acid supplements on acute exacerbations of chronic respiratory disease, asthma control, pneumonia and lung function in adults. Contemporary Clinical Trials2016;47:185-95. [DOI: 10.1016/j.cct.2016.01.003]">Gold 2016</a>). One study (<a href="./references#CD011511-bbs2-0064" title="FlorioG , RubanoA , PatellaV . Effect of sublingual specific immunotherapy associated to vitamin D3 and lactobacillus reuteri in asthmatic teens. American Journal of Respiratory and Critical Care Medicine2015;191:A4269. PatellaV , FlorioG , PalmieriM . Vitamin D3 associated to lactobacillus reuteri improves effects of allergen immunotherapy in asthmatic children. In: European Respiratory Society 23rd Annual Congress; 2013 Sep 7-11; Barcelona. 2013. ">Patella 2013</a>) has not been published further, though full results were presented in two published abstracts referenced in the previous Cochrane Review, mitigating concerns about publication bias (<a href="./references#CD011511-bbs2-0117" title="MartineauAR , CatesCJ , UrashimaM , JensenM , GriffithsAP , NurmatovU , et al. Vitamin D for the management of asthma. Cochrane Database of Systematic Reviews2016, Issue 9. Art. No: CD011511. [DOI: 10.1002/14651858.CD011511.pub2]">Martineau 2016</a>). Lastly, two studies were terminated prior to publication (<a href="./references#CD011511-bbs2-0061" title="NCT02424552. Effect of vitamin D as add-on therapy for vitamin D insufficient patients with severe asthma (EVITA) [EVITA Trial: Effect of vitamin D as add-on therapy for vitamin D insufficient patients with severe asthma: a randomized, double-blind, placebo-controlled trial]. clinicaltrials.gov/ct2/show/NCT02424552 (first received 23 April 2015). ">NCT02424552</a>; <a href="./references#CD011511-bbs2-0066" title="UMIN000004160. A randomized, double blind, comparative study of vitamin D3 versus placebo in small children with asthma to prevent asthma attack. center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000004995 (first received 1 October 2010). ">UMIN000004160</a>). <a href="./references#CD011511-bbs2-0061" title="NCT02424552. Effect of vitamin D as add-on therapy for vitamin D insufficient patients with severe asthma (EVITA) [EVITA Trial: Effect of vitamin D as add-on therapy for vitamin D insufficient patients with severe asthma: a randomized, double-blind, placebo-controlled trial]. clinicaltrials.gov/ct2/show/NCT02424552 (first received 23 April 2015). ">NCT02424552</a> terminated due to recruitment issues, with an actual enrolment of 54 relative to an intended enrolment of 160 people. As this study terminated before results were obtained, there is a low risk of selective publication bias. <a href="./references#CD011511-bbs2-0066" title="UMIN000004160. A randomized, double blind, comparative study of vitamin D3 versus placebo in small children with asthma to prevent asthma attack. center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000004995 (first received 1 October 2010). ">UMIN000004160</a> does not state a reason for termination, but no results are reported. </p> <p>Overall, numerous studies contributed data to the primary outcome of this systematic review, with consistent null findings, symmetrical funnel plots, and no strong indications of publication bias. </p> </section> <section id="CD011511-sec-0085"> <h3 class="title" id="CD011511-sec-0085">Agreements and disagreements with other studies or reviews</h3> <p>We are aware of 13 other systematic reviews and meta‐analyses that have synthesised evidence from randomised controlled trials of vitamin D in people with asthma. Seven of these, including the previous Cochrane Review, found protective effects (<a href="./references#CD011511-bbs2-0071" title="ChenZ , PengC , MeiJ , ZhuL , KongH . Vitamin D can safely reduce asthma exacerbations among corticosteroid-using children and adults with asthma: a systematic review and meta-analysis of randomized controlled trials. Nutrition Research2021;92:49-61. [DOI: 10.1016/j.nutres.2021.05.010]">Chen 2021</a>; <a href="./references#CD011511-bbs2-0088" title="JolliffeDA , GreenbergL , HooperRL , GriffithsCJ , CamargoCA , KerleyCP , et al. Vitamin D supplementation to prevent asthmaexacerbations: a systematic review and meta-analysis of individual participant data. Lancet Respiratory Medicine2017;5(11):881-90. [DOI: 10.1016/ S2213-2600(17)30306-5]">Jolliffe 2017</a>; <a href="./references#CD011511-bbs2-0094" title="LiuM , Wang J and SunX . A meta-analysis on vitamin D supplementation and asthma treatment. Frontiers in Nutrition2021;9:860628. [DOI: 10.3389/fnut.2022.860628]">Liu 2021</a>; <a href="./references#CD011511-bbs2-0117" title="MartineauAR , CatesCJ , UrashimaM , JensenM , GriffithsAP , NurmatovU , et al. Vitamin D for the management of asthma. Cochrane Database of Systematic Reviews2016, Issue 9. Art. No: CD011511. [DOI: 10.1002/14651858.CD011511.pub2]">Martineau 2016</a>; <a href="./references#CD011511-bbs2-0103" title="PojsupapS , IlirianiK , SampaioT , O’HearnK , KinR , KovesiT , et al. Efficacy of high-dose vitamin D in pediatric asthma: a systematic review and meta-analysis. Journal of Asthma2015;52:382-90. [DOI: 10.3109/02770903.2014.980509]">Pojsupap 2015</a>; <a href="./references#CD011511-bbs2-0106" title="RiverinBD , MaguireJL , LiP . Vitamin D supplementation for childhood asthma: a systematic review and meta-analysis. PLoS ONE2015;10(8):e0136841.">Riverin 2015</a>; <a href="./references#CD011511-bbs2-0114" title="XiaoL , XingC , YangZ , XuS , WangM , DuH , et al. Vitamin D supplementation for the prevention of childhood acute respiratory infections: a systematic review of randomised controlled trials. British Journal of Nutrition2015;114:1026-34.">Xiao 2015</a>) whilst six did not (<a href="./references#CD011511-bbs2-0074" title="De Menezes RiosAC , FonsecaRS , CostaNC , AzevedoBG , NeriDA , Sampaio RibeiroFM , et al. Efficacy of vitamin D supplementation in children with asthma and vitamin D deficiency: a systematic review. Respirology2021;26(S3):378. [DOI: 10.1111/resp.14150]">De Menezes Rios 2021</a>; <a href="./references#CD011511-bbs2-0075" title="FaresMM , AlkhaledLH , MrouehSM , AklEA . Vitamin D supplementation in children with asthma: a systematic review and meta-analysis. BMC Research Notes2015;8:23. [DOI: 10.1186/s13104-014-0961-3]">Fares 2015</a>; <a href="./references#CD011511-bbs2-0080" title="HaoM , XuR , LuoN , LiuM , XieJ , ZhangW . The effect of vitamin D supplementation in children with asthma: a meta-analysis.. Frontiers in Pediatrics2022;10:840617. [DOI: 10.3389/fped.2022.840617]">Hao 2022</a>; <a href="./references#CD011511-bbs2-0092" title="KumarJ , KumarP , GoyalJP , ThakurC , ChoudharyP , MeenaJ , et al. Vitamin D supplementation in childhood asthma: a systematic review and meta-analysis of randomised controlled trials. ERJ Open Research2022;8(2):662. [DOI: 10.1183/23120541.00662-2021]">Kumar 2022</a>; <a href="./references#CD011511-bbs2-0095" title="LuoJ , LiuD , Liu C-T. Can vitamin D supplementation in addition to asthma controllers improve clinical outcomes in patients with asthma? A meta-analysis. Medicine2015;94(50):e2185.">Luo 2015</a>; <a href="./references#CD011511-bbs2-0102" title="NitzanI , MimouniFB , NunAB , KasirerY , MendlovicJ . Vitamin D and asthma: a systematic review of clinical trials. Current Nutrition Reports2022;11(2):311-17. [DOI: 10.1007/s13668-022-00411-6]">Nitzan 2022</a>), with a trend towards the earlier reviews identifying a protective effect and more recent studies obtaining null findings. </p> <p>The null findings of this systematic review stand in contrast with the report of an overall effect of vitamin D identified in the previous Cochrane Review on this topic (<a href="./references#CD011511-bbs2-0117" title="MartineauAR , CatesCJ , UrashimaM , JensenM , GriffithsAP , NurmatovU , et al. Vitamin D for the management of asthma. Cochrane Database of Systematic Reviews2016, Issue 9. Art. No: CD011511. [DOI: 10.1002/14651858.CD011511.pub2]">Martineau 2016</a>). A previous meta‐analysis of individual participant data (IPDMA) on the same topic was consistent with this previous Cochrane Review, identifying an overall protective effect of vitamin D on the rate ratio of asthma exacerbations requiring systemic corticosteroids (RR 0.74, 95% CI 0.56 to 0.97) (<a href="./references#CD011511-bbs2-0088" title="JolliffeDA , GreenbergL , HooperRL , GriffithsCJ , CamargoCA , KerleyCP , et al. Vitamin D supplementation to prevent asthmaexacerbations: a systematic review and meta-analysis of individual participant data. Lancet Respiratory Medicine2017;5(11):881-90. [DOI: 10.1016/ S2213-2600(17)30306-5]">Jolliffe 2017</a>). Baseline 25(OH)D level did not significantly modify this effect (P value for interaction = 0.25). However, this IPDMA did not find a protective effect of vitamin D on the proportion of participants experiencing one or more exacerbations requiring systemic corticosteroids (OR 0.75, 95% CI 0.51 to 1.09). </p> <p>We acknowledge that the previous Cochrane Review assessed its core findings as being based on high‐quality evidence, yet our updated review has now arrived at contrasting null results, also based on high‐quality evidence. We identify two potential reasons for these differing findings, which together give confidence that the true effect lies close to that of the estimate of the effect in this current review. </p> <p>First, the current review draws evidence from a far larger pool of studies than the previous Cochrane Review (20 versus 9) including all studies previously analysed. It analyses a greater number of participants, with more diversity in characteristics and the capacity to conduct subgroup analyses which concur with our primary null finding in every case, except for the aforementioned single study finding a positive effect of calcidiol. Thus, the null findings obtained are likely to be a better assessment of the true relationship between vitamin D supplementation and asthma. We also applied more rigorous exclusion criteria than some reviews identifying a protective effect. For instance, studies considered by <a href="./references#CD011511-bbs2-0071" title="ChenZ , PengC , MeiJ , ZhuL , KongH . Vitamin D can safely reduce asthma exacerbations among corticosteroid-using children and adults with asthma: a systematic review and meta-analysis of randomized controlled trials. Nutrition Research2021;92:49-61. [DOI: 10.1016/j.nutres.2021.05.010]">Chen 2021</a> were excluded by our review because they were not placebo‐controlled (<a href="./references#CD011511-bbs2-0025" title="BarisS , KiykimA , OzenA , TulunayA , Karakoc-AydinerE , BarlanIB . Vitamin D as an adjunct to subcutaneous allergen immunotherapy in asthmatic children sensitized to house dust mite. Allergy2014;69(2):246-53. SafaB , Karakoc-AydinerE , CaganH , KiykimA , TulunayA , AkkocT , et al. 25 (OH) vitamin D3 as an adjunct to subcutaneous allergen immunotherapy: Is it effective? In: 31st Congress of the European Academy of Allergy and Clinical Immunology; 2012 June 16-20; Geneva. 2012. ">Baris 2014</a>), not blinded (<a href="./references#CD011511-bbs2-0030" title="DodamaniMH , MuthuV , ThakurR , PalA , SehgalIS , DhooriaS , et al. A randomised trial of vitamin D in acute-stage allergic bronchopulmonary aspergillosis complicating asthma. Mycoses2019;62:4. [DOI: 10.1111/myc.12879]">Dodamani 2019</a>), or because duration of follow‐up was less than 12 weeks (<a href="./references#CD011511-bbs2-0029" title="deGrootJC , vanRoonEN , StormH , BelEH , ten BrinkeA . The effect of a single high dose vitamin D3 on neutrophilic airway inflammation in nonatopic asthma. European Respiratory Journal2012;40(Suppl 56):P1790. De GrootJC , Van RoonEN , StormH , VeegerNJ , BelEH , Ten BrinkeA . The effect of vitamin D on airway inflammation in non-atopic asthma. American Journal of Respiratory and Critical Care Medicine2014;189:A1390. De GrootJC , vanRoonEN , StormH , VeegerNJ , ZwindermanAH , HiemstraPS , et al. Vitamin D reduces eosinophilic airway inflammation in non-atopic asthma. Journal of Allergy and Clinical Immunology2015;135(3):670-5. ">De Groot 2015</a>). The review by <a href="./references#CD011511-bbs2-0094" title="LiuM , Wang J and SunX . A meta-analysis on vitamin D supplementation and asthma treatment. Frontiers in Nutrition2021;9:860628. [DOI: 10.3389/fnut.2022.860628]">Liu 2021</a> also included <a href="./references#CD011511-bbs2-0030" title="DodamaniMH , MuthuV , ThakurR , PalA , SehgalIS , DhooriaS , et al. A randomised trial of vitamin D in acute-stage allergic bronchopulmonary aspergillosis complicating asthma. Mycoses2019;62:4. [DOI: 10.1111/myc.12879]">Dodamani 2019</a> despite its open‐label methodology. </p> <p>A second potential explanation for the null findings in this updated review relates to a secular trend towards increasingly widespread population use of vitamin D supplementation (<a href="./references#CD011511-bbs2-0091" title="KantorED , RehmCD , DuM , WhiteE , GiovannucciEL . Trends in dietary supplement use among US adults from 1999-2012. JAMA2016;316(14):1464–74. [DOI: 10.1001/jama.2016.14403]">Kantor 2016</a>). For instance, the growing popularity of vitamin D supplements in the general population (and particularly in the subset of people taking part in clinical trials) may have led to increased use of vitamin D supplements among participants randomised to placebo in more recent versus less recent trials. This could have attenuated potential benefits of vitamin D, and increased the probability of null findings in more recent trials. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD011511-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011511.pub3/media/CDSR/CD011511/urn:x-wiley:14651858:media:CD011511:CD011511-FIG-01" target="_blank"><b></b></a></p> </div><img alt="original image" data-id="CD011511-fig-0001" src="/cdsr/doi/10.1002/14651858.CD011511.pub3/media/CDSR/CD011511/image_n/nCD011511-FIG-01.png"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011511.pub3/media/CDSR/CD011511/image_t/tCD011511-FIG-01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011511.pub3/full#CD011511-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011511.pub3/media/CDSR/CD011511/image_n/nCD011511-FIG-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011511-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011511.pub3/media/CDSR/CD011511/urn:x-wiley:14651858:media:CD011511:CD011511-FIG-02" target="_blank"><b></b></a></p> </div><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD011511-fig-0002" src="/cdsr/doi/10.1002/14651858.CD011511.pub3/media/CDSR/CD011511/image_n/nCD011511-FIG-02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011511.pub3/media/CDSR/CD011511/image_t/tCD011511-FIG-02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011511.pub3/full#CD011511-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011511.pub3/media/CDSR/CD011511/image_n/nCD011511-FIG-02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011511-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011511.pub3/media/CDSR/CD011511/urn:x-wiley:14651858:media:CD011511:CD011511-FIG-03" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: vitamin D versus placebo (all studies), outcome 1.1: proportion of participants experiencing one or more asthma exacerbations treated with systemic corticosteroids" data-id="CD011511-fig-0003" src="/cdsr/doi/10.1002/14651858.CD011511.pub3/media/CDSR/CD011511/image_n/nCD011511-FIG-03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011511.pub3/media/CDSR/CD011511/image_t/tCD011511-FIG-03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>Forest plot of comparison: vitamin D versus placebo (all studies), outcome 1.1: proportion of participants experiencing one or more asthma exacerbations treated with systemic corticosteroids </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011511.pub3/full#CD011511-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011511.pub3/media/CDSR/CD011511/image_n/nCD011511-FIG-03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011511-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011511.pub3/media/CDSR/CD011511/urn:x-wiley:14651858:media:CD011511:CD011511-FIG-04" target="_blank"><b></b></a></p> </div><img alt="Funnel plot of comparison 1: Vitamin D versus placebo (all studies), outcome 1.2 Rate ratio, exacerbation requiring corticosteroids" data-id="CD011511-fig-0004" src="/cdsr/doi/10.1002/14651858.CD011511.pub3/media/CDSR/CD011511/image_n/nCD011511-FIG-04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011511.pub3/media/CDSR/CD011511/image_t/tCD011511-FIG-04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 4</div> <div class="figure-caption"> <p>Funnel plot of comparison 1: Vitamin D versus placebo (all studies), outcome 1.2 Rate ratio, exacerbation requiring corticosteroids </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011511.pub3/full#CD011511-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011511.pub3/media/CDSR/CD011511/image_n/nCD011511-FIG-04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011511-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011511.pub3/media/CDSR/CD011511/urn:x-wiley:14651858:media:CD011511:CD011511-FIG-05" target="_blank"><b></b></a></p> </div><img alt="Funnel plot of comparison: Vitamin D versus placebo (all studies), outcome: 1.11 End‐study FEV1, % predicted" data-id="CD011511-fig-0005" src="/cdsr/doi/10.1002/14651858.CD011511.pub3/media/CDSR/CD011511/image_n/nCD011511-FIG-05.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011511.pub3/media/CDSR/CD011511/image_t/tCD011511-FIG-05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 5</div> <div class="figure-caption"> <p>Funnel plot of comparison: Vitamin D versus placebo (all studies), outcome: 1.11 End‐study FEV1, % predicted </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011511.pub3/full#CD011511-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011511.pub3/media/CDSR/CD011511/image_n/nCD011511-FIG-05.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011511-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011511.pub3/media/CDSR/CD011511/urn:x-wiley:14651858:media:CD011511:CD011511-FIG-06" target="_blank"><b></b></a></p> </div><img alt="Funnel plot of comparison: 1 Vitamin D versus placebo (all studies), outcome: 1.9 People with one or more study‐defined exacerbations" data-id="CD011511-fig-0006" src="/cdsr/doi/10.1002/14651858.CD011511.pub3/media/CDSR/CD011511/image_n/nCD011511-FIG-06.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011511.pub3/media/CDSR/CD011511/image_t/tCD011511-FIG-06.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 6</div> <div class="figure-caption"> <p>Funnel plot of comparison: 1 Vitamin D versus placebo (all studies), outcome: 1.9 People with one or more study‐defined exacerbations </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011511.pub3/full#CD011511-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011511.pub3/media/CDSR/CD011511/image_n/nCD011511-FIG-06.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011511-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011511.pub3/media/CDSR/CD011511/urn:x-wiley:14651858:media:CD011511:CD011511-CMP-001.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Vitamin D versus placebo, Outcome 1: Proportion of participants with one or more exacerbations treated with systemic corticosteroids" data-id="CD011511-fig-0007" src="/cdsr/doi/10.1002/14651858.CD011511.pub3/media/CDSR/CD011511/image_n/nCD011511-CMP-001.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011511.pub3/media/CDSR/CD011511/image_t/tCD011511-CMP-001.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1: Vitamin D versus placebo, Outcome 1: Proportion of participants with one or more exacerbations treated with systemic corticosteroids </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011511.pub3/references#CD011511-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011511.pub3/media/CDSR/CD011511/image_n/nCD011511-CMP-001.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011511-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011511.pub3/media/CDSR/CD011511/urn:x-wiley:14651858:media:CD011511:CD011511-CMP-001.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Vitamin D versus placebo, Outcome 2: Rate of exacerbations treated with systemic corticosteroids" data-id="CD011511-fig-0008" src="/cdsr/doi/10.1002/14651858.CD011511.pub3/media/CDSR/CD011511/image_n/nCD011511-CMP-001.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011511.pub3/media/CDSR/CD011511/image_t/tCD011511-CMP-001.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1: Vitamin D versus placebo, Outcome 2: Rate of exacerbations treated with systemic corticosteroids </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011511.pub3/references#CD011511-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011511.pub3/media/CDSR/CD011511/image_n/nCD011511-CMP-001.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011511-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011511.pub3/media/CDSR/CD011511/urn:x-wiley:14651858:media:CD011511:CD011511-CMP-001.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Vitamin D versus placebo, Outcome 3: Time to first exacerbation treated with systemic corticosteroids" data-id="CD011511-fig-0009" src="/cdsr/doi/10.1002/14651858.CD011511.pub3/media/CDSR/CD011511/image_n/nCD011511-CMP-001.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011511.pub3/media/CDSR/CD011511/image_t/tCD011511-CMP-001.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1: Vitamin D versus placebo, Outcome 3: Time to first exacerbation treated with systemic corticosteroids </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011511.pub3/references#CD011511-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011511.pub3/media/CDSR/CD011511/image_n/nCD011511-CMP-001.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011511-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011511.pub3/media/CDSR/CD011511/urn:x-wiley:14651858:media:CD011511:CD011511-CMP-001.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Vitamin D versus placebo, Outcome 4: Proportion of participants with one or more exacerbations requiring systemic corticosteroids (stratified by baseline 25[OH]D)" data-id="CD011511-fig-0010" src="/cdsr/doi/10.1002/14651858.CD011511.pub3/media/CDSR/CD011511/image_n/nCD011511-CMP-001.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011511.pub3/media/CDSR/CD011511/image_t/tCD011511-CMP-001.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1: Vitamin D versus placebo, Outcome 4: Proportion of participants with one or more exacerbations requiring systemic corticosteroids (stratified by baseline 25[OH]D) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011511.pub3/references#CD011511-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011511.pub3/media/CDSR/CD011511/image_n/nCD011511-CMP-001.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011511-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011511.pub3/media/CDSR/CD011511/urn:x-wiley:14651858:media:CD011511:CD011511-CMP-001.05" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Vitamin D versus placebo, Outcome 5: Proportion of participants with one or more exacerbations requiring systemic corticosteroids (stratified by daily dose equivalent)" data-id="CD011511-fig-0011" src="/cdsr/doi/10.1002/14651858.CD011511.pub3/media/CDSR/CD011511/image_n/nCD011511-CMP-001.05.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011511.pub3/media/CDSR/CD011511/image_t/tCD011511-CMP-001.05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.5</div> <div class="figure-caption"> <p>Comparison 1: Vitamin D versus placebo, Outcome 5: Proportion of participants with one or more exacerbations requiring systemic corticosteroids (stratified by daily dose equivalent) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011511.pub3/references#CD011511-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011511.pub3/media/CDSR/CD011511/image_n/nCD011511-CMP-001.05.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011511-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011511.pub3/media/CDSR/CD011511/urn:x-wiley:14651858:media:CD011511:CD011511-CMP-001.06" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Vitamin D versus placebo, Outcome 6: Rate ratio, exacerbations requiring systemic corticosteroids (stratified by vitamin D type)" data-id="CD011511-fig-0012" src="/cdsr/doi/10.1002/14651858.CD011511.pub3/media/CDSR/CD011511/image_n/nCD011511-CMP-001.06.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011511.pub3/media/CDSR/CD011511/image_t/tCD011511-CMP-001.06.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.6</div> <div class="figure-caption"> <p>Comparison 1: Vitamin D versus placebo, Outcome 6: Rate ratio, exacerbations requiring systemic corticosteroids (stratified by vitamin D type) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011511.pub3/references#CD011511-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011511.pub3/media/CDSR/CD011511/image_n/nCD011511-CMP-001.06.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011511-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011511.pub3/media/CDSR/CD011511/urn:x-wiley:14651858:media:CD011511:CD011511-CMP-001.07" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Vitamin D versus placebo, Outcome 7: Proportion of participants with one or more exacerbations treated with systemic corticosteroids (stratified by dosing regimen)" data-id="CD011511-fig-0013" src="/cdsr/doi/10.1002/14651858.CD011511.pub3/media/CDSR/CD011511/image_n/nCD011511-CMP-001.07.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011511.pub3/media/CDSR/CD011511/image_t/tCD011511-CMP-001.07.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.7</div> <div class="figure-caption"> <p>Comparison 1: Vitamin D versus placebo, Outcome 7: Proportion of participants with one or more exacerbations treated with systemic corticosteroids (stratified by dosing regimen) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011511.pub3/references#CD011511-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011511.pub3/media/CDSR/CD011511/image_n/nCD011511-CMP-001.07.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011511-fig-0014"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011511.pub3/media/CDSR/CD011511/urn:x-wiley:14651858:media:CD011511:CD011511-CMP-001.08" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Vitamin D versus placebo, Outcome 8: Proportion of participants with one or more exacerbations requiring systemic corticosteroids (stratified by age)" data-id="CD011511-fig-0014" src="/cdsr/doi/10.1002/14651858.CD011511.pub3/media/CDSR/CD011511/image_n/nCD011511-CMP-001.08.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011511.pub3/media/CDSR/CD011511/image_t/tCD011511-CMP-001.08.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.8</div> <div class="figure-caption"> <p>Comparison 1: Vitamin D versus placebo, Outcome 8: Proportion of participants with one or more exacerbations requiring systemic corticosteroids (stratified by age) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011511.pub3/references#CD011511-fig-0014">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011511.pub3/media/CDSR/CD011511/image_n/nCD011511-CMP-001.08.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011511-fig-0015"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011511.pub3/media/CDSR/CD011511/urn:x-wiley:14651858:media:CD011511:CD011511-CMP-001.09" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Vitamin D versus placebo, Outcome 9: Proportion of participants with one or more exacerbations treated with systemic corticosteroids (excluding trials at unclear risk of bias)" data-id="CD011511-fig-0015" src="/cdsr/doi/10.1002/14651858.CD011511.pub3/media/CDSR/CD011511/image_n/nCD011511-CMP-001.09.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011511.pub3/media/CDSR/CD011511/image_t/tCD011511-CMP-001.09.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.9</div> <div class="figure-caption"> <p>Comparison 1: Vitamin D versus placebo, Outcome 9: Proportion of participants with one or more exacerbations treated with systemic corticosteroids (excluding trials at unclear risk of bias) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011511.pub3/references#CD011511-fig-0015">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011511.pub3/media/CDSR/CD011511/image_n/nCD011511-CMP-001.09.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011511-fig-0016"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011511.pub3/media/CDSR/CD011511/urn:x-wiley:14651858:media:CD011511:CD011511-CMP-001.10" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Vitamin D versus placebo, Outcome 10: Proportion of participants with one or more exacerbation as defined in primary trials (excluding trials at high risk of bias)" data-id="CD011511-fig-0016" src="/cdsr/doi/10.1002/14651858.CD011511.pub3/media/CDSR/CD011511/image_n/nCD011511-CMP-001.10.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011511.pub3/media/CDSR/CD011511/image_t/tCD011511-CMP-001.10.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.10</div> <div class="figure-caption"> <p>Comparison 1: Vitamin D versus placebo, Outcome 10: Proportion of participants with one or more exacerbation as defined in primary trials (excluding trials at high risk of bias) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011511.pub3/references#CD011511-fig-0016">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011511.pub3/media/CDSR/CD011511/image_n/nCD011511-CMP-001.10.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011511-fig-0017"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011511.pub3/media/CDSR/CD011511/urn:x-wiley:14651858:media:CD011511:CD011511-CMP-001.11" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Vitamin D versus placebo, Outcome 11: Proportion of participants with one or more exacerbations treated with systemic corticosteroids (risk difference)" data-id="CD011511-fig-0017" src="/cdsr/doi/10.1002/14651858.CD011511.pub3/media/CDSR/CD011511/image_n/nCD011511-CMP-001.11.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011511.pub3/media/CDSR/CD011511/image_t/tCD011511-CMP-001.11.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.11</div> <div class="figure-caption"> <p>Comparison 1: Vitamin D versus placebo, Outcome 11: Proportion of participants with one or more exacerbations treated with systemic corticosteroids (risk difference) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011511.pub3/references#CD011511-fig-0017">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011511.pub3/media/CDSR/CD011511/image_n/nCD011511-CMP-001.11.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011511-fig-0018"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011511.pub3/media/CDSR/CD011511/urn:x-wiley:14651858:media:CD011511:CD011511-CMP-001.12" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Vitamin D versus placebo, Outcome 12: Proportion of participants with one or more exacerbations requiring emergency department visit or hospitalisation, or both" data-id="CD011511-fig-0018" src="/cdsr/doi/10.1002/14651858.CD011511.pub3/media/CDSR/CD011511/image_n/nCD011511-CMP-001.12.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011511.pub3/media/CDSR/CD011511/image_t/tCD011511-CMP-001.12.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.12</div> <div class="figure-caption"> <p>Comparison 1: Vitamin D versus placebo, Outcome 12: Proportion of participants with one or more exacerbations requiring emergency department visit or hospitalisation, or both </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011511.pub3/references#CD011511-fig-0018">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011511.pub3/media/CDSR/CD011511/image_n/nCD011511-CMP-001.12.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011511-fig-0019"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011511.pub3/media/CDSR/CD011511/urn:x-wiley:14651858:media:CD011511:CD011511-CMP-001.13" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Vitamin D versus placebo, Outcome 13: End‐study C‐ACT/ACT score" data-id="CD011511-fig-0019" src="/cdsr/doi/10.1002/14651858.CD011511.pub3/media/CDSR/CD011511/image_n/nCD011511-CMP-001.13.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011511.pub3/media/CDSR/CD011511/image_t/tCD011511-CMP-001.13.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.13</div> <div class="figure-caption"> <p>Comparison 1: Vitamin D versus placebo, Outcome 13: End‐study C‐ACT/ACT score</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011511.pub3/references#CD011511-fig-0019">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011511.pub3/media/CDSR/CD011511/image_n/nCD011511-CMP-001.13.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011511-fig-0020"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011511.pub3/media/CDSR/CD011511/urn:x-wiley:14651858:media:CD011511:CD011511-CMP-001.14" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Vitamin D versus placebo, Outcome 14: End‐study FEV1, % predicted" data-id="CD011511-fig-0020" src="/cdsr/doi/10.1002/14651858.CD011511.pub3/media/CDSR/CD011511/image_n/nCD011511-CMP-001.14.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011511.pub3/media/CDSR/CD011511/image_t/tCD011511-CMP-001.14.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.14</div> <div class="figure-caption"> <p>Comparison 1: Vitamin D versus placebo, Outcome 14: End‐study FEV1, % predicted</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011511.pub3/references#CD011511-fig-0020">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011511.pub3/media/CDSR/CD011511/image_n/nCD011511-CMP-001.14.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011511-fig-0021"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011511.pub3/media/CDSR/CD011511/urn:x-wiley:14651858:media:CD011511:CD011511-CMP-001.15" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Vitamin D versus placebo, Outcome 15: Proportion of participants with one or more serious adverse events due to any cause" data-id="CD011511-fig-0021" src="/cdsr/doi/10.1002/14651858.CD011511.pub3/media/CDSR/CD011511/image_n/nCD011511-CMP-001.15.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011511.pub3/media/CDSR/CD011511/image_t/tCD011511-CMP-001.15.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.15</div> <div class="figure-caption"> <p>Comparison 1: Vitamin D versus placebo, Outcome 15: Proportion of participants with one or more serious adverse events due to any cause </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011511.pub3/references#CD011511-fig-0021">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011511.pub3/media/CDSR/CD011511/image_n/nCD011511-CMP-001.15.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011511-fig-0022"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011511.pub3/media/CDSR/CD011511/urn:x-wiley:14651858:media:CD011511:CD011511-CMP-001.16" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Vitamin D versus placebo, Outcome 16: Proportion of participants with fatal asthma exacerbation" data-id="CD011511-fig-0022" src="/cdsr/doi/10.1002/14651858.CD011511.pub3/media/CDSR/CD011511/image_n/nCD011511-CMP-001.16.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011511.pub3/media/CDSR/CD011511/image_t/tCD011511-CMP-001.16.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.16</div> <div class="figure-caption"> <p>Comparison 1: Vitamin D versus placebo, Outcome 16: Proportion of participants with fatal asthma exacerbation </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011511.pub3/references#CD011511-fig-0022">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011511.pub3/media/CDSR/CD011511/image_n/nCD011511-CMP-001.16.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011511-fig-0023"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011511.pub3/media/CDSR/CD011511/urn:x-wiley:14651858:media:CD011511:CD011511-CMP-001.17" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Vitamin D versus placebo, Outcome 17: Proportion of participants with one or more exacerbation as defined in primary trials" data-id="CD011511-fig-0023" src="/cdsr/doi/10.1002/14651858.CD011511.pub3/media/CDSR/CD011511/image_n/nCD011511-CMP-001.17.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011511.pub3/media/CDSR/CD011511/image_t/tCD011511-CMP-001.17.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.17</div> <div class="figure-caption"> <p>Comparison 1: Vitamin D versus placebo, Outcome 17: Proportion of participants with one or more exacerbation as defined in primary trials </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011511.pub3/references#CD011511-fig-0023">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011511.pub3/media/CDSR/CD011511/image_n/nCD011511-CMP-001.17.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011511-fig-0024"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011511.pub3/media/CDSR/CD011511/urn:x-wiley:14651858:media:CD011511:CD011511-CMP-001.18" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Vitamin D versus placebo, Outcome 18: % eosinophils, lower airway" data-id="CD011511-fig-0024" src="/cdsr/doi/10.1002/14651858.CD011511.pub3/media/CDSR/CD011511/image_n/nCD011511-CMP-001.18.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011511.pub3/media/CDSR/CD011511/image_t/tCD011511-CMP-001.18.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.18</div> <div class="figure-caption"> <p>Comparison 1: Vitamin D versus placebo, Outcome 18: % eosinophils, lower airway</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011511.pub3/references#CD011511-fig-0024">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011511.pub3/media/CDSR/CD011511/image_n/nCD011511-CMP-001.18.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011511-fig-0025"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011511.pub3/media/CDSR/CD011511/urn:x-wiley:14651858:media:CD011511:CD011511-CMP-001.19" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Vitamin D versus placebo, Outcome 19: End‐study log 10 total IgE, IU/ml" data-id="CD011511-fig-0025" src="/cdsr/doi/10.1002/14651858.CD011511.pub3/media/CDSR/CD011511/image_n/nCD011511-CMP-001.19.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011511.pub3/media/CDSR/CD011511/image_t/tCD011511-CMP-001.19.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.19</div> <div class="figure-caption"> <p>Comparison 1: Vitamin D versus placebo, Outcome 19: End‐study log 10 total IgE, IU/ml</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011511.pub3/references#CD011511-fig-0025">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011511.pub3/media/CDSR/CD011511/image_n/nCD011511-CMP-001.19.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011511-fig-0026"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011511.pub3/media/CDSR/CD011511/urn:x-wiley:14651858:media:CD011511:CD011511-CMP-001.20" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Vitamin D versus placebo, Outcome 20: End‐study FVC, % predicted" data-id="CD011511-fig-0026" src="/cdsr/doi/10.1002/14651858.CD011511.pub3/media/CDSR/CD011511/image_n/nCD011511-CMP-001.20.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011511.pub3/media/CDSR/CD011511/image_t/tCD011511-CMP-001.20.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.20</div> <div class="figure-caption"> <p>Comparison 1: Vitamin D versus placebo, Outcome 20: End‐study FVC, % predicted</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011511.pub3/references#CD011511-fig-0026">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011511.pub3/media/CDSR/CD011511/image_n/nCD011511-CMP-001.20.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011511-fig-0027"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011511.pub3/media/CDSR/CD011511/urn:x-wiley:14651858:media:CD011511:CD011511-CMP-001.21" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Vitamin D versus placebo, Outcome 21: End‐study PEFR (L/min)" data-id="CD011511-fig-0027" src="/cdsr/doi/10.1002/14651858.CD011511.pub3/media/CDSR/CD011511/image_n/nCD011511-CMP-001.21.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011511.pub3/media/CDSR/CD011511/image_t/tCD011511-CMP-001.21.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.21</div> <div class="figure-caption"> <p>Comparison 1: Vitamin D versus placebo, Outcome 21: End‐study PEFR (L/min)</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011511.pub3/references#CD011511-fig-0027">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011511.pub3/media/CDSR/CD011511/image_n/nCD011511-CMP-001.21.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011511-fig-0028"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011511.pub3/media/CDSR/CD011511/urn:x-wiley:14651858:media:CD011511:CD011511-CMP-001.22" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Vitamin D versus placebo, Outcome 22: Withdrawals from trial" data-id="CD011511-fig-0028" src="/cdsr/doi/10.1002/14651858.CD011511.pub3/media/CDSR/CD011511/image_n/nCD011511-CMP-001.22.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011511.pub3/media/CDSR/CD011511/image_t/tCD011511-CMP-001.22.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.22</div> <div class="figure-caption"> <p>Comparison 1: Vitamin D versus placebo, Outcome 22: Withdrawals from trial</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011511.pub3/references#CD011511-fig-0028">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011511.pub3/media/CDSR/CD011511/image_n/nCD011511-CMP-001.22.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011511-fig-0029"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011511.pub3/media/CDSR/CD011511/urn:x-wiley:14651858:media:CD011511:CD011511-CMP-001.23" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Vitamin D versus placebo, Outcome 23: Withdrawals from trial (excluding trials at high risk of bias)" data-id="CD011511-fig-0029" src="/cdsr/doi/10.1002/14651858.CD011511.pub3/media/CDSR/CD011511/image_n/nCD011511-CMP-001.23.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011511.pub3/media/CDSR/CD011511/image_t/tCD011511-CMP-001.23.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.23</div> <div class="figure-caption"> <p>Comparison 1: Vitamin D versus placebo, Outcome 23: Withdrawals from trial (excluding trials at high risk of bias) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011511.pub3/references#CD011511-fig-0029">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011511.pub3/media/CDSR/CD011511/image_n/nCD011511-CMP-001.23.svg" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD011511-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Summary of findings table ‐ Vitamin D compared to placebo for the management of asthma</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Vitamin D compared to placebo for the management of asthma</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> children and adults with predominantly mild to moderate asthma<br/><b>Setting:</b> primary and secondary care<br/><b>Intervention:</b> vitamin D<br/><b>Comparison:</b> placebo </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with placebo</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with vitamin D</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Proportion of participants with one or more exacerbations treated with systemic corticosteroids<br/>follow‐up: range 3 months to 40 months </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>219 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>226 per 1000</b><br/>(185 to 273) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>OR 1.04</b><br/>(0.81 to 1.34) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1778<br/>(14 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊕<br/>High<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Proportion of participants with one or more exacerbations requiring emergency department visit or hospitalisation, or both </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>79 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>46 per 1000</b><br/>(22 to 94) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>OR 0.56</b><br/>(0.26 to 1.21) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1070<br/>(9 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/>Moderate<sup>b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>End‐study asthma control test score<br/>assessed with: childhood Asthma Control Test, or linearly transformed Asthma Control Test<br/>Scale from: 0 to 27 </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean end‐study asthma control test score was <b>22.98</b> points </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD <b>0.23 points higher</b><br/>(0.26 lower to 0.73 higher) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1271<br/>(7 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/>Moderate<sup>c</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>End‐study forced expiratory volume in 1 second, % predicted</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean end‐study forced expiratory volume in 1 second, % predicted was <b>93.80</b> % </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD <b>0.2 % higher</b><br/>(1.24 lower to 1.63 higher) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1286<br/>(11 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊕<br/>High </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Proportion of participants with one or more serious adverse events due to any cause</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>55 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>49 per 1000</b><br/>(32 to 76) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>OR 0.89</b><br/>(0.56 to 1.41) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1556<br/>(12 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊕<br/>High </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Proportion of participants with fatal asthma exacerbation</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>0 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>0 per 1000</b><br/>(0 to 0) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1976<br/>(16 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/>Low<sup>d</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Withdrawals from trial</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>86 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>90 per 1000</b><br/>(68 to 119) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>OR 1.05</b><br/>(0.77 to 1.43) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2225<br/>(20 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊕<br/>High </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><br/><b>CI:</b> confidence interval; <b>MD:</b> mean difference; <b>OR:</b> odds ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>See interactive version of this table: <a href="https://gdt.gradepro.org/presentations/#/isof/isof_question_revman_web_436923543367697621" target="_blank">https://gdt.gradepro.org/presentations/#/isof/isof_question_revman_web_436923543367697621</a>. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup> Each of these GRADE assessments is discussed in full under Quality of the evidence.<br/><sup>b</sup> Downgraded one level due to imprecision, as 95% CI ranged from 0.26 to 1.21 and evidence drew on fewer studies than the primary outcome<br/><sup>c</sup> Downgraded one level due to heterogeneity, as I² = 29%<br/><sup>d</sup> Downgraded two levels due to imprecision, as no events occurred in either arm of any trial considered </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Summary of findings table ‐ Vitamin D compared to placebo for the management of asthma</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011511.pub3/full#CD011511-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD011511-tbl-0002"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Sensitivity analysis: random‐effects versus fixed‐effect models</span></div> <tbody> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Analysis</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Random‐effects model</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Fixed‐effect model</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>People with one or more exacerbations requiring systemic corticosteroids</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>(OR 1.04, 95% CI 0.81 to 1.34)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>(OR 1.04, 95% CI 0.81 to 1.34)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>People with one or more exacerbations requiring systemic corticosteroids (risk difference)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>(RD 0.00, 95% CI ‐0.02 to 0.03)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>(RD 0.00, 95% CI ‐0.02 to 0.03)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>FEV1, % predicted</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>(MD 0.20, 95% CI ‐1.24 to 1.63)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>(MD 0.34, 95% CI ‐0.81 to 1.48)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>End‐study C‐ACT/ACT score (0 to 27)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MD 0.23 (‐0.26 to 0.73)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MD 0.20 (‐0.21 to 0.60)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>People with fatal asthma exacerbation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No events occurred (RD 0.00, 95% CI ‐0.01 to 0.01)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No events occurred (RD 0.00, 95% CI ‐0.01 to 0.01)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>People with 1 or more serious adverse event due to any cause</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>(OR 0.89, 95% CI 0.56 to 1.41)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>(OR 0.89, 95% CI 0.57 to 1.38)</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="3"> <div class="table-footnote"> <p>Abbreviations: C‐ACT/ACT, Childhood Asthma Control Test/ Asthma Control Test; CI, confidence interval; FEV1, forced expiratory volume in one second ; MD, mean difference; OR, odds ratio; RD, risk difference. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Sensitivity analysis: random‐effects versus fixed‐effect models</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011511.pub3/full#CD011511-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD011511-tbl-0003"> <div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Definitions of asthma exacerbation used in primary trials</span></div> <tbody> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Study</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Definition</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011511-bbs2-0001" title="AglipayM , BirkenC , DaiD , ParkinP , MaguireJ . 70 high dose vitamin D for the prevention of wheezing in preschoolers: a secondary analysis of a randomized clinical trial. Paediatrics and Child Health2019;24(S2):e27-8. [DOI: 10.1093/pch/pxz066.069]AglipayM , BirkenCS , ParkinPC , LoebMB , ThorpeK , ChenY , et al. TARGet Kids! Collaboration. Effect of high-dose vs standard-dose wintertime vitamin D supplementation on viral upper respiratory tract infections in young healthy children. JAMA2017;318(3):245-54. [DOI: 10.1001/jama.2017.8708.]">Aglipay 2019</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Wheezing episode in children with asthma reported in parent completed symptom checklist, based on the International Study of Asthma and Allergies in Childhood </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011511-bbs2-0003" title="CamargoC , ToopL , SluyterJ , LawesCM , WaayerD , KhawKT , et al. Effect of monthly vitamin D supplementation on preventing exacerbations of asthma or chronic obstructive pulmonary disease in older adults: post hoc analysis of a randomized controlled trial. Nutrients2021;13:521. [DOI: 10.3390/nu13020521]SluyterJ , CamargoCA , WaayerD , LawesCM , ToopL , KhawKT , et al. Effect of monthly, high-dose, long-term vitamin D on lung function: a randomized controlled trial. Nutrients2017;9:1353. [DOI: 10.3390/nu9121353]">Camargo 2021</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Any prescription of oral corticosteroids more than 20 days apart for a short period (e.g. several days) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011511-bbs2-0004" title="CastroM , KingTS , KunselmanSJ , CabanaMD , DenlingerL , HolguinF , et al. Effect of vitamin D3 on asthma treatment failures in adults with symptomatic asthma and lower vitamin D levels: the VIDA randomized clinical trial. JAMA2014;311(20):2083-91. DenlingerLC , KingTS , CardetJC , CraigT , HolguinF , JacksonDJ , et al. Vitamin D supplementation and the risk of colds in patients with asthma. American Journal of Respiratory and Critical Care Medicine2016;193(6):634–41. DenlingerLC , KingTS , CardetJC , CraigTJ , HolguinF , KraftM , et al. Vitamin D supplementation and the risk of colds in patients with asthma. Journal of Allergy and Clinical Immunology2015;135:AB109. JiaoJ , KingTS , McKenzieM , BacharierLB , DixonAE , CodispotiCD , et al. Effects of vitamin D3 supplementation in adults with asthma complicated by sinonasal disease. American Journal of Respiratory and Critical Care Medicine2015;191:A4148. JiaoJ , KingTS , McKenzieM , BacharierLB , DixonAE , CodispotiCD , et al. Vitamin D3 therapy in patients with asthma complicated by sinonasal disease: secondary analysis of the Vitamin D Add-on Therapy Enhances Corticosteroid Responsiveness in Asthma trial. Journal of Allergy and Clinical Immunology2016;138(2):589-92. MooreWC , KingTS , BleeckerER , MeyersDA , PetersSP , WenzelSE . Sarp clinical clusters predict steroid responsiveness and risk of asthma exacerbations in the asthma net vida (vitamin D in asthma) trial. American Journal of Respiratory and Critical Care Medicine2015;191:A6055. ReidB , GirodetP , BoomerJS , Abdel-GadirA , ZhengK , WechslerME , et al. Vitamin D3 treatment of vitamin D insufficient asthmatics does not alter immune cell function. Journal of Allergy and Clinical Immunology2016;138(1):286-9. ">Castro 2014</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Meeting criteria for treatment failure and 1 or more of the following:</p> <p> <ul id="CD011511-list-0009"> <li> <p>failure to respond to rescue algorithm within 48 hours;</p> </li> <li> <p>FEV1 of less than 50% of baseline measurement on 2 consecutive measurements;</p> </li> <li> <p>FEV1 of less than 40% of predicted level on 2 consecutive measurements;</p> </li> <li> <p>use of 16 puffs/day or more of as‐needed levalbuterol for 48 hours;</p> </li> <li> <p>experiencing an exacerbation of asthma according to physician opinion;</p> </li> <li> <p>use of oral or parenteral corticosteroids due to asthma.</p> </li> </ul> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011511-bbs2-0005" title="DucharmeFM , JensenM , MailhotG , AlosN , WhiteJ , RousseauE , et al. Impact of two oral doses of 100,000 IU of vitamin D3 in preschoolers with viral induced asthma: a pilot randomised controlled trial. Trials2019;20(1):138. [DOI: 10.1186/s13063-019-3184-z]">Ducharme 2019</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Exacerbation requiring rescue oral corticosteroids</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011511-bbs2-0006" title="FornoE , BacharierLB , PhipatanakulW , GuilbertTW , CabanaMD , RossK , et al. Effect of vitamin D3 supplementation on severe asthma exacerbations in children with asthma and low vitamin D levels: The VDKA Randomized Clinical Trial. JAMA2020;324(8):752-60. HanYY , FornoE , BacharierLB , PhipatanakulW , GuilbertTW , CabanaMD , et al. Vitamin D supplementation, lung function and asthma control in children with asthma and low vitamin D levels. European Respiratory Journal2021;58(4):2100989. [DOI: 10.1183/13993003.00989-2021]N/a. Errors in flow diagram. JAMA2021;326(1):90. [DOI: 10.1001/jama.2021.9465.]RosserFJ , HanYY , FornoE , BacharierLB , PhipatanakulW , GuilbertTW , et al. Effect of vitamin D supplementation on total andallergen-specific IgE in children with asthma andlow vitamin D levels. Journal of Allergy and Clinical Immunology2021;149(1):440-4.E2. [PMID: 10.1016/j.jaci.2021.05.037]">Forno 2020</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Either:</p> <p> <ul id="CD011511-list-0010"> <li> <p>use of systemic corticosteroids for at least 3 days; or</p> </li> <li> <p>hospitalisation or emergency department visit because of asthma, requiring systemic corticosteroids </p> </li> </ul> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011511-bbs2-0008" title="JensenM , MailhotG , AlosN , RousseauE , WhiteJ , KhamessanA , et al. Vitamin D intervention in preschoolers with viral-induced asthma (DIVA): a pilot randomised controlled trial. American Journal of Respiratory and Critical Care Medicine2015;191:A3360. JensenME , MailhotG , AlosN , RousseauE , WhiteJ , KhamessanA , et al. Vitamin D intervention in preschoolers with viral-induced asthma (DIVA): a pilot randomised controlled trial. Trials2016;17:353. [DOI: 10.1186/s13063-016-1483-1]">Jensen 2016</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Exacerbation requiring rescue oral corticosteroids, documented in medical or pharmacy records or both </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011511-bbs2-0009" title="JerzynskaJ , StelmachW , RychlikB , LechańskaJ , PodleckaD , StelmachI . The clinical effect of vitamin D supplementation combined with grass-specific sublingual immunotherapy in children with allergic rhinitis. Allergy and Asthma Proceedings2016;37(2):105-14. [DOI: 10.2500/aap.2016.37.3921]">Jerzynska 2016</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Exacerbation not defined in study manuscript, individual participant data defined as requiring steroid course </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011511-bbs2-0011" title="KerleyCP , HutchinsonK , CormicanL , FaulJ , GreallyP , CoghlanD , et al. Vitamin D3 for uncontrolled childhood asthma: A pilot study. Paediatric Allergy and Immunology2016;27:404-12. [PMID: 10.1111/pai.12547]">Kerley 2016</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Exacerbation not defined in study manuscript, individual participant data defined as requiring steroid course </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011511-bbs2-0012" title="LewisE , FernandezC , NellaA , HoppR , GallagherJC , CasaleTB . Relationship of 25-hydroxyvitamin D and asthma control in children. Annals of Allergy, Asthma and Immunology2012;108(4):281-2. LewisE , FernandezC , NellaAA , HoppR , CasaleT , GallagherC . The relationship of vitamin D and asthma in children. Journal of Allergy and Clinical Immunology2011;127(2):AB262. ">Lewis 2012</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Exacerbation not defined or reported in study manuscript</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011511-bbs2-0013" title="MajakP , JerzyiskaJ , SmejdaK , StelmachI , TimlerD , StelmachW . Correlation of vitamin D with Foxp3 induction and steroid-sparing effect of immunotherapy in asthmatic children. Annals of Allergy, Asthma and Immunology2012;109(5):329-35. MajakP , RychlikB , StelmachI . The effect of oral steroids with and without vitamin D3 on early efficacy of immunotherapy in asthmatic children. Clinical and Experimental Allergy2009;39(12):1830-41. ">Majak 2009</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Exacerbation not defined or reported in study manuscript; authors confirmed that no exacerbations requiring systemic corticosteroid treatment occurred in the study </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011511-bbs2-0014" title="MajakP , Olszowiec-ChlebnaM , SmejdaK , StelmachI . Vitamin D supplementation in children may prevent asthma exacerbation triggered by acute respiratory infection. Journal of Allergy and Clinical Immunology2011;127(5):1294-6. ">Majak 2011</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Reported but not defined in study manuscript; authors confirmed that no exacerbations requiring systemic corticosteroid treatment occurred in the study </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011511-bbs2-0015" title="MartineauAR , MacLaughlinBD , HooperRL , BarnesNC , JolliffeDA , ChoudhuryAB , et al. Double-blind multi-centre randomised controlled trial of vitamin D3 supplementation in adults with inhaled corticosteroid-treated asthma (ViDiAs). Thorax2014;69:A51-2. MartineauAR , MacLaughlinBD , HooperRL , BarnesNC , JolliffeDA , GreillerCL , et al. Double-blind randomised placebo-controlled trial of bolus-dose vitamin D3 supplementation in adults with asthma (ViDiAs). Thorax2015;70(5):451-7. ">Martineau 2015</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Deterioration in asthma resulting in (A) treatment with oral corticosteroids, or (B) hospital admission or emergency department treatment, or (C) decrease in the morning PEFR to more than 25% below the mean run‐in value on 2 or more consecutive days </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011511-bbs2-0017" title="TachimotoH , MezawaH , SegawaT , AkiyamaN , IdaH , UrashimaM . Improved control of childhood asthma with low-dose, short-term vitamin D supplementation: a randomized, double-blind, placebo-controlled trial. Allergy2016;71(7):1001-9. ">Tachimoto 2016</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Worsening of asthma symptoms prompting a need for a change in asthma treatment (from authors) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD011511-bbs2-0018" title="ThakurC , KumarJ , KumarP , GoyalJP , SinghK , GuptaA . Vitamin‐D supplementation as an adjunct to standard treatmentof asthma in children: a randomized controlled trial (ViDASTA Trial). Pediatric Pulmonology2021;56:1427–33. [DOI: 10.1002/ppul.25287]">Thakur 2021</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Reported but not defined in study manuscript</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011511-bbs2-0019" title="UrashimaM , SegawaT , OkazakiM , KuriharaM , WadaY , IdaH . Randomized trial of vitamin D supplementation to prevent seasonal influenza A in school children. American Journal of Clinical Nutrition2010;91(5):1255-60. ">Urashima 2010</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Asthma attack that included wheezing, improved by inhalation of a beta‐stimulant in participants who already had a diagnosis of asthma; authors confirmed that no exacerbations requiring systemic corticosteroid treatment occurred in the study </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011511-bbs2-0020" title="YadavM , MittalK . Effect of vitamin D supplementation on moderate to severe bronchial asthma. Indian Journal of Pediatrics2014;81(7):650-4. ">Yadav 2014</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Reported but not defined in study manuscript</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="2"> <div class="table-footnote"> <p>FEV1, forced expiratory volume in one second; PEFR, peak expiratory flow rate.</p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Definitions of asthma exacerbation used in primary trials</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011511.pub3/full#CD011511-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD011511-tbl-0004"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Vitamin D versus placebo</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.1 Proportion of participants with one or more exacerbations treated with systemic corticosteroids <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>14</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1778</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.04 [0.81, 1.34]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.2 Rate of exacerbations treated with systemic corticosteroids <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1599</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Rate Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.86 [0.62, 1.19]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.3 Time to first exacerbation treated with systemic corticosteroids <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>850</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Hazard Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.82 [0.59, 1.15]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.4 Proportion of participants with one or more exacerbations requiring systemic corticosteroids (stratified by baseline 25[OH]D) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1274</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.99 [0.74, 1.33]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.4.1 Baseline 25(OH)D &lt; 25 nmol/L (10 ng/ml)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>198</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.78 [0.15, 3.96]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.4.2 Baseline 25(OH)D 25 to 49.9 nmol/L (10 to 19.9 ng/ml)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>515</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.91 [0.57, 1.44]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.4.3 Baseline 25(OH)D 50 to 74.9 nmol/L (20 to 29.9 ng/ml)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>419</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.16 [0.60, 2.25]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.4.4 Baseline 25(OH)D ≥ 75nmol/L (30 ng/ml)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>142</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.98 [0.49, 1.95]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.5 Proportion of participants with one or more exacerbations requiring systemic corticosteroids (stratified by daily dose equivalent) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1134</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.13 [0.81, 1.58]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.5.1 ≤ 2000</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>942</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.13 [0.75, 1.69]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.5.2 &gt; 2000</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>192</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.15 [0.63, 2.07]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.6 Rate ratio, exacerbations requiring systemic corticosteroids (stratified by vitamin D type) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1599</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Rate Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.86 [0.62, 1.19]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.6.1 Vitamin D3 (cholecalciferol) only</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1487</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Rate Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.93 [0.68, 1.28]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.6.2 Calcidiol only</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>112</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Rate Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.43 [0.22, 0.82]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.7 Proportion of participants with one or more exacerbations treated with systemic corticosteroids (stratified by dosing regimen) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1712</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.16 [0.92, 1.47]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.7.1 Daily dosing</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1201</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.23 [0.91, 1.66]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.7.2 Monthly or greater than monthly bolus dosing</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>511</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.09 [0.68, 1.77]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.8 Proportion of participants with one or more exacerbations requiring systemic corticosteroids (stratified by age) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>14</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1778</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.04 [0.81, 1.34]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.8.1 age &lt; 5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>69</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.15 [0.82, 5.64]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.8.2 age 5 to 16</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>837</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.28 [0.83, 1.97]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.8.3 Adults</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>872</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.85 [0.58, 1.24]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.9 Proportion of participants with one or more exacerbations treated with systemic corticosteroids (excluding trials at unclear risk of bias) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1365</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.96 [0.71, 1.30]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.10 Proportion of participants with one or more exacerbation as defined in primary trials (excluding trials at high risk of bias) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1439</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.90 [0.62, 1.30]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.11 Proportion of participants with one or more exacerbations treated with systemic corticosteroids (risk difference) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>14</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1778</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.00 [‐0.02, 0.03]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.12 Proportion of participants with one or more exacerbations requiring emergency department visit or hospitalisation, or both <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1070</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.56 [0.26, 1.21]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.13 End‐study C‐ACT/ACT score <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1271</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.23 [‐0.26, 0.73]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.14 End‐study FEV1, % predicted <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1286</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.20 [‐1.24, 1.63]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.15 Proportion of participants with one or more serious adverse events due to any cause <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1556</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.89 [0.56, 1.41]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.16 Proportion of participants with fatal asthma exacerbation <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>16</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1976</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.00 [‐0.01, 0.01]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.17 Proportion of participants with one or more exacerbation as defined in primary trials <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1539</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.77 [0.51, 1.17]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.18 % eosinophils, lower airway <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>525</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.38 [‐1.92, 1.15]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.19 End‐study log 10 total IgE, IU/ml <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>366</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.07 [‐0.13, 0.26]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.20 End‐study FVC, % predicted <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>476</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.84 [‐3.60, 7.29]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.21 End‐study PEFR (L/min) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>476</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>4.84 [‐8.95, 18.62]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.22 Withdrawals from trial <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>20</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2225</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.05 [0.77, 1.43]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.23 Withdrawals from trial (excluding trials at high risk of bias) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>17</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2003</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.11 [0.80, 1.53]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Vitamin D versus placebo</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011511.pub3/references#CD011511-tbl-0004">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD011511.pub3&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="de#CD011511-note-0007">Deutsch</a> </li> <li class="section-language"> <a class="" href="es#CD011511-note-0012">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD011511-note-0016">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD011511-note-0011">Français</a> </li> <li class="section-language"> <a class="" href="id#CD011511-note-0017">Bahasa Indonesia</a> </li> <li class="section-language"> <a class="" href="ja#CD011511-note-0015">日本語</a> </li> <li class="section-language"> <a class="" href="ko#CD011511-note-0009">한국어</a> </li> <li class="section-language"> <a class="" href="ms#CD011511-note-0010">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="pl#CD011511-note-0018">Polski</a> </li> <li class="section-language"> <a class="" href="ro#CD011511-note-0019">Română</a> </li> <li class="section-language"> <a class="" href="ru#CD011511-note-0008">Русский</a> </li> <li class="section-language"> <a class="" href="zh_HANS#CD011511-note-0013">简体中文</a> </li> <li class="section-language"> <a class="" href="zh_HANT#CD011511-note-0014">繁體中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734064000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734064000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772746000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011511\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011511\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011511\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD011511\x2epub3"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011511\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011511\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011511\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011511\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011511\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD011511\x2epub3"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011511\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011511\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011511\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD011511\x2epub3"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011511\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011511\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011511\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD011511\x2epub3"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=STpJR8yz&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD011511.pub3&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD011511.pub3';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD011511.pub3/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD011511.pub3/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD011511.pub3%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740714601263"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD011511.pub3/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740714601267"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD011511.pub3/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918d72a93b86937f',t:'MTc0MDcxNDYwMS4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 